<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/atom10full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:openSearch="http://a9.com/-/spec/opensearchrss/1.0/" xmlns:georss="http://www.georss.org/georss" xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr="http://purl.org/syndication/thread/1.0" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0"><id>tag:blogger.com,1999:blog-9029913</id><updated>2012-05-31T22:12:59.146-04:00</updated><category term="treatment options" /><category term="high grade serous" /><category term="microlaparoscope" /><category term="China" /><category term="journal of medicine and the person" /><category term="keyhole surgery" /><category term="forecasting" /><category term="newly diagnosed" /><category term="honest" /><category term="care" /><category term="nras" /><category term="sebaceus carcinoma" /><category term="Nanotax" /><category term="postmenopausal hormone therapy" /><category term="Peutz–Jeghers syndrome" /><category term="Developing Evidence to Inform Decisions About Effectiveness" /><category term="anxiety" /><category term="near misses" /><category term="endoscopist" /><category term="work hours" /><category term="metaplasia" /><category term="PMH" /><category term="differential diagnosis" /><category term="postoperative" /><category term="IV/IP ovarian" /><category term="carcinosarcoma" /><category term="penetrant genes" /><category term="fibromyalgia syndrome" /><category term="genetic" /><category term="pregnant" /><category term="top 5 blog" /><category term="alternative medicine" /><category term="home hospice" /><category term="online ratings" /><category term="papillary serous ovarian" /><category term="nerve-sparing surgery" /><category term="OCAC" /><category term="psychosocial cancer care" /><category term="prognostic variable" /><category term="enterocolitis" /><category term="abstract index" /><category term="genetic information" /><category term="postmenopause" /><category term="websites" /><category term="nonrandomized trials" /><category term="ovarian carcinoid" /><category term="family healthware impact trial" /><category term="NCCN" /><category term="intraoperative electron beam radiation therapy" /><category term="Nodular Histiocytic Aggregates" /><category term="Columbia" /><category term="TGen" /><category term="molecular biology" /><category term="short duration" /><category term="oncology nurse" /><category term="post-diagnosis" /><category term="post adjuvant therapy" /><category term="medical teaching" /><category term="venous thromboembolism" /><category term="venlafaxine" /><category term="saskatoon" /><category term="cutaneous squamous cell carcinomas" /><category term="sgo annual meeting 2012" /><category term="dendritic cells" /><category term="RNA.treatment" /><category term="longterm followup" /><category term="heated chemo" /><category term="systems" /><category term="Altuzan" /><category term="NCCS" /><category term="orientation" /><category term="liposomal doxorubicin" /><category term="cancer patients genetics breast colorectal ovarian health" /><category term="attitude" /><category term="patient advisory committee" /><category term="ICT" /><category term="B1 2536" /><category term="caboplatin" /><category term="genetic risk" /><category term="surgery  gastrointestinal" /><category term="visual loss" /><category term="failure to diagose" /><category term="genetic risk assessment" /><category term="photoacoustic imaging" /><category term="ePrognosis" /><category term="doxorubicin" /><category term="compassion" /><category term="annual conference" /><category term="miR-428" /><category term="Cary Vera Garcia" /><category term="copay" /><category term="genetic records" /><category term="index" /><category term="Prediction" /><category term="vaccines" /><category term="low grade serous" /><category term="oncogene" /><category term="imatinib" /><category term="gene cards" /><category term="RT. benefit" /><category term="Professional-patient relations; recurrence" /><category term="drug drug interactions" /><category term="teal" /><category term="IVF" /><category term="triple negative" /><category term="canadian provinces" /><category term="predictions" /><category term="OCRA" /><category term="stromal ovarian cancer" /><category term="IL-2" /><category term="rare disease clinical trials" /><category term="teratoma" /><category term="miR-429" /><category term="cardiology" /><category term="postmenopausal cysts" /><category term="chocolate" /><category term="japanese" /><category term="Decoding Annie Parker" /><category term="compassionate allowances" /><category term="acute abdominal venous thrombosis" /><category term="IL-3" /><category term="Healthlinx" /><category term="genetic analysis" /><category term="mesenteric infarction" /><category term="Mayo" /><category term="cancer progress timeline" /><category term="hvo" /><category term="Bristow" /><category term="cardiac" /><category term="community oncology programs" /><category term="GPX3" /><category term="phase 1 clinical trials" /><category term="research programs" /><category term="hype hope reality gap cancer" /><category term="high mortality rate cancers" /><category term="flavonoid" /><category term="robotic" /><category term="multiresistant" /><category term="non-serous" /><category term="radiologists" /><category term="RMI" /><category term="pharmactist" /><category term="bankruptcy" /><category term="Oncotech" /><category term="melena" /><category term="regulation" /><category term="diverticulosis" /><category term="tumor resistance" /><category term="worldwide clinical trials" /><category term="restless leg syndrome" /><category term="symptomatic ovarian cancer" /><category term="chemotherapy" /><category term="cryopreservation" /><category term="complimentary therapies" /><category term="simple cysts" /><category term="restaging" /><category term="familial pancreatic syndrome" /><category term="initial" /><category term="IL-1" /><category term="Li-Fraumeni syndrome" /><category term="pseudotumor" /><category term="ileus" /><category term="eva trial" /><category term="international genome consortium" /><category term="NIH clinical trials" /><category term="Imipramine" /><category term="2011" /><category term="FIGO" /><category term="blood" /><category term="unknown clinical significance" /><category term="ROCA" /><category term="chemotherapeutic errors" /><category term="IP clinical trial" /><category term="brca clinical trial" /><category term="private clinics" /><category term="flu" /><category term="panniculitis" /><category term="CD56" /><category term="decison-making" /><category term="CYP2D6" /><category term="fatal" /><category term="markman" /><category term="hospital ratings" /><category term="slogans" /><category term="complementary therapies" /><category term="vietnam" /><category term="videos" /><category term="2010" /><category term="ExAblate" /><category term="staging system" /><category term="appendiceal" /><category term="hospital safety" /><category term="cancer survivorshipm" /><category term="U.S. colonoscopy" /><category term="latino women" /><category term="retreat" /><category term="weekly" /><category term="KRAS" /><category term="Calypso trial" /><category term="Bethesda" /><category term="glucocorticoids" /><category term="over diagnoses" /><category term="aspirin" /><category term="diagnosis" /><category term="U.S." /><category term="patient portal" /><category term="2009" /><category term="misinterpretation" /><category term="collaboration" /><category term="terry fox" /><category term="editorial" /><category term="self reported" /><category term="alberta guidelines" /><category term="Quebec" /><category term="IL-13Rα2" /><category term="9p22.s" /><category term="RNA" /><category term="hMSH2" /><category term="IAPO" /><category term="effective health care program" /><category term="re-operation rates" /><category term="Capecitabine" /><category term="hormone" /><category term="healthcare canada" /><category term="HGG" /><category term="adolescents" /><category term="open access" /><category term="F-18 FDG PET/CT" /><category term="Lee" /><category term="north american breast cancer group" /><category term="benign disease" /><category term="Canada presentation" /><category term="genetics" /><category term="irinotecan" /><category term="oncimmune" /><category term="endoscopic gynecologic surgery" /><category term="hereditary risk recall" /><category term="2007" /><category term="interative" /><category term="brca1 brca1" /><category term="personalized therapy" /><category term="BIBF 1120" /><category term="text" /><category term="patient advocate foundation" /><category term="warfarin" /><category term="opinion" /><category term="million women study" /><category term="caregivers" /><category term="8765delAG" /><category term="stand up to cancer" /><category term="2006" /><category term="expert opininon journal" /><category term="ama" /><category term="Technorati Tags: ca125" /><category term="swallowing" /><category term="hypertermia" /><category term="consumer" /><category term="variants of uncertain signifcants" /><category term="CHEK1" /><category term="London" /><category term="Ovarian steroid cell tumor" /><category term="ovarian sex cord tumor" /><category term="low level CA125" /><category term="physician awareness" /><category term="oral cancer" /><category term="splenectomy" /><category term="EGF" /><category term="Dee" /><category term="barrier" /><category term="health care systems" /><category term="medical homes" /><category term="endometrial" /><category term="whole abdominal radiation therapy" /><category term="social status" /><category term="CHEK2" /><category term="voice" /><category term="prognostics" /><category term="Cancer Australia" /><category term="misdiagnose" /><category term="steven lewis" /><category term="world cancer day" /><category term="biologic" /><category term="kimberly-clark" /><category term="robert wood johnson foundation" /><category term="frozen section" /><category term="population" /><category term="ovarian cancer survivours" /><category term="pre existing condition insurance plans" /><category term="colo-rectal" /><category term="angiotensin receptor blockers" /><category term="clinical trial toronto" /><category term="hromone prevention" /><category term="vitamin b6" /><category term="CA125 Antigen; CA-125" /><category term="residual" /><category term="t cells" /><category term="CA125; Surveillance; CA-125" /><category term="clinical trial funding" /><category term="D.C." /><category term="Gynecologic Oncologists" /><category term="extreme suffering" /><category term="well being" /><category term="androgens" /><category term="inequality" /><category term="cleveland clinic" /><category term="sex-cord stromal" /><category term="gene patents" /><category term="single agent pegylated liposomal doxorubicin" /><category term="cancer survivors" /><category term="young adults" /><category term="leg cramps" /><category term="breast surgery" /><category term="male breast cancer" /><category term="granulocyte macrophage colony-stimulating factor" /><category term="negative trials" /><category term="adenocarcinoma" /><category term="risk second primary breast" /><category term="bilateral prophylactic mastectomy" /><category term="familial colorectal cancer type X" /><category term="oral nutrition" /><category term="HGM" /><category term="lipid levels" /><category term="FOXL2" /><category term="firefox" /><category term="interactive map" /><category term="the art of oncology" /><category term="performance measures" /><category term="Nestle" /><category term="combination drugs" /><category term="Alzheimer" /><category term="lhin" /><category term="PCORI" /><category term="Lotocki" /><category term="reports" /><category term="surgical ligatures" /><category term="primary peritoneal" /><category term="mortality" /><category term="data privacy" /><category term="tinnitus" /><category term="end of life care" /><category term="malignant colonic obstruction" /><category term="comprehension" /><category term="premm" /><category term="single agent" /><category term="Phytochemicals" /><category term="gynecologic foundation" /><category term="oncofertility" /><category term="research partnership" /><category term="tyrosine kinase inhibitors" /><category term="stats" /><category term="markers" /><category term="womens college hospital" /><category term="turquoise" /><category term="request" /><category term="interprofessional care" /><category term="ontario government" /><category term="personalized medicine coalition" /><category term="variants of unknown significance" /><category term="immune therapy" /><category term="physician-patient communication" /><category term="allele" /><category term="self-pay" /><category term="ovarian cancer canada" /><category term="older patients" /><category term="barbie" /><category term="outpatient surgery" /><category term="ICGC data portal" /><category term="considerations" /><category term="middle income" /><category term="grieving" /><category term="patient access" /><category term="dna methylation" /><category term="Andre Picard" /><category term="advanced breast cancer" /><category term="intraparenchymal" /><category term="provincial guidelines" /><category term="sex cord-stromal" /><category term="post traumatic stress disorder" /><category term="acupuntcure" /><category term="pap" /><category term="weeks" /><category term="not optimal" /><category term="psychostimulants" /><category term="desprate" /><category term="after cancer" /><category term="offspring mortality" /><category term="premature ovarian failure" /><category term="matching service" /><category term="cancer related" /><category term="menopause international" /><category term="Barb" /><category term="hereditary breast and ovarian" /><category term="postoperative ileus" /><category term="Benivegna" /><category term="residual disease" /><category term="carcinosarcomas" /><category term="ovarian cancer and us opinion" /><category term="foregiveness" /><category term="women of teal" /><category term="ear damage" /><category term="ellence" /><category term="washington post" /><category term="anticoagulation" /><category term="endometriod" /><category term="canadian patient safety" /><category term="oral etoposide" /><category term="mammograms" /><category term="Immunovaccine" /><category term="art of oncology series" /><category term="hypothermia" /><category term="second surgery" /><category term="FORCE" /><category term="physicians" /><category term="calcium and magnesium" /><category term="Linus Pauling Institute" /><category term="popular" /><category term="critique" /><category term="MGH" /><category term="Environmental exposures" /><category term="listserv" /><category term="high dose" /><category term="risk factors" /><category term="david haas" /><category term="hypomotility" /><category term="NaPi2b" /><category term="surveillance" /><category term="histologic" /><category term="RLS" /><category term="reduction" /><category term="AEZS-108" /><category term="bladder" /><category term="Cetuximab" /><category term="acute" /><category term="unexpected deaths" /><category term="oral" /><category term="Laurie Singer Sievers" /><category term="risk reduction" /><category term="complicatons" /><category term="quality care" /><category term="aetna" /><category term="fast track" /><category term="Pemetrexed" /><category term="plos blog" /><category term="questionnaires" /><category term="rs1649942" /><category term="PFPS" /><category term="policy canada" /><category term="uterus" /><category term="anaesethesia" /><category term="divisions" /><category term="progressive disease" /><category term="free clinic" /><category term="asthma" /><category term="juvenile granulosa" /><category term="ovarian cancer recurrence" /><category term="health policy" /><category term="methylation" /><category term="BAF250a" /><category term="new drugs" /><category term="financial hardship" /><category term="ovarian remnants" /><category term="newreel" /><category term="bile duct" /><category term="gene tests" /><category term="tumor samples" /><category term="Thromboprophylaxis" /><category term="clincial trials mailing list healthcare professionals" /><category term="comparitive effectiveness research" /><category term="James Lind Alliance" /><category term="Austria" /><category term="miR 21" /><category term="chronic illness" /><category term="hopenet" /><category term="tumour spread" /><category term="define" /><category term="extrapancreatic malignancies" /><category term="ovarian cancer litigation" /><category term="facing our risk" /><category term="cancer screening" /><category term="age of onsetLynch Syndrome" /><category term="self seeding cancer cells" /><category term="Oklahoma" /><category term="NICE guidelines" /><category term="patient summaries" /><category term="pharmacology" /><category term="educate" /><category term="INNO-206" /><category term="apology" /><category term="insured patients" /><category term="NY-ESO-1" /><category term="minor errors" /><category term="ovarian cancer subtypes" /><category term="lesbians" /><category term="selumetinib" /><category term="ghostwriting" /><category term="bone mineral density" /><category term="stresses" /><category term="eating" /><category term="UELS" /><category term="doctor's notes" /><category term="characteristics" /><category term="Sunesis" /><category term="uroepithelial tract" /><category term="microsatellite" /><category term="management" /><category term="job posting" /><category term="predicitive" /><category term="melanoma of genital tract" /><category term="constipation" /><category term="don berwick" /><category term="side effects" /><category term="histopathology" /><category term="chemotherapy induced" /><category term="Womens Oncology Research and Dialogue" /><category term="upgrading" /><category term="socio-economic status" /><category term="GCT" /><category term="Lipodox" /><category term="top U.S. hospitals" /><category term="magic mushrooms" /><category term="diagnostics; Urine; HE4" /><category term="inappropriate tests" /><category term="credit" /><category term="low volume hospitals" /><category term="paternalsim" /><category term="abandoned" /><category term="imaging errors" /><category term="survival estimates" /><category term="drug companies" /><category term="single chain variable fragments" /><category term="world trade center" /><category term="clinical trials canada" /><category term="cancer mortality" /><category term="pre-counselling" /><category term="IP taxol" /><category term="electrosurgery" /><category term="multivitamins" /><category term="cancer related diseases" /><category term="pinterest" /><category term="reproductive age group" /><category term="suicide" /><category term="chronic pain" /><category term="ovarian cancers" /><category term="caelyx" /><category term="double heliz" /><category term="health insurance" /><category term="patient groups" /><category term="mini review" /><category term="copyrighting" /><category term="academic publishing" /><category term="anti-angiogenesis" /><category term="supplements" /><category term="primary surgery" /><category term="IP/IV" /><category term="annual ovarian cancer conference" /><category term="Elesclomol" /><category term="genetic test results" /><category term="memories" /><category term="scFvs" /><category term="adenomas" /><category term="centralized care" /><category term="laptops" /><category term="Kentucky" /><category term="CO-338" /><category term="tumor suppressor genes" /><category term="Mesothelium" /><category term="GCS" /><category term="nausea" /><category term="assays" /><category term="reunion" /><category term="Lapatinib" /><category term="molecular profiling clinical trial" /><category term="relevant therapy" /><category term="tmor specimens" /><category term="longterm survivors" /><category term="Breakaway from Cancer" /><category term="stockings" /><category term="Texas" /><category term="economics" /><category term="brca survival rates" /><category term="malignancy" /><category term="history" /><category term="ototoxicity" /><category term="2012 conference" /><category term="north american native" /><category term="web based learning module" /><category term="DPX-0907" /><category term="isoflavones" /><category term="aspiring" /><category term="abdomen" /><category term="genome" /><category term="electronic medical records" /><category term="pre-menpausal" /><category term="estrogen" /><category term="surgery outcomes" /><category term="intergroup" /><category term="two step" /><category term="video" /><category term="germany" /><category term="surgeons" /><category term="symptom tracking" /><category term="ovarian cancer epidemiology" /><category term="WHI" /><category term="prognostic disclosure" /><category term="ovarian carcinoid tumor" /><category term="south africa" /><category term="saskatchewan" /><category term="thermography" /><category term="blog stats" /><category term="accidental findings" /><category term="serous ovarian cancer" /><category term="legally binding" /><category term="international" /><category term="hormonal contraception" /><category term="urothelial carcinoma" /><category term="GCIG" /><category term="Keywords: CASP8; Epithelial ovarian cancer; Polymorphism; Genetic association" /><category term="recurrent ovarian cancer" /><category term="primary ovarian trabecular carcinoid" /><category term="RapidArc" /><category term="high grade" /><category term="intraperionteal" /><category term="gastrointestinal perforation" /><category term="human cell environment" /><category term="race" /><category term="Libby" /><category term="ablative radiation" /><category term="germ cell ovarian" /><category term="breast density" /><category term="cancer registry" /><category term="Hereditary breast and ovarian cancer syndrome" /><category term="endometrioid borderline ovarian cancer" /><category term="surrogates" /><category term="top doctors" /><category term="integrated care" /><category term="high platelets" /><category term="offspring mortality risk" /><category term="minimally invasive surgery" /><category term="mutations" /><category term="breast cancer detection" /><category term="informed decision making" /><category term="ancestry" /><category term="underdiagnosis" /><category term="access" /><category term="vido" /><category term="cancer subtypes" /><category term="metachronous" /><category term="guidelines international network conference" /><category term="realistic" /><category term="Rosiglitazone" /><category term="desparate" /><category term="nursing" /><category term="pbs" /><category term="neuromotor" /><category term="family planning" /><category term="Clarke-Pearson" /><category term="fallopian tube" /><category term="Hawaii" /><category term="endometrioid ovarian cancer" /><category term="discrimination" /><category term="POU5F1" /><category term="red tape" /><category term="Sean Patrick" /><category term="Docetaxel; Abdominal radiation; Chemosensitizer; ovarian cancer" /><category term="mademoiselle" /><category term="noninvasive" /><category term="ovarian cancer search engine" /><category term="gender" /><category term="immune system" /><category term="Trastuzamab" /><category term="lynch syndrome associated cancers" /><category term="attitudes" /><category term="colorectal cancer metastases to ovary" /><category term="synthroid" /><category term="liposomes" /><category term="late stage" /><category term="surgical education" /><category term="supportive care needs" /><category term="first primary" /><category term="oncology closures" /><category term="cell types" /><category term="gerson" /><category term="human spirit" /><category term="Intrapleural paclitaxel" /><category term="Symptoms; Assessment;  intensity" /><category term="body size" /><category term="lupus" /><category term="Transmucosal" /><category term="miR-410" /><category term="JCO" /><category term="black box" /><category term="occult cancers" /><category term="specialized gyn cancer centers" /><category term="FIT protocol.Forsythe" /><category term="ovarian cancer symptoms" /><category term="annual statement" /><category term="walking" /><category term="canadian doctors for medicare" /><category term="arbitration" /><category term="NCCAM" /><category term="phosphate" /><category term="vasectomy" /><category term="Leslie Worthington" /><category term="XRT" /><category term="IN-CAM" /><category term="older" /><category term="nintedanib" /><category term="war on cancer" /><category term="sopa" /><category term="cervical" /><category term="Rucaparib" /><category term="IFN-γ" /><category term="MD Anderson" /><category term="calcijex" /><category term="oral anticoagulation" /><category term="ovarian cancer alliance Ohio" /><category term="WHO" /><category term="small bowel" /><category term="crisis" /><category term="PLD" /><category term="CYP3A4" /><category term="delays" /><category term="fighting spirit" /><category term="word of hope" /><category term="health care costs" /><category term="ombudsman" /><category term="HDAC" /><category term="erythropoietin" /><category term="breast colorectal ovarian" /><category term="cancer type" /><category term="mind body medicine" /><category term="procedures" /><category term="Time Magazine" /><category term="ovarian small-cell" /><category term="standardized patients" /><category term="doctor appointments" /><category term="risk malignancy index" /><category term="endocriniology" /><category term="G-I-N" /><category term="W5" /><category term="VT" /><category term="GOG-0262" /><category term="handouts" /><category term="bethesda guidelines" /><category term="duty" /><category term="MMP7" /><category term="Paxil" /><category term="Opaxio" /><category term="first cycle chemotherapy" /><category term="IBC" /><category term="goff" /><category term="book" /><category term="antioxidant" /><category term="chemosuppressant" /><category term="Claudin 5" /><category term="passion" /><category term="natural history" /><category term="Australia Canada" /><category term="breast implants" /><category term="conglomerates" /><category term="Paclitaxel" /><category term="pleural catheter" /><category term="participants" /><category term="alchohol" /><category term="chemoprevention" /><category term="strangers" /><category term="patient data" /><category term="OCAN" /><category term="polyps" /><category term="money" /><category term="definitive radiation therapy" /><category term="hormonal therapy" /><category term="endo of life care" /><category term="prediagnostic" /><category term="news" /><category term="MK4827" /><category term="gilbert" /><category term="ascites" /><category term="twins" /><category term="TDP-B" /><category term="gynaecologic" /><category term="mixed cell histology" /><category term="criteria" /><category term="awards voice spirit cancer survivor ovarian" /><category term="genome web" /><category term="RECIST" /><category term="migraines" /><category term="TDP-A" /><category term="genetic data" /><category term="self referrals" /><category term="RAD51D" /><category term="contradicitons" /><category term="thrombocytopenia" /><category term="5382insC" /><category term="practical consideration" /><category term="evolutin" /><category term="Lovastatin" /><category term="bleomycin" /><category term="sterotactic radiosurgery" /><category term="genomics research" /><category term="NDP" /><category term="complex cyst" /><category term="oncolytics biotech" /><category term="ovarian cancer examples" /><category term="RAD51C" /><category term="heart failure" /><category term="clinical trials" /><category term="CA125; endometriosis" /><category term="the underwear affair" /><category term="vitamin D" /><category term="mixed cell types" /><category term="conferences" /><category term="oral mucositis" /><category term="Arrayit" /><category term="European Journal of Medical Research" /><category term="awareness day" /><category term="Orac" /><category term="counselling" /><category term="DVT" /><category term="DS-3078a" /><category term="diagnostics" /><category term="early discontinuation" /><category term="BRIP1" /><category term="Malignant ascites; Paracentesis; Diuretics; Intraperitoneal chemotherapy; Bispecific antibodies; Antiangiogenetic agents; Biological therapies" /><category term="palliative surgery" /><category term="cancer outcomes" /><category term="HER2 gene" /><category term="colonic stents" /><category term="circulating cancer cells" /><category term="genetic tests" /><category term="brentuximab" /><category term="vitamin E" /><category term="AJCC" /><category term="Promestriene" /><category term="ihi" /><category term="AHA" /><category term="G-CSF" /><category term="gyn cancer" /><category term="Rebecca Esparza" /><category term="mixed ovarian carcinomas" /><category term="asbestos" /><category term="spirtual care" /><category term="Hot flushes" /><category term="liver tumors" /><category term="decision-making" /><category term="cancer vaccines" /><category term="ovarian cancer national alliance" /><category term="sex cord" /><category term="curetoday" /><category term="ovarian" /><category term="hypersenitivity" /><category term="RCCA" /><category term="dietary fiber" /><category term="free trial" /><category term="standard of care" /><category term="uterine fibroids" /><category term="debbie" /><category term="pictures" /><category term="serous cell type" /><category term="origins ovarian cancer" /><category term="biomarkers" /><category term="tumor markers" /><category term="mixed mesodermal" /><category term="noncarriers" /><category term="Yondelis" /><category term="cutaneous metastases" /><category term="4th grade" /><category term="medications" /><category term="Goldman" /><category term="incidentalome" /><category term="young cancer patients" /><category term="circulating tumor cells" /><category term="chemotherapy induced nausea" /><category term="defining" /><category term="community oncologists" /><category term="hyperthermic intraoperative intraperitoneal chemotherapy" /><category term="safeguards" /><category term="student research" /><category term="abstract" /><category term="antitumor effects" /><category term="young adults with cancer" /><category term="hormonal" /><category term="KRAS mutation" /><category term="lynch syndrome screening" /><category term="immunoproteome" /><category term="histology" /><category term="gynecologists" /><category term="PAX8" /><category term="aromatase inhibitors" /><category term="cancer myths" /><category term="ovarian cancer awareness month March" /><category term="universal pharmacare" /><category term="C6-ceramide" /><category term="newsletter" /><category term="severity" /><category term="symptoms ovarian cancer wrong lancet" /><category term="differentiation" /><category term="monoclonal antibody diagnostics" /><category term="education lynch syndrome" /><category term="dying at home" /><category term="nurse" /><category term="protenuria" /><category term="gulf coast" /><category term="weight loss" /><category term="geyncologic oncology" /><category term="CFS" /><category term="ovarian cancer clinical trials" /><category term="hormone receptor testing" /><category term="beliefs" /><category term="treatment response" /><category term="racial" /><category term="courts" /><category term="FAMM" /><category term="fallopian tube masses" /><category term="peer review" /><category term="shingles" /><category term="Arava" /><category term="FOBT" /><category term="bioethics" /><category term="hazard ratios" /><category term="microRNA-16" /><category term="greg pawelski" /><category term="Anticancer therapy" /><category term="personal genomics" /><category term="healthcare decisions" /><category term="vaccine clinical trial" /><category term="killer t cells" /><category term="drug naming" /><category term="thyroid" /><category term="epimutations" /><category term="advanced directives" /><category term="herbal medicines" /><category term="MLH1" /><category term="uterine cancer" /><category term="Nordic" /><category term="Swenerton" /><category term="Effectiveness" /><category term="patients preferences" /><category term="copayments" /><category term="fda review" /><category term="colorectal  cancer" /><category term="MLH2" /><category term="failure" /><category term="compassion fatigue" /><category term="malignant pleural effusion" /><category term="Octretide" /><category term="sonogram" /><category term="Sandi" /><category term="cancer fundamentals" /><category term="assessment" /><category term="farnesyl transferase inhibitor" /><category term="accountability" /><category term="penn" /><category term="flower" /><category term="patient information" /><category term="targeted agents" /><category term="assistance" /><category term="estrogen receptor" /><category term="CIHR" /><category term="Society" /><category term="stomach" /><category term="warning.Lyrica" /><category term="testosterone" /><category term="system" /><category term="ultra-low-molecular-weight heparin semuloparin" /><category term="bisphosphonates" /><category term="first line chemotherapy" /><category term="spread patterns" /><category term="ABT-767" /><category term="hypercalcemic type" /><category term="electronic patients rights" /><category term="exclusions" /><category term="Dr Orr" /><category term="credibility" /><category term="patient factor" /><category term="whistleblower" /><category term="breast imaging" /><category term="cancer world" /><category term="drug industry" /><category term="biospecimens" /><category term="tracy gorden" /><category term="video-assisted thoracic surgery" /><category term="psychosexual" /><category term="expert opinions" /><category term="tumeric" /><category term="Cediranib" /><category term="OXiGENE" /><category term="gyneacologic" /><category term="c.difficile" /><category term="patient management" /><category term="neuropsychological" /><category term="online poll" /><category term="ovarian cancer information needs" /><category term="nccn guidelines" /><category term="navigator" /><category term="network" /><category term="survivor" /><category term="con side" /><category term="older therapies" /><category term="PI3K Inhibitors" /><category term="transportation industry impairment" /><category term="founder mutation" /><category term="Eisai" /><category term="mice offspring" /><category term="clinical utility card" /><category term="Trinova-1" /><category term="Target Ovarian Cancer Pathfinder study" /><category term="womens health initiative" /><category term="understanding" /><category term="duty of care" /><category term="robotic stereotactic body radiosurgery" /><category term="DIM" /><category term="self monitoring" /><category term="ovarian cancer video" /><category term="prospero" /><category term="european society gynecologic oncology" /><category term="bleeds" /><category term="GOG186H" /><category term="cancer. genetics  common cancers" /><category term="Farletuzumab" /><category term="e-patients" /><category term="2012 familial cancer conference" /><category term="CA-125" /><category term="BRCA" /><category term="gene" /><category term="ischemia" /><category term="disabled" /><category term="RRSO" /><category term="pseudomyxoma peritonei" /><category term="mychart" /><category term="LOVD" /><category term="personalized" /><category term="cancer surgeons" /><category term="LapOvCa-trial" /><category term="Lig4" /><category term="qatar" /><category term="ductal carcinomas in situ" /><category term="androgen" /><category term="19p13.1" /><category term="alternatives" /><category term="markets" /><category term="blood brain barrier" /><category term="hormone treatments" /><category term="ocrf" /><category term="patient reporting" /><category term="searches" /><category term="obstruction" /><category term="Egypt" /><category term="chemoresistant" /><category term="recruiting" /><category term="palliative care training" /><category term="health costs" /><category term="infectious disease" /><category term="chemotherapy induced menopause" /><category term="american cancer society" /><category term="Manitoba" /><category term="public comments" /><category term="XRCC2" /><category term="dietary. phytoestrogens" /><category term="microRNA" /><category term="hyperthermic intraperitoneal intraoperative chemotherapy" /><category term="province" /><category term="humane care" /><category term="asco 2011 abstracts" /><category term="OGX-427" /><category term="physician as typist" /><category term="oncology clinic closures" /><category term="carotenoids" /><category term="retroperitoneal" /><category term="spirtuality" /><category term="INCTR" /><category term="BCl-3" /><category term="tubal intra epithelial" /><category term="Bortezomib" /><category term="silence" /><category term="ice cream" /><category term="QOL oncologists" /><category term="positron Emmission Mammography" /><category term="groups" /><category term="frontiers magazine" /><category term="biobanks" /><category term="Crispin" /><category term="ovarian primary peritoneal cancer risk side effects" /><category term="sexual health" /><category term="off-label" /><category term="non Ashkenazi" /><category term="sepsis" /><category term="impact" /><category term="VCAM-1" /><category term="data standardization" /><category term="health knowledge" /><category term="consumer involvement" /><category term="electronic healthcare records" /><category term="CIHI" /><category term="open books" /><category term="unknowns" /><category term="Illumina" /><category term="personalized medicine" /><category term="internet study" /><category term="transdermal" /><category term="medscape" /><category term="Flexishield" /><category term="canadian patient safety institute" /><category term="Dr Urban" /><category term="quality cancer care" /><category term="glycoprotein" /><category term="myriad.prices" /><category term="breast cancer related genetic testing management" /><category term="early clinical trials" /><category term="10 year followup" /><category term="second opinions" /><category term="PET-CT" /><category term="Holistic Health Research Foundation of Canada" /><category term="topoisomerase 1 inhibitors" /><category term="blood products" /><category term="endocrine" /><category term="failures" /><category term="pew research" /><category term="influenza" /><category term="height" /><category term="prescriptions" /><category term="genome canada" /><category term="genetic mutations" /><category term="healthcare system ontario" /><category term="corporate sponsorship" /><category term="Brydon" /><category term="oral anticoagulants" /><category term="HER" /><category term="Hyperthermic Intraperitoneal Chemotherapy HIPEC" /><category term="high risk" /><category term="clones" /><category term="bowels" /><category term="cochrane reviews" /><category term="exemestane" /><category term="hematuria" /><category term="copy numbers" /><category term="genetic tersting" /><category term="scans" /><category term="GOG-0252" /><category term="cancer indicence" /><category term="participatory evidence" /><category term="vitamin A" /><category term="leadership seminar" /><category term="oral contraceptives" /><category term="Patina" /><category term="dna repair pathways" /><category term="survivorship research" /><category term="trauma" /><category term="ultrasound" /><category term="global pharmacy canada" /><category term="measurement" /><category term="continuity of care" /><category term="patients like me" /><category term="outcomes" /><category term="call for participants" /><category term="nexavar" /><category term="comparisons" /><category term="second primary malignancy" /><category term="serous uterine" /><category term="cancer risk patterns in diabetes" /><category term="low dose" /><category term="Practice Guideline" /><category term="resources" /><category term="ovarian cancer prevention" /><category term="family physician" /><category term="potassium iodide iodine" /><category term="patient empowerment" /><category term="small bowel perforation" /><category term="CD171;     Chemoresistance;     L1CAM antibodies;     Pancreatic cancer;     Ovarian cancer" /><category term="false positives" /><category term="PRECEDENT" /><category term="national patient safety" /><category term="stage borderline" /><category term="Prophylactic Oophorectomy" /><category term="PS-341" /><category term="p53-AAb" /><category term="color Doppler" /><category term="European Cancer Organisation" /><category term="fasting" /><category term="perioperative" /><category term="IV" /><category term="United States" /><category term="Pertuzumab" /><category term="subsequent primary" /><category term="ICGC" /><category term="soy" /><category term="PANVAC" /><category term="premenopausal" /><category term="cancer control canada" /><category term="maligancies" /><category term="personalized cancer therapy" /><category term="cancer care U.S." /><category term="non-enrolment" /><category term="endoscopy" /><category term="PJS" /><category term="ovarian masses" /><category term="benefits" /><category term="slides" /><category term="do not resuscitate" /><category term="risk variants" /><category term="pre test" /><category term="intraperitoneal" /><category term="reporters" /><category term="healthcare services" /><category term="primary ovarian neuroendocrine tumors" /><category term="end of life decisions" /><category term="audits" /><category term="blood donations" /><category term="documentary" /><category term="NVP-BEZ235" /><category term="surrogate decision makers" /><category term="thryoid cancer" /><category term="world health report" /><category term="decision making.legislation" /><category term="Sweden" /><category term="survey" /><category term="participation" /><category term="physician supply" /><category term="gubar" /><category term="general health" /><category term="chemobrain" /><category term="vitamin c" /><category term="Palonosetron" /><category term="adherence" /><category term="anti inflammatory" /><category term="Oncotype" /><category term="cumulative risk" /><category term="Gynecologic cancer; Symptoms; assessment" /><category term="abdominal-pelvic radiotherapy" /><category term="bilateral salpingo-oophorectomy" /><category term="I.P." /><category term="neglect" /><category term="cystic" /><category term="hospital discharge" /><category term="cryopreserved" /><category term="marshall edwards" /><category term="colonoscopy" /><category term="POET/CT" /><category term="stay" /><category term="genetic variation" /><category term="stem cell research" /><category term="sertoli-leydig" /><category term="dose exposure" /><category term="Canfosfamide" /><category term="sentinel nodes" /><category term="socioeconomics" /><category term="bilateral oophorectomy" /><category term="doctor patient relationships" /><category term="fear" /><category term="preimplantation" /><category term="arth-forth" /><category term="micrometastases" /><category term="oligodendrogliomas" /><category term="infections" /><category term="Fox Chase" /><category term="sFANCD2" /><category term="rare cancers" /><category term="hVps37A" /><category term="healthcare systems" /><category term="chemicals" /><category term="professionals" /><category term="sex cord-stromal ovarian" /><category term="virtual follow-up" /><category term="emetogenic" /><category term="older age" /><category term="experts" /><category term="TLE3" /><category term="excedrin" /><category term="PALB2" /><category term="WAPRT" /><category term="ALK7" /><category term="IP" /><category term="low grade" /><category term="cognitive function" /><category term="ethics informed consent" /><category term="heavy lifting" /><category term="drain placement" /><category term="diabetes" /><category term="incidence rates" /><category term="simulation" /><category term="rheumatology" /><category term="blood cell counts" /><category term="meaning of life" /><category term="Belotecan" /><category term="extraovarian endometriosis" /><category term="gynaecologic cancers" /><category term="ENMD-2076" /><category term="fracture" /><category term="inhibitor" /><category term="ruling" /><category term="unknown primary" /><category term="Corticosteroids" /><category term="retractions" /><category term="pet food recalls" /><category term="IN" /><category term="longwoods" /><category term="artificial hydration" /><category term="breast cancer surgery" /><category term="hormone receptor positive" /><category term="concepts" /><category term="cancer advocacy coalition" /><category term="trait" /><category term="labs" /><category term="genitourinary" /><category term="resensitization" /><category term="Wiley-Blackwell" /><category term="TROP-2" /><category term="hospital" /><category term="infection control" /><category term="visits" /><category term="oncologist burnout" /><category term="Thailandespin B" /><category term="burnout" /><category term="sandi pniauskas" /><category term="ascities" /><category term="global health status" /><category term="Ixabepilone" /><category term="early treatment" /><category term="contraceptives" /><category term="media reporting" /><category term="oral carcinoma" /><category term="poultry" /><category term="Canada U.S." /><category term="patient charter of rights" /><category term="large bowel" /><category term="anaemia" /><category term="Thailandespin A" /><category term="interactive medical" /><category term="mothers with cancer" /><category term="physical well being" /><category term="borderline ovarian" /><category term="resistant tumors" /><category term="tracers" /><category term="MMMT" /><category term="diagnostic" /><category term="granulosa ovarian cancer" /><category term="crca" /><category term="NV-128" /><category term="1930" /><category term="FK228" /><category term="OvPlexT" /><category term="$$" /><category term="realites" /><category term="disorders" /><category term="endometrial carcinoma; ovarian carcinoma; PPP2R1A; PP2A; high-grade serous; mutations; uterine carcinoma" /><category term="SYK" /><category term="Kat" /><category term="aromatese inhibitors" /><category term="IP cisplatin" /><category term="trying to please" /><category term="progestins" /><category term="lefunomide" /><category term="aggression" /><category term="references" /><category term="ADZ5363" /><category term="OncoMap" /><category term="johns hopkins" /><category term="guidelines international network" /><category term="too much information" /><category term="recall" /><category term="miR-155" /><category term="who does what" /><category term="bmi" /><category term="uterine" /><category term="vitamin" /><category term="founder mutations" /><category term="ureter" /><category term="OxyContin" /><category term="integrin inhibitors" /><category term="IUD" /><category term="herparin" /><category term="expenses" /><category term="study" /><category term="decreasing progression free survival rates" /><category term="anesthesia" /><category term="african americans" /><category term="data collection" /><category term="HE4" /><category term="studies" /><category term="TYMS rs495139" /><category term="herbal mushrooms" /><category term="phase 11" /><category term="native" /><category term="out of pocket expenses" /><category term="harvard" /><category term="pharma" /><category term="anemia drugs" /><category term="immunohistochemical analysis" /><category term="subpopulations" /><category term="chemosensory alterations" /><category term="lymph node dissection" /><category term="sunshine" /><category term="OCATS" /><category term="pathologic response" /><category term="CancerGEM" /><category term="cure" /><category term="contactless imaging" /><category term="minorities" /><category term="Ted Okon" /><category term="challenge" /><category term="stem cell treatments" /><category term="legal services" /><category term="korea" /><category term="diffusion weighted imaging" /><category term="VATS" /><category term="excuses" /><category term="low dose enhanced CT" /><category term="mixed histology" /><category term="translational research" /><category term="wait times" /><category term="robotic surgery" /><category term="private insurance canada" /><category term="LDL" /><category term="PITX2" /><category term="community cancer centers" /><category term="new lesions" /><category term="consumer rights" /><category term="pleasing" /><category term="OncologyMAP" /><category term="research validity" /><category term="differences" /><category term="other" /><category term="perspective" /><category term="California Teachers Study" /><category term="vintafolide" /><category term="melanoma" /><category term="genetic alterations" /><category term="ultrasound gel" /><category term="BSB4uD" /><category term="protein inhibitor" /><category term="Cancerwise" /><category term="extracolonic" /><category term="tubal ligation" /><category term="plymorphism" /><category term="phase 111b" /><category term="financial reimbursement" /><category term="PMS2" /><category term="IL" /><category term="array testing" /><category term="thompson" /><category term="congestive heart failure" /><category term="Scottish" /><category term="top blogs" /><category term="Caris" /><category term="veliparib" /><category term="patient voices" /><category term="individualization" /><category term="bone marrow" /><category term="natural healing" /><category term="Lowell" /><category term="stem cell" /><category term="borderline tumours" /><category term="university of health network" /><category term="registry" /><category term="CPT-11" /><category term="severely ill" /><category term="Ovarian neoplasms; CA125; Decision-making; Surveillance; HE4" /><category term="psychology" /><category term="liver" /><category term="ZD6474" /><category term="fertility sparing surger" /><category term="audo" /><category term="advances" /><category term="combined HRT" /><category term="Novartis" /><category term="obsturctions" /><category term="sloca" /><category term="risk factors ovarian cancer" /><category term="living" /><category term="polymer micell nanotechnology" /><category term="IP therapy" /><category term="SPORE grant" /><category term="inflammation" /><category term="survival rates" /><category term="trial" /><category term="ovarian cancer ascites" /><category term="Michiana" /><category term="reporting" /><category term="ovarian granulosa" /><category term="survivorship care" /><category term="rectovaginal" /><category term="osteoporosis" /><category term="observations" /><category term="Ohio" /><category term="stem cell transplant" /><category term="miR-335" /><category term="research methods" /><category term="intestinal" /><category term="Ovacom" /><category term="notch signaling pathway" /><category term="carcinomatosis" /><category term="geography" /><category term="pericardiocentesis" /><category term="misclassification" /><category term="research Japan" /><category term="reproductive factors" /><category term="seakers" /><category term="antiangiogenic therapy" /><category term="near death" /><category term="genetic profile" /><category term="cancer survivorship" /><category term="webMD" /><category term="i.p. chemotherapy" /><category term="USA" /><category term="ovarian cancer blogger" /><category term="Arab" /><category term="recalls" /><category term="upper gastro-intestinal" /><category term="type 2" /><category term="c.5266dupC" /><category term="medical research" /><category term="subtype" /><category term="access  fda" /><category term="slow growing" /><category term="brain metastases" /><category term="placebo" /><category term="chinese herbal medicine" /><category term="human experiments" /><category term="cancer control strategy" /><category term="law" /><category term="Wyllie Ohagan" /><category term="clinical trial older ovarian cancer women" /><category term="Tumor interstitial fluid" /><category term="DTC advertising" /><category term="mucin 16" /><category term="braf" /><category term="lucier" /><category term="Britain" /><category term="omega-3" /><category term="recurrance" /><category term="miscarriages" /><category term="conflict of interest" /><category term="Folkman" /><category term="yeast" /><category term="FTY720" /><category term="religion" /><category term="vinblastine" /><category term="calculation" /><category term="national healthcare" /><category term="public policy" /><category term="Teal journal" /><category term="undertreatment" /><category term="warning" /><category term="chemoprotection" /><category term="vancouver" /><category term="mets" /><category term="emesis" /><category term="Toronto" /><category term="ovarian research canada" /><category term="Symptoms;  monitoring" /><category term="physician training" /><category term="web-based education" /><category term="poll" /><category term="fertility preservation" /><category term="women diagnostics nothing healthcare cancer" /><category term="peritoneal effusion" /><category term="clinical research" /><category term="drug shortages canada" /><category term="dna markers" /><category term="hyperthroidism" /><category term="lower extremity" /><category term="presurgical" /><category term="Heat Biologics" /><category term="registration" /><category term="diagnostic tool" /><category term="governments" /><category term="cognition" /><category term="inoperable abdominal tumors" /><category term="23 and me" /><category term="therapy" /><category term="myiad" /><category term="colon cancer" /><category term="Methotrexate" /><category term="floxuridine" /><category term="survivorship studies" /><category term="longterm side effects" /><category term="genomic assay" /><category term="Filgrastim" /><category term="ideas" /><category term="tumours" /><category term="adverse drug reactions" /><category term="clinicopathological" /><category term="practical" /><category term="orphan" /><category term="new generation" /><category term="HIPC" /><category term="dose selection" /><category term="HER2 VRP" /><category term="cancer related cachexia" /><category term="hospital errors" /><category term="canadian healthcare system" /><category term="financing" /><category term="in-hospital mortality" /><category term="single persons" /><category term="advisory" /><category term="FINAVAST" /><category term="somatic" /><category term="option" /><category term="healhcare" /><category term="immunhistochemistry" /><category term="reactions" /><category term="micronutriends" /><category term="underweight" /><category term="specialized centers" /><category term="complimentary" /><category term="granulosa cell tumor;  palliative therapy;  radiotherapy" /><category term="fatigue" /><category term="Shanghai" /><category term="failed" /><category term="out of pocket" /><category term="concierge medicine" /><category term="malignant transformation" /><category term="inhome chemotherapy" /><category term="gamma knife surgery" /><category term="psychological" /><category term="asco 2012" /><category term="ovarian cancer imaging" /><category term="awareness" /><category term="MRR" /><category term="patterns of care" /><category term="parking costs cancer centres" /><category term="asco 2011" /><category term="harper" /><category term="hallmarks of cancer" /><category term="neoadjuvant" /><category term="telemedicine" /><category term="blame" /><category term="biomedical research" /><category term="HDL" /><category term="tp53" /><category term="Carol" /><category term="relevance" /><category term="survivorship planning" /><category term="Prometheus" /><category term="unstudied" /><category term="estrogen therapy" /><category term="patients' voices" /><category term="vasilev" /><category term="false" /><category term="CA 72" /><category term="donate" /><category term="50+ years of age" /><category term="molecular assays" /><category term="systemic" /><category term="consequences" /><category term="Magee Women's Hospital" /><category term="heparin" /><category term="HER2 and mucinous ovarian" /><category term="psychosocial" /><category term="warning letter" /><category term="Ovotax" /><category term="function" /><category term="mmr mutation carriers" /><category term="disparities" /><category term="arginine" /><category term="tv" /><category term="ow bone density" /><category term="government grants" /><category term="Vismodegib" /><category term="subjective" /><category term="symptom burden" /><category term="support360" /><category term="financial information" /><category term="p53 gene" /><category term="trials" /><category term="clusters" /><category term="GTA" /><category term="Pfizer" /><category term="universal healthcare system" /><category term="negative" /><category term="transparency" /><category term="Jewish" /><category term="pancreatectomy" /><category term="hereditary nonpolyposis colorectal cancer" /><category term="Maritimes" /><category term="errors" /><category term="spoptosis" /><category term="annual cancer statistics" /><category term="platinum sensitive" /><category term="changing the health care system" /><category term="port placements" /><category term="santa" /><category term="trial methods" /><category term="Methylphenidate" /><category term="self management" /><category term="cme" /><category term="Pertuzamab" /><category term="CA125" /><category term="multiregion" /><category term="loud and clear" /><category term="treatment related secondary cancers" /><category term="intratumor" /><category term="follow-up" /><category term="colorectal cancer imaging" /><category term="blood transfusions" /><category term="delayed ovarian cancer care" /><category term="amazon" /><category term="immune function" /><category term="physician characteristics" /><category term="European mortality statistics" /><category term="borderline" /><category term="the lab" /><category term="ecnomics" /><category term="MRI" /><category term="simvastin" /><category term="sex." /><category term="presentations" /><category term="rosalind franlin" /><category term="SWOG trial" /><category term="cardiovascular" /><category term="crysopreservation" /><category term="university waterloo" /><category term="malignant cells" /><category term="history of ovarian cancer surgery" /><category term="no mutation" /><category term="goals" /><category term="politician" /><category term="enomics" /><category term="Avastin" /><category term="commentary" /><category term="experiences" /><category term="ras" /><category term="QCRF" /><category term="185delAG" /><category term="dr amit oza" /><category term="ovarian cancer treatments" /><category term="dna tests" /><category term="peer mentoring" /><category term="drug shortage" /><category term="individualized medicine" /><category term="world report" /><category term="clinicopathology" /><category term="accelerated approval" /><category term="ethics" /><category term="dysphagia" /><category term="postage stamp" /><category term="addiction" /><category term="cancer cluster symptoms" /><category term="prostate cancer" /><category term="spices" /><category term="self manage" /><category term="2012 cancer conference" /><category term="quest diagnostics" /><category term="A Monster Calls" /><category term="chemotherapy induced alopecia" /><category term="cancer genetics" /><category term="advanced ovarian cancer" /><category term="2010 conference" /><category term="health news review" /><category term="2012 WCIO conference" /><category term="ovarian cancer newsletter" /><category term="anthropometry" /><category term="canadian healthcare system myths" /><category term="anger" /><category term="critical review" /><category term="correspondence" /><category term="adhesion barrier" /><category term="stem cells" /><category term="adult granulosa ovarian" /><category term="PAI" /><category term="breast cancer survivors" /><category term="health evidence canada" /><category term="sertoli" /><category term="techniques" /><category term="gas-x" /><category term="abdominal swelling" /><category term="ENC105" /><category term="P1K3CA" /><category term="regulations" /><category term="problems" /><category term="sleep disturbances" /><category term="granai" /><category term="gastric cancer" /><category term="DARE" /><category term="Urban" /><category term="red meat" /><category term="Australasia" /><category term="president" /><category term="content" /><category term="poverty" /><category term="education" /><category term="packaging" /><category term="save the patient" /><category term="ovarian squamous" /><category term="Gould" /><category term="loyalty" /><category term="cost effectiveness" /><category term="preferences" /><category term="ports" /><category term="myelosuppression" /><category term="Ethyol" /><category term="lifestyle" /><category term="sleep" /><category term="committee" /><category term="moderate" /><category term="pediatric" /><category term="lactolose" /><category term="proteins" /><category term="investigators" /><category term="graves disease" /><category term="off label" /><category term="folate-receptor" /><category term="Eleftherios Diamandis" /><category term="ethical dilemma" /><category term="stakeholder" /><category term="neuropathic pain" /><category term="Laurie" /><category term="cancer of unknown primary" /><category term="community oncology clinics" /><category term="fluid" /><category term="breast fellowship" /><category term="fibre" /><category term="costs" /><category term="aacr" /><category term="doctor patient communication" /><category term="cassandra experience" /><category term="miracle mineral solution" /><category term="bowel perforation" /><category term="ovarian cysts" /><category term="online physician ratings" /><category term="donations" /><category term="HNPCC" /><category term="calculator" /><category term="hereditary" /><category term="chemotherapy resistance" /><category term="patient file" /><category term="CA125 Antigen; early detection" /><category term="quality of life" /><category term="research grants" /><category term="Gemzar" /><category term="beta-blocker" /><category term="hens" /><category term="telephone genetic testing" /><category term="amalgamate" /><category term="concealment" /><category term="solid tumor clinical trial" /><category term="biologics" /><category term="educator" /><category term="CA-19-9" /><category term="Symptoms; assessment" /><category term="familial risk" /><category term="hope-ology" /><category term="disadvantage" /><category term="older cancer drugs" /><category term="patient decisions" /><category term="UK Collaborative Trial Ovarian Cancer Screening" /><category term="cancer. ovarian" /><category term="ESAS" /><category term="alone" /><category term="screeing" /><category term="DICER1" /><category term="MSKCC" /><category term="canhelp" /><category term="patient seminar" /><category term="L'Oreal" /><category term="leaflets" /><category term="wishes" /><category term="breast cancer study" /><category term="VEGFR-2" /><category term="CUP" /><category term="heath" /><category term="premedication" /><category term="Pazopanib" /><category term="chapter 11" /><category term="Voreloxin" /><category term="neuroendocrine differentiation" /><category term="patient reports" /><category term="conscience clauses" /><category term="triple negative breast cancer" /><category term="treatments" /><category term="Bevacizumab" /><category term="caucasian" /><category term="integrated medicine" /><category term="tungsten particles" /><category term="standardisation" /><category term="Surveillance; Follow-up; FIGO staging; CA-125" /><category term="ME-344" /><category term="Elaine" /><category term="hypercoagulability" /><category term="qigong" /><category term="acrylamide" /><category term="neuro-oncologists" /><category term="GOG 157" /><category term="research awards" /><category term="saliva" /><category term="ovarian cancer mayo management genetics" /><category term="PRD" /><category term="PARP inhibitor" /><category term="feedback" /><category term="patients online" /><category term="heated chemotherapy" /><category term="colorectal cancer" /><category term="interleukin-12" /><category term="miR-200c" /><category term="google fast flip" /><category term="genetic screening" /><category term="natural S-equol" /><category term="6174delT" /><category term="stage" /><category term="combination with cisplatin" /><category term="children" /><category term="google scholar" /><category term="breach" /><category term="research" /><category term="PAF" /><category term="cause" /><category term="unpublished" /><category term="occult" /><category term="patients voice" /><category term="clinical trials funding" /><category term="pelvic pain" /><category term="consumer driven genomics" /><category term="alternative and complimentary medicine" /><category term="back to the future" /><category term="social media postings" /><category term="darbopoetin" /><category term="Uruguay" /><category term="SAVE-ONCO" /><category term="reoperation rates" /><category term="prospective trial" /><category term="jobs" /><category term="perforations" /><category term="comparative effectiveness research" /><category term="glycoproteins" /><category term="clinicians" /><category term="HUG(HUGO) O" /><category term="internal malignancy" /><category term="weight changes" /><category term="E39 peptide" /><category term="PLCO" /><category term="artifacts" /><category term="beneficent" /><category term="erythropoietin-stimulating agents" /><category term="progress" /><category term="metastasis" /><category term="healthcare management" /><category term="sgo white paper" /><category term="oncology drugs" /><category term="patient activation" /><category term="patient charters" /><category term="skin cancers" /><category term="plain text summary" /><category term="wait lists" /><category term="PET scans" /><category term="specialist" /><category term="linkedin" /><category term="renal function" /><category term="deep vein thrombrosis" /><category term="NCI" /><category term="las vegas" /><category term="platinum dna" /><category term="herbal medicine" /><category term="canadian medical association" /><category term="ARBs" /><category term="fistula" /><category term="power imbalance" /><category term="peritoneal carcinomatosis" /><category term="asymptomatic" /><category term="continuous therapy" /><category term="simutation" /><category term="Intraperitoneal Radioimmunotherapy" /><category term="EGFR" /><category term="S. 1674" /><category term="commercialization" /><category term="long term care" /><category term="cancer risks" /><category term="Quest" /><category term="parking" /><category term="scalp cooling" /><category term="rare tumors" /><category term="life expectancy" /><category term="protection" /><category term="molecular" /><category term="patch" /><category term="heterogeneity" /><category term="dna damaging drugs" /><category term="The Eve Appeal" /><category term="cooperative" /><category term="pan-canadian" /><category term="EphA2" /><category term="cats" /><category term="biotech" /><category term="OPN" /><category term="ovarian cancer overview" /><category term="family practice" /><category term="patients notes" /><category term="n-acetyl l-aspartate" /><category term="desmoid tumors" /><category term="intensive care" /><category term="panic" /><category term="secondary care" /><category term="NORD" /><category term="epidemiology" /><category term="hysterectomy" /><category term="naproxen" /><category term="Susan Lowell Butler" /><category term="sleep deprivation" /><category term="bureaucracy" /><category term="OvPlex . UK" /><category term="ATE" /><category term="platinum-resistant" /><category term="communication imaging" /><category term="RAF" /><category term="10 deadliest cancers" /><category term="ginkgo biloba" /><category term="medication events chemotherapy" /><category term="botanical research" /><category term="censorship" /><category term="vulvar" /><category term="Frydman" /><category term="conditional" /><category term="vascular disease" /><category term="decision making" /><category term="salzburg global seminar" /><category term="chemotherapy and patient safety" /><category term="ovarian cancer survivors" /><category term="violations" /><category term="BRCAPRO" /><category term="BMJ" /><category term="alaska" /><category term="radiation oncologist" /><category term="last birth" /><category term="LMP" /><category term="gathering" /><category term="abscess" /><category term="ovarian cancer 2011" /><category term="declaration" /><category term="omentum" /><category term="cancer drug fund" /><category term="teal heart" /><category term="psychsocial" /><category term="goiter" /><category term="rational therapeutics" /><category term="international standards" /><category term="shutterfly" /><category term="rural" /><category term="Reolysin" /><category term="stigmatism" /><category term="tissue specimens" /><category term="cancerworld" /><category term="when" /><category term="Confocal Microendoscopy" /><category term="economics of cancer" /><category term="cancer bureaucracy" /><category term="VDR rs2228570" /><category term="adjuvant" /><category term="twitter" /><category term="gadolinium" /><category term="hedgehog pathway" /><category term="virus" /><category term="empowered patient" /><category term="standards" /><category term="treatment refusal" /><category term="cancergazing" /><category term="doctor-patient" /><category term="SG2000" /><category term="post examination" /><category term="dietary interventions" /><category term="ovarian cancer management" /><category term="continuity care" /><category term="ATM" /><category term="imp;implications" /><category term="Coumadin" /><category term="GOG 0239 trial" /><category term="cachexia" /><category term="MAb B43.13" /><category term="Australia" /><category term="standard" /><category term="surviivorship" /><category term="world conference on interventional oncology" /><category term="healthcare institutions" /><category term="nadir" /><category term="injection" /><category term="MCAT2015" /><category term="Akt" /><category term="warnings" /><category term="natural products" /><category term="patient rights" /><category term="longterm sde effects" /><category term="anatomy" /><category term="kodak" /><category term="aarp" /><category term="seminar" /><category term="minister of health" /><category term="dual primaries" /><category term="hsien-hsien lei" /><category term="bullying" /><category term="ovarian cancer grants" /><category term="FA-BRCA" /><category term="oshawa" /><category term="drug warnings" /><category term="dietary" /><category term="Leiden Variation Database" /><category term="insurance denial" /><category term="dosage" /><category term="Mabcure" /><category term="dna testing" /><category term="articles" /><category term="Bisphosphonate" /><category term="postmarketing studies" /><category term="lymphocyte" /><category term="signoidoscopy" /><category term="Donna Stecker" /><category term="leukemia" /><category term="ovarian tissue" /><category term="concurrent" /><category term="Ketoconazole" /><category term="research UK" /><category term="chinese women" /><category term="analysis" /><category term="womens health matter" /><category term="siRNA-EphA2-DOPC" /><category term="F-FDG" /><category term="self advocacy" /><category term="serous tubal intraepithelial" /><category term="borderline ovarian cancer" /><category term="psa" /><category term="treatment related second primary" /><category term="consumer representation" /><category term="single cell" /><category term="recommendations" /><category term="Oral Mucosal" /><category term="local oestrogen" /><category term="psychiatry" /><category term="MRSA" /><category term="pediatrics" /><category term="symptoms" /><category term="IV  carboplatin" /><category term="narratives" /><category term="radiation technology" /><category term="clinical trials cost" /><category term="2011 conference" /><category term="ontario doctor pay" /><category term="refusals" /><category term="award" /><category term="partnership for patients" /><category term="patient privacy" /><category term="epi procolon" /><category term="workload" /><category term="clinical trials ovarian cancer" /><category term="new regimens" /><category term="medical error" /><category term="u.s. news" /><category term="genetic variances" /><category term="search" /><category term="e-care records" /><category term="para-aortic" /><category term="specialists" /><category term="stroke" /><category term="neuroendocrine cervical" /><category term="teens" /><category term="patient safety canada" /><category term="OvaCheck" /><category term="lymphedema" /><category term="subgroups" /><category term="delayed treatment" /><category term="family doctors" /><category term="lungs" /><category term="transvaginal ultrasound" /><category term="unfunded cancer drugs" /><category term="TP53 (gene)" /><category term="diaphram" /><category term="centralisation" /><category term="relatives" /><category term="updates" /><category term="kittens" /><category term="recap" /><category term="Ottawa" /><category term="hematologic" /><category term="practice" /><category term="Muir-Torre Syndrome" /><category term="patient exploitation" /><category term="germline genetic variation" /><category term="lost in transition" /><category term="ginko" /><category term="childbirth in cancer survivors" /><category term="Endocyte" /><category term="patient perspective" /><category term="education campaign" /><category term="aspartame" /><category term="peritonei" /><category term="Phenoxodiol" /><category term="ginger" /><category term="work" /><category term="alternative" /><category term="cnn" /><category term="DTC" /><category term="sponsors" /><category term="non-brca" /><category term="p53;circulating" /><category term="press release" /><category term="oregovamab" /><category term="Recurrences" /><category term="american college of radiology" /><category term="anaplastic large cell lymphoma" /><category term="optimal" /><category term="coworkers" /><category term="endogenous" /><category term="approvals" /><category term="malignant ascites" /><category term="ovarian cancer book" /><category term="european cancer centres" /><category term="insurance" /><category term="contraindications" /><category term="books for children" /><category term="tuberculous Peritonitis" /><category term="unnecessary healthcare" /><category term="rare genetic mutations" /><category term="sulfonylureas" /><category term="explanation" /><category term="RAD51" /><category term="cruciferous vegetables" /><category term="ovarian primary peritoneal cancer risk side effects DVT" /><category term="sentinel cancer" /><category term="population cancer screening" /><category term="comparative effectiveness trials" /><category term="optimal cytoreduction" /><category term="Boston" /><category term="off label drug use" /><category term="planning" /><category term="low dose decitabine" /><category term="continuity of patient care" /><category term="frontiers in oncology" /><category term="underserved" /><category term="responsibilites" /><category term="diagnostic errors" /><category term="23andme" /><category term="Ovarian Cancer Association Consortium" /><category term="bleach" /><category term="rehospitalization rates" /><category term="comments" /><category term="ESMO" /><category term="dose density" /><category term="high tech" /><category term="Ashkenazi Jewish" /><category term="oral chemotherapies" /><category term="TRAIL" /><category term="non hormonal therapies" /><category term="second maligancies" /><category term="secondary tumors" /><category term="triple heterozygosity" /><category term="grade" /><category term="pediatric cancers" /><category term="patient decision aids" /><category term="delayed surgery" /><category term="healing journey" /><category term="treatment intervals" /><category term="healthcare providers" /><category term="BEAT" /><category term="genetic risks" /><category term="upper abdominal surgery" /><category term="shaared care model" /><category term="appetite" /><category term="burger" /><category term="partial colectomy" /><category term="vitamins" /><category term="MRC" /><category term="BRCA2; SNP" /><category term="ptsd" /><category term="single-gene" /><category term="MicroRNA let-7a" /><category term="MLPA" /><category term="women's health" /><category term="COTI-2" /><category term="ultrasonography" /><category term="Avemar" /><category term="questions" /><category term="Epoetin" /><category term="upstaging" /><category term="aurora-B protein" /><category term="radiation induced cancer; radiotherapy; second cancer" /><category term="hypocritical" /><category term="illness" /><category term="stool dna test" /><category term="nevada cancer institute" /><category term="Darbepoetin" /><category term="early career investigator funding" /><category term="low penetrance" /><category term="physician comparisons" /><category term="tricyclic" /><category term="human rights" /><category term="pre counselling" /><category term="ages" /><category term="discharge" /><category term="high-grade glioma" /><category term="DPX-Suvivac" /><category term="google health" /><category term="fertility" /><category term="Ovarian Cancer Academy" /><category term="P13K" /><category term="institutional" /><category term="cancer systems canada" /><category term="surgical management" /><category term="peripheral neuropathy" /><category term="decision aids" /><category term="overview" /><category term="dna generational changes" /><category term="SEMS" /><category term="chromosomerisk" /><category term="closson" /><category term="Adhesiolysis" /><category term="dr Ilana cass" /><category term="medicaid" /><category term="physician abuse" /><category term="sgo 2012" /><category term="diagnostic test" /><category term="cancer patient unmet needs" /><category term="poster session" /><category term="uncommon" /><category term="ovarian germ cell" /><category term="relative survival rates" /><category term="genomic sequencing" /><category term="integrity" /><category term="proteinuria" /><category term="nurse practitoners" /><category term="NBOCC" /><category term="hansard" /><category term="ny times" /><category term="consolidated radiotherapy" /><category term="clinical practice" /><category term="healthcare politics" /><category term="EDR" /><category term="salpingectomy" /><category term="industrialized" /><category term="phase 0" /><category term="iphone app" /><category term="GINECO" /><category term="angiogenesis" /><category term="shame" /><category term="reimplantation" /><category term="human abuses" /><category term="measuring" /><category term="couples" /><category term="SU2C" /><category term="mutation carriers" /><category term="monotherapy" /><category term="epigenetic drugs" /><category term="academic health science centres" /><category term="research results" /><category term="AMG 386" /><category term="citizen participation" /><category term="phase 1" /><category term="GAP-107B8" /><category term="home care" /><category term="cancer stem cells" /><category term="Peg Ford" /><category term="disgusted" /><category term="double brca" /><category term="breakthoughs" /><category term="catheters" /><category term="obesity" /><category term="Curcumin" /><category term="Anti-inflammatory" /><category term="aprepitant" /><category term="venous thrombeombolism" /><category term="acquired" /><category term="hedgog pathway inhibitor" /><category term="public disclosure" /><category term="hospital costs" /><category term="screening colorectal cancer" /><category term="Avandia" /><category term="phase 2" /><category term="cancer referrals" /><category term="MYH gene" /><category term="food" /><category term="canadian partnership against cancer" /><category term="santa claus" /><category term="Norweigian Cancer Genomics Consortium" /><category term="genetic variants" /><category term="guidance" /><category term="patient reported outcomes" /><category term="clinial trials" /><category term="in vitro chemosensitivity testing" /><category term="MLN8237" /><category term="urine" /><category term="health insurance canada prescriptions" /><category term="Zaida" /><category term="oestrogen" /><category term="pharmaceutical companies" /><category term="hypertension" /><category term="multidisciplinary" /><category term="non-hormonal" /><category term="whole body imaging" /><category term="cognitive impairment" /><category term="platinum refractory" /><category term="community" /><category term="adverse event" /><category term="gynecologist" /><category term="overall survival" /><category term="doxorubicinm" /><category term="secondary" /><category term="doxil" /><category term="stage 1 ovarian cancer" /><category term="extreme drug resistance assays" /><category term="sand balloon" /><category term="self reporting" /><category term="red cross" /><category term="research integrity" /><category term="workplace" /><category term="ADE" /><category term="obituary" /><category term="facebook" /><category term="survivorship" /><category term="sporadic breast cancer" /><category term="breast cancer documentary" /><category term="antiretrovirals" /><category term="breast intraperitoneal" /><category term="at-risk" /><category term="Professor Quinn" /><category term="samples" /><category term="unconscious" /><category term="diet" /><category term="ADC" /><category term="Brivanib" /><category term="neuroendocrine tumors" /><category term="risk reduction surgery" /><category term="professional practice" /><category term="early stage ovarian cancer" /><category term="tumor dimension" /><category term="molecular profiling" /><category term="palliative care" /><category term="gynecologic surgery" /><category term="national organiztion rare disorders" /><category term="rct" /><category term="early detection" /><category term="ProLindac" /><category term="HIPPA" /><category term="patient engagement" /><category term="cancer statistics" /><category term="Carolyn Benivegna" /><category term="cancer diagnosis" /><category term="imaging" /><category term="stromal cells" /><category term="oral sodium phosphate" /><category term="bowel" /><category term="adverse medical events" /><category term="canadian politics" /><category term="meaningful use" /><category term="charity" /><category term="telethon" /><category term="lymphatic ascites" /><category term="serrated polyps" /><category term="precauctions" /><category term="borderline ovarian cancer survival" /><category term="nanoparticles" /><category term="online education" /><category term="6TG" /><category term="system abuses" /><category term="diversity" /><category term="gold standard" /><category term="idiot" /><category term="SBRT" /><category term="cancer.ovarian" /><category term="misunderstanding" /><category term="ovarian yolk sac" /><category term="colorectal cancer screening" /><category term="LAPTM4B" /><category term="invasive" /><category term="tai chi" /><category term="cancer clusters" /><category term="variances" /><category term="AG-014699" /><category term="surgical safety" /><category term="AT13148" /><category term="consultant" /><category term="information technology" /><category term="reimbursement" /><category term="blood product agents" /><category term="uninformative" /><category term="lack of action" /><category term="Women's Health Initatiave" /><category term="doxil." /><category term="GALNT1 gene" /><category term="Prima Biomed" /><category term="external radiation" /><category term="drug implants" /><category term="SNP" /><category term="plant for life" /><category term="invasive ovarian cancers" /><category term="presentation" /><category term="ovarian cancer and us" /><category term="pegfilgrastim" /><category term="south jersey" /><category term="legislative" /><category term="nanosystems" /><category term="2012 study" /><category term="fractures" /><category term="breast cancer" /><category term="professional" /><category term="EGP-1" /><category term="managed care" /><category term="bryostatin" /><category term="Fox12" /><category term="health care changes" /><category term="Counterfeit pharmaceuticals" /><category term="H1N1" /><category term="Primary peritoneal cancer; Low-grade serous carcinoma; Ovarian cancer" /><category term="krukenberg" /><category term="VEGF" /><category term="subspeciality" /><category term="BMS-582664" /><category term="randomized trials" /><category term="experiments" /><category term="2nd surgery" /><category term="sex cord stromal" /><category term="contrast" /><category term="spain" /><category term="darlene gray" /><category term="classifications" /><category term="parents without children" /><category term="global" /><category term="safety alert" /><category term="CA 125 patient survey" /><category term="sensory perception" /><category term="first degree" /><category term="followup; Surveillance" /><category term="unmeasurable" /><category term="2nd line therapy" /><category term="blue button" /><category term="Folate Binding Protein" /><category term="table of contents" /><category term="scc" /><category term="ICD-9" /><category term="usual care" /><category term="Canary Foundation" /><category term="secondary cancers" /><category term="voices into action" /><category term="disease clusters" /><category term="clinical" /><category term="performance status" /><category term="assembly" /><category term="gray matter" /><category term="research bias" /><category term="serous; Survival" /><category term="mortality rates" /><category term="age" /><category term="karenitecin" /><category term="patient safety day" /><category term="msh3" /><category term="september 2010" /><category term="vomiting" /><category term="prophylatic" /><category term="Carboplatin" /><category term="qualaquin" /><category term="venous thrombosis" /><category term="washington state university" /><category term="patterns" /><category term="ZYBRESTAT" /><category term="clinical trial mortality rates" /><category term="unrealistic optimism" /><category term="geriatric" /><category term="adverse events" /><category term="peri menopause" /><category term="chart" /><category term="folllowup" /><category term="hereditary breast cancer" /><category term="life" /><category term="modern doctor" /><category term="bereaved" /><category term="medical diseases" /><category term="Epimutation" /><category term="U/S" /><category term="brain cancer" /><category term="myths" /><category term="environmental risks" /><category term="miR-31" /><category term="ovarian cancer diet" /><category term="qualitative research" /><category term="child" /><category term="combination therapies" /><category term="high risk ovarian" /><category term="Israel" /><category term="lung" /><category term="abstracts 2011 asco" /><category term="hospital comparisons" /><category term="corporate" /><category term="elderly ovarian cancer patients" /><category term="cardio" /><category term="cytoreduction" /><category term="agreements" /><category term="osteopathic medicine" /><category term="huh" /><category term="medical debt" /><category term="Liverpool" /><category term="telecare" /><category term="TheraPlas®" /><category term="wigs" /><category term="synchronous" /><category term="breast cancer lymph nodes" /><category term="mammography" /><category term="ACOR" /><category term="cancer facts" /><category term="acanthosis nigricans" /><category term="arterial thrombosis" /><category term="cancer therapy secondary events" /><category term="cancer world declaration" /><category term="Kate Murphy" /><category term="genetics colorectal" /><category term="physician online ratings" /><category term="magnesium" /><category term="family patient engagement" /><category term="mistletoe" /><category term="urinary tract injury" /><category term="HUGE" /><category term="genome research" /><category term="cancer.genetics" /><category term="breast cancer biomarkers" /><category term="bioscience" /><category term="survivors debate" /><category term="ACS" /><category term="treatment resistance" /><category term="IOTA" /><category term="pain" /><category term="febrile neutropenia" /><category term="marketing" /><category term="incontinence" /><category term="stereotactic radiosurgery" /><category term="CT scan" /><category term="abdominal aortic aneurysms" /><category term="legal actions" /><category term="breast cancer treatment" /><category term="Dan McMorris" /><category term="direct to consumers" /><category term="high grade ovarian" /><category term="2012 sgo conference" /><category term="short" /><category term="taxane" /><category term="pseudoscience" /><category term="libby's hope" /><category term="Aflibercept" /><category term="length" /><category term="individual tumor cells" /><category term="permetrexed" /><category term="target ovarian cancer pathfinder study 2012" /><category term="impairments" /><category term="women over 50" /><category term="goodfellow" /><category term="nccn conference" /><category term="hot flashes" /><category term="cochrane collaboration canada" /><category term="research US" /><category term="co-morbidities" /><category term="NAA" /><category term="lonafarnib" /><category term="knowledge" /><category term="research funding" /><category term="interval debulking" /><category term="appreciative inquiry" /><category term="womens health initative" /><category term="artists" /><category term="automated" /><category term="Edmond" /><category term="patient safety institute" /><category term="lunafest" /><category term="oncogenetic counselling" /><category term="saudi arabia" /><category term="misconduct" /><category term="placebos" /><category term="Cathy" /><category term="radiotherapy" /><category term="epithelial" /><category term="Oncotype DX test" /><category term="ovarian cancer guidelines" /><category term="baggage" /><category term="organizations" /><category term="alleles" /><category term="fish" /><category term="outcome prediction score" /><category term="PennMed" /><category term="funding" /><category term="elle" /><category term="poland" /><category term="breast feeding" /><category term="dynamic  constrast mri" /><category term="mesothelioma" /><category term="microspheres" /><category term="Tracy" /><category term="rupture" /><category term="major complications" /><category term="sandoz" /><category term="physician ratings" /><category term="NEJM" /><category term="trial design" /><category term="extreme drug resistance" /><category term="ill" /><category term="arimidex" /><category term="neutropenia" /><category term="patient organizations" /><category term="lynch syndrome. colorectal adenomas" /><category term="veterinarians" /><category term="endometrioid" /><category term="grass roots" /><category term="urine collection" /><category term="patient portals" /><category term="mistakes" /><category term="Coleman" /><category term="ceRNA" /><category term="ovarian cancer in remission" /><category term="abuse" /><category term="CT/PET" /><category term="parents with cancer" /><category term="endometrial carcinoma; ovarian carcinoma; PPP2R1A; PP2A; high-grade serous; mutations; dual malignancies" /><category term="miR" /><category term="morale obligations" /><category term="cbc" /><category term="peglyated liposomal doxorubicin" /><category term="elsevier" /><category term="national" /><category term="book review" /><category term="Li-Fraumeni" /><category term="risk perceptions" /><category term="financial statements" /><category term="patient centered research" /><category term="older cancer patients" /><category term="antigens" /><category term="GOG 172" /><category term="ovarian patients followup cancer" /><category term="breast cancer and system diseases" /><category term="Antiangiogenic Agents" /><category term="ductal carcinoma in situ" /><category term="newsweek" /><category term="ACOG" /><category term="genomes unzipped" /><category term="Intraperitoneal access ports" /><category term="dexamethasone" /><category term="Cyberchondria" /><category term="radical fimbriectomy" /><category term="MRE11" /><category term="AURELIA" /><category term="blood pressure" /><category term="government of canada" /><category term="personal health records" /><category term="DepoVax" /><category term="organ transplant" /><category term="minnesota" /><category term="annual report" /><category term="breast cancer surgeons" /><category term="hype" /><category term="residual tumor" /><category term="PF-01367338" /><category term="food effect" /><category term="counseling" /><category term="health care utlilization and outcomes" /><category term="cognitive change" /><category term="public hospitals" /><category term="scleroderma" /><category term="lymphocyst" /><category term="omentectomy" /><category term="medical education" /><category term="MEK" /><category term="national registry" /><category term="GOG-0218" /><category term="stopping" /><category term="Gail model" /><category term="nurse ratios" /><category term="Afibercept" /><category term="pediatric ovarian cancer" /><category term="GOG 0126-T" /><category term="surviving" /><category term="pretreatment" /><category term="rare genetic syndromes" /><category term="tumor volume" /><category term="esophageal cancer" /><category term="respectful insolence" /><category term="conflict" /><category term="omega fatty acids" /><category term="terminal" /><category term="canadian patient charter" /><category term="spouses" /><category term="long distance" /><category term="chronic disease" /><category term="hopelessness" /><category term="US" /><category term="appendiceal cancer" /><category term="us healthcare" /><category term="data" /><category term="HUGO" /><category term="expert opinion" /><category term="drug-drug interactions" /><category term="fecal immunochemical testing" /><category term="damages" /><category term="adnexal mass" /><category term="Surgical mortality" /><category term="CDKN1A" /><category term="infectious" /><category term="bioidenticals" /><category term="progestin" /><category term="four biomarker panel" /><category term="memoire of a debulked woman" /><category term="Diindolylmethane" /><category term="authors" /><category term="Ovarian cancer; Endometriosis; Pathogenesis; Oxidative stress; Microarray; Clear cell carcinoma; Microenvironment" /><category term="breast cancer diagnostics" /><category term="detection" /><category term="patient issues" /><category term="doctors notes" /><category term="alice little" /><category term="renal cell carcinoma" /><category term="serous borderline ovarian" /><category term="healing" /><category term="ovarian stromal cancer" /><category term="drug interactions" /><category term="dense" /><category term="oral aromatase inhibitors" /><category term="Claudins" /><category term="bleeding" /><category term="contralateral" /><category term="peritoneal washings" /><category term="reconstruction" /><category term="satisfaction" /><category term="health records" /><category term="UK" /><category term="direct to consumer" /><category term="exon" /><category term="early stage breast cancer" /><category term="right to know" /><category term="Spirtos" /><category term="magazines" /><category term="choices" /><category term="readers digest" /><category term="fats" /><category term="Diamandis" /><category term="Procrit" /><category term="epigenomics" /><category term="high-grade" /><category term="drug coverage" /><category term="young women" /><category term="podcast" /><category term="Flit" /><category term="Halt Medical" /><category term="Dee Edwards memorial" /><category term="patient referrals" /><category term="Vitamin B" /><category term="Matter" /><category term="obstacles" /><category term="immune response" /><category term="western medicine" /><category term="quality of care" /><category term="second look" /><category term="personalised cancer" /><category term="vargatef" /><category term="gene expression profile" /><category term="romanow" /><category term="lower leg" /><category term="patient-reported outcomes" /><category term="Joan" /><category term="brain metastasis" /><category term="vaccine research" /><category term="curis" /><category term="CKD" /><category term="progression free survival" /><category term="memoir of a debulked woman" /><category term="Apoptotic dna blood test" /><category term="determinants" /><category term="pleural effusion" /><category term="easy-to-use" /><category term="hRad17" /><category term="belinostat" /><category term="children's book" /><category term="stem cell biology" /><category term="HRI" /><category term="OvaDx" /><category term="Pniauskas" /><category term="breast screening" /><category term="white blood cell count" /><category term="sofafenib" /><category term="Syndromes" /><category term="cell damage" /><category term="Dr Yi Pan" /><category term="pakistan" /><category term="Ashkenazi" /><category term="imatinib mesylate" /><category term="hormones" /><category term="nodoz" /><category term="nytimes" /><category term="elsevier open access" /><category term="canada healthcare system" /><category term="cholesterol" /><category term="incidental findings" /><category term="FIT" /><category term="dietary guidelines" /><category term="initial surgery" /><category term="MSI" /><category term="negligence" /><category term="fiber" /><category term="womens health" /><category term="Australia; New South Wales; Ovarian neoplasms; CA125 Antigen; Anxiety; Decision-making; Surveillance; Medical gaze" /><category term="stable" /><category term="jeopardy" /><category term="non-natural menopause" /><category term="friend" /><category term="inquiries" /><category term="copays" /><category term="mastectomy" /><category term="pharmacogenomics" /><category term="TKM 080301" /><category term="Regina" /><category term="serous borderline" /><category term="cancer genetics risks" /><category term="fashion magazines" /><category term="neulasta" /><category term="animal models" /><category term="HRT" /><category term="faceboo" /><category term="nonadherence" /><category term="language" /><category term="anticogulants" /><category term="rare" /><category term="MK-4827" /><category term="decisions" /><category term="mTOR" /><category term="limitations" /><category term="amsterdame 11" /><category term="dimethylsphingosine" /><category term="LIGASURE" /><category term="seth's blog" /><category term="dendritic" /><category term="gynecologic cancer" /><category term="health and illness" /><category term="icu" /><category term="Pat" /><category term="privitisation" /><category term="microarray" /><category term="colorectal cancer prevention" /><category term="House of Commons" /><category term="nurses health study" /><category term="empower her" /><category term="emergent care" /><category term="2012 ASCO abstract" /><category term="choosing wisely" /><category term="fluorouracil" /><category term="electronic health records" /><category term="contaminants" /><category term="relapse" /><category term="gynaecologic survivorship care plan" /><category term="Prima" /><category term="paid" /><category term="neuroprotective" /><category term="CIPROFLOXACIN" /><category term="patient charter" /><category term="juice plus" /><category term="QOL" /><category term="thioridazine" /><category term="happiness" /><category term="C6ORF97" /><category term="friends" /><category term="childhood cancer" /><category term="C6ORF96" /><category term="culture" /><category term="gastric" /><category term="maintenance therapy" /><category term="misdiagnosis" /><category term="admissions" /><category term="fecal incontinence" /><category term="questionnaire" /><category term="dissection" /><category term="signals" /><category term="time" /><category term="PND" /><category term="protein" /><category term="blogger" /><category term="pegylated liposomal doxorubicin" /><category term="intestinal perforation" /><category term="EpCAM" /><category term="genetic discrimination" /><category term="osteoporois" /><category term="genetic testing effects" /><category term="online programmes" /><category term="immunohistochemistry" /><category term="genetic diversity" /><category term="recurrent venous thrombosis. transdermal oestrogens" /><category term="alendronate" /><category term="health care system" /><category term="ovarian cancer clinical trial" /><category term="lancet oncology ovarian cancer detection study" /><category term="unknown clinical variance" /><category term="epigenome" /><category term="prospective study" /><category term="malignant bowel obstruction" /><category term="hospital volume" /><category term="low income" /><category term="NKTR-102" /><category term="randomization" /><category term="glossary" /><category term="left sided colonic obstruction" /><category term="mother" /><category term="Munk" /><category term="patients for patient safety" /><category term="microRNAs" /><category term="OCEANS trial" /><category term="perforation" /><category term="co-pay" /><category term="cowbird" /><category term="primary care physicians" /><category term="pregabalin" /><category term="help with hard questions" /><category term="poxviruses" /><category term="Obstretricians and Gynaecologists" /><category term="micelles" /><category term="letter" /><category term="platinum-resistance" /><category term="health care" /><category term="nutritional supplements" /><category term="pelvic ultrasound" /><category term="comorbidities" /><category term="HAI" /><category term="patient cenetered outcomes research institute" /><category term="GRIPS" /><category term="DMRT1" /><category term="endometrium" /><category term="weight" /><category term="my sister's voice" /><category term="pink" /><category term="cancer and pregnancy" /><category term="European Congress" /><category term="centres" /><category term="OCRP" /><category term="matching services" /><category term="navigation service" /><category term="recurrence" /><category term="inclusion" /><category term="play  playwright" /><category term="rs879882" /><category term="oncotype dx" /><category term="ears" /><category term="NSAIDs" /><category term="epidemic" /><category term="staging" /><category term="statement" /><category term="surgical intervention" /><category term="cancer progress" /><category term="international federation gynecology and obstetrics" /><category term="TRC105" /><category term="theory" /><category term="alleric reactions" /><category term="staging systems" /><category term="double primaries" /><category term="early menopause" /><category term="p53; Ovarian cancer; Biomarker; Autoantibody; p53; CA125" /><category term="hand foot syndrome" /><category term="gynaecological cancers" /><category term="ovarian cancer pathology" /><category term="ego" /><category term="ovaries" /><category term="rationing" /><category term="women's college hospital" /><category term="Switzerland" /><category term="gynecologic cancers in   pregnancy" /><category term="humanities" /><category term="early diagnosis" /><category term="dichloroacetate" /><category term="paraneoplastic" /><category term="survivor ovarian" /><category term="tissue samples" /><category term="C6ORF211" /><category term="cash" /><category term="1970" /><category term="psychosocial care" /><category term="lymphomas" /><category term="ovarian cancer screening" /><category term="check list" /><category term="borderline ovarian tumors" /><category term="evidenced based medicine" /><category term="HBOC" /><category term="meat" /><category term="enacct" /><category term="adult granulosa ovarian cell" /><category term="psychosocial factors" /><category term="second line treatment" /><category term="SSRI" /><category term="womens magazines" /><category term="GINA" /><category term="eribulin" /><category term="donor's rights" /><category term="clinical trial results" /><category term="in research" /><category term="early stage ovarian cancer survival" /><category term="adverse reactions" /><category term="negative studies" /><category term="exercise" /><category term="business" /><category term="empty reviews" /><category term="survivourship" /><category term="hereditary non polyposis colorectal cancer" /><category term="C. difficile" /><category term="therapies" /><category term="skin cancer" /><category term="neonatal" /><category term="grades" /><category term="algorithm" /><category term="LPA" /><category term="links" /><category term="amino acids" /><category term="video CME" /><category term="social networks" /><category term="restreat" /><category term="immunotherapy" /><category term="dose" /><category term="acr appropriateness criteria" /><category term="EU" /><category term="kreppner" /><category term="dna stool sample" /><category term="participatory medicine" /><category term="gynecologic" /><category term="post WHI" /><category term="founder HERA" /><category term="infertility" /><category term="oncology massage" /><category term="phase11" /><category term="evolution" /><category term="undiagnosis" /><category term="radiation oncologists" /><category term="drug responses" /><category term="etastasis" /><category term="stromal" /><category term="glucose" /><category term="platinum resistant ovarian cancer" /><category term="orc oncology" /><category term="evidenced informed" /><category term="VDA agents" /><category term="Genetic Alliance" /><category term="Nevada" /><category term="rectal" /><category term="database" /><category term="ICT-140" /><category term="objective" /><category term="viscum album L" /><category term="Antiandrogen" /><category term="luncheon" /><category term="maintenance chemotherapy" /><category term="adverse reaction" /><category term="young age" /><category term="communication" /><category term="ontario hospital association. data sharing" /><category term="high grade serous ovarian" /><category term="spiritual needs" /><category term="probiotic" /><category term="colon cancer screening" /><category term="Supercentenarian" /><category term="ovarian cancer detection study" /><category term="estrogen receptor positive" /><category term="Ovary" /><category term="h lee moffitt" /><category term="negative emotions" /><category term="beta-carotene" /><category term="Sandostatin" /><category term="biosimilars" /><category term="commentaries" /><category term="olaparib NEJM" /><category term="physician blog" /><category term="spanish" /><category term="cindy owens" /><category term="drug" /><category term="Kaiser Permanente" /><category term="resistant cancers" /><category term="flu patch" /><category term="patient preferences" /><category term="waist hip ration" /><category term="neupogen" /><category term="rationale therapeutics" /><category term="Brussels" /><category term="word on cancer" /><category term="investigation" /><category term="surgical menopause" /><category term="regime" /><category term="genetic testing" /><category term="cell therapeutics" /><category term="extracolonic tumors" /><category term="gallbladder" /><category term="variant" /><category term="p53" /><category term="older people" /><category term="gairdner" /><category term="UICC" /><category term="TMI" /><category term="followup" /><category term="Poly C12U" /><category term="lung cancer risk" /><category term="phase2" /><category term="posting" /><category term="followupcommunication" /><category term="septated" /><category term="SCL34A2" /><category term="BIG 00-01 trial" /><category term="IL-17" /><category term="2012 asian oncology" /><category term="reality" /><category term="antibodies" /><category term="gene expression" /><category term="chemotherapy dosing" /><category term="PAI-1" /><category term="pollack" /><category term="Dove study" /><category term="knowledge translation" /><category term="homecare" /><category term="Livestrong" /><category term="networking" /><category term="solid tumors" /><category term="annual meeting" /><category term="ethnicity" /><category term="drug development" /><category term="wrong symptoms ovarian cancer" /><category term="drug safety" /><category term="qigong exercise" /><category term="PET" /><category term="BNC105" /><category term="homeopathy" /><category term="fleming" /><category term="fruit" /><category term="PREMM model" /><category term="introduction" /><category term="epigenetic cancer pill" /><category term="community engagement" /><category term="Cabozantinib" /><category term="application" /><category term="protein CRD-BP" /><category term="gynecologic oncology" /><category term="gene testing" /><category term="dialogue" /><category term="physician owned centers" /><category term="evaluation" /><category term="asia oncology" /><category term="readmission rates" /><category term="perfusion CT" /><category term="variants unknown significance" /><category term="polaneczky" /><category term="BRCA 2" /><category term="Ontario Institute Cancer Research" /><category term="exam" /><category term="unique" /><category term="patent trial australia" /><category term="Oncolytic biotech" /><category term="micropapillary" /><category term="case reports in oncology" /><category term="recent progress" /><category term="pituitary" /><category term="urinary markers" /><category term="osteopathy" /><category term="Target Ovarian Cancer" /><category term="bowel prep" /><category term="Varian Medical System" /><category term="karen mason" /><category term="hours of work" /><category term="Lovenox" /><category term="BRCA 1" /><category term="cancer in pets" /><category term="time interval" /><category term="Ridaforolimus" /><category term="MK-0457" /><category term="eof" /><category term="prophylactic lynch syndrome surgery" /><category term="regional differences" /><category term="ALCL" /><category term="canadian research" /><category term="neuropathy" /><category term="medical tourism" /><category term="monk debates" /><category term="polo like" /><category term="DISCOVAR" /><category term="individualized therapy" /><category term="courses" /><category term="finance" /><category term="toxic chemicals" /><category term="injectable contraceptivs" /><category term="gonadotropin" /><category term="dancing with N.E.D." /><category term="high risk families" /><category term="France" /><category term="drug monographs" /><category term="osteopontin" /><category term="patient advocacy organizations" /><category term="how" /><category term="lurker" /><category term="AVX901" /><category term="dose-limiting" /><category term="pshyological impact" /><category term="Docetaxel; Abdominal radiation; Chemosensitizer; low dose radiation" /><category term="primary care providers" /><category term="cutaneous" /><category term="tranquilizers" /><category term="premalignant" /><category term="department of defense" /><category term="cancer.. ovarian" /><category term="systematic reviews" /><category term="social aspect" /><category term="ovarian stem cells" /><category term="serous; mutations" /><category term="second primary cancer" /><category term="advanced stage borderline" /><category term="self-referral" /><category term="adjuvant chemotherapy" /><category term="cancer in pregnancy" /><category term="online health information" /><category term="estimates" /><category term="social determinants of health" /><category term="ccr" /><category term="international male breast cancer program" /><category term="International Congress of Genetics" /><category term="interviews" /><category term="internet drug purchases" /><category term="whole brain radiation" /><category term="IL-18" /><category term="predisposition" /><category term="detroit" /><category term="DiaTech" /><category term="platelets" /><category term="imedex" /><category term="osteopathic physicians" /><category term="Correlogic" /><category term="shorter" /><category term="fundraising" /><category term="Winnipeg" /><category term="empowerment" /><category term="pelvic inflammatory disease" /><category term="Seattle" /><category term="cochrane consumers" /><category term="meonpause" /><category term="Treosulfan" /><category term="treatment related menopause" /><category term="Owareness" /><category term="nursing guidelines" /><category term="CT scans" /><category term="cardiac catherterization" /><category term="empathy" /><category term="corporations" /><category term="quinine sulfate" /><category term="infusion pumps" /><category term="assay tests" /><category term="brain tumors" /><category term="politicans" /><category term="critical care" /><category term="bone mets" /><category term="checklists" /><category term="ovarian cancer brain metastases" /><category term="ebulletin" /><category term="susan g. komen" /><category term="IOM" /><category term="smells" /><category term="5-FU" /><category term="breast cancer incident rates" /><category term="non mutation carriers" /><category term="sedatives" /><category term="clinical trial reporting" /><category term="preclinical" /><category term="epigenetics" /><category term="mcgill university" /><category term="wsj" /><category term="cancer costs" /><category term="breast cancer genes" /><category term="nurses" /><category term="pancreas" /><category term="antiooxidants" /><category term="keratoacanthomas" /><category term="to err is human" /><category term="gravy train" /><category term="unnecessary surgeries" /><category term="central lines" /><category term="survivorship advocate program" /><category term="arguments" /><category term="pharmacy" /><category term="books" /><category term="asymptomtic" /><category term="death" /><category term="nci clinical trials cooperative group" /><category term="leydig" /><category term="consumer health" /><category term="healthcare challenges" /><category term="masses" /><category term="pacilitaxel" /><category term="support groups" /><category term="intenational" /><category term="acute pain" /><category term="FAP" /><category term="lymph node" /><category term="outcomes research" /><category term="latitude" /><category term="cancer education" /><category term="HER2" /><category term="LGBT" /><category term="Myriad" /><category term="patient accrual" /><category term="montage" /><category term="foreign trained" /><category term="policy makers" /><category term="adverse drug events" /><category term="times" /><category term="anaesthesia" /><category term="Ondansetron Injection" /><category term="alternative complimentary" /><category term="lymphadenectomy" /><category term="CCLE" /><category term="pox vaccines" /><category term="herbal remedies" /><category term="american institute for cancer research" /><category term="computers" /><category term="varian cancer association consortium" /><category term="prevalence" /><category term="prostate" /><category term="HER3" /><category term="disease" /><category term="Triglycerides" /><category term="electrolyte" /><category term="TroVax" /><category term="american hospital association" /><category term="BRACAnalysis" /><category term="intensity modulated whole abdominal radiotherapy" /><category term="colorectal cancer clinical trial" /><category term="Edmonton" /><category term="skills" /><category term="XRCC" /><category term="PET imaging" /><category term="canadian health care crisis" /><category term="deandra trevino salem" /><category term="reference book" /><category term="IP chemotherapy" /><category term="Comerci" /><category term="advertising" /><category term="anemia" /><category term="surgery" /><category term="canadian institute of health research" /><category term="breakthrough" /><category term="Ki-67" /><category term="survival rates cancer" /><category term="dove project" /><category term="contraceptive pill" /><category term="mayo clinic" /><category term="uncertain clinical significance" /><category term="tumorigenesis" /><category term="CHUM" /><category term="place of death" /><category term="Peutz-Jeghers" /><category term="activist" /><category term="herbs" /><category term="nucleic acids" /><category term="share" /><category term="recovery" /><category term="cancer prevention" /><category term="election" /><category term="ebm" /><category term="antiemetic" /><category term="lesion" /><category term="terminal prognosis" /><category term="fears" /><category term="symptom clusters" /><category term="MCL1" /><category term="smoking" /><category term="interventions" /><category term="opiods" /><category term="bone metastases" /><category term="erythropoiesis-stimulating agents" /><category term="tumor types" /><category term="risks" /><category term="autoantibodies" /><category term="P27 gene" /><category term="exact sciences" /><category term="bottlenecks" /><category term="ovarian genome" /><category term="Epogen" /><category term="cancer" /><category term="Quality of life; Symptom Index" /><category term="4" /><category term="serous ovarian" /><category term="loss" /><category term="oral contraceptive" /><category term="chemotherapy related hair loss" /><category term="Washington Times" /><category term="children and cancer communication" /><category term="parents with children" /><category term="multinational study" /><category term="psychiatrist" /><category term="Princess Margaret Hospital" /><category term="herpes zoster virus" /><category term="extracolonic cancers" /><category term="legs" /><category term="circulating cells" /><category term="same day surgery" /><category term="Acetyl-L-carnitine hydrochloride" /><category term="blood clots" /><category term="Ganoderma lucidum" /><category term="octreotide" /><category term="CA 125" /><category term="childhood cancers" /><category term="treatment failure" /><category term="EMR" /><category term="scientists" /><category term="SIK2 gene" /><category term="2012 asco" /><category term="FDG-PET/CT" /><category term="pyridoxine" /><category term="surgical mesh" /><category term="approval" /><category term="cycles" /><category term="ASCO" /><category term="laughter" /><category term="oxycarbazepine" /><category term="Bioidentical" /><category term="Argentina" /><category term="asia-pacific" /><category term="evidence based recommendations" /><category term="intensity modulated WAR" /><category term="fear of death" /><category term="doxetaxel" /><category term="VTE" /><category term="BPA" /><category term="prognosis" /><category term="ABCC2" /><category term="influence" /><category term="menopause symptoms" /><category term="media" /><category term="CYP2C19" /><category term="nagourney" /><category term="Fenretinide" /><category term="physician assistant" /><category term="forums" /><category term="ipad" /><category term="public engagement" /><category term="environment" /><category term="drug regulations" /><category term="conference" /><category term="hospital rooms" /><category term="life beyond cancer foundation" /><category term="surprise question" /><category term="activism" /><category term="global leader" /><category term="happiness scale" /><category term="return to work" /><category term="biomed journal" /><category term="guidelines conference" /><category term="death at home" /><category term="sargramostim" /><category term="connections" /><category term="psycho-oncology" /><category term="politics" /><category term="etoposide" /><category term="urothelial" /><category term="mushrooms" /><category term="hand-foot reactions" /><category term="healthcare organization" /><category term="webinars" /><category term="etarfolatide" /><category term="oncology training" /><category term="Iran" /><category term="ovarian cancer surgery" /><category term="healthy eating" /><category term="shark cartilage" /><category term="healthcare" /><category term="borderline tumors" /><category term="dacogen" /><category term="CMAJ" /><category term="BRCAx" /><category term="oral chemotherapy" /><category term="nerve damage" /><category term="cure magazine" /><category term="contrast enhanced ultrasound" /><category term="uninsured patients" /><category term="gene variants" /><category term="webcasts" /><category term="medical genomics" /><category term="debate" /><category term="ovarian cancer risks" /><category term="system errors" /><category term="drug costs" /><category term="hypothyroidism" /><category term="treatment cycles" /><category term="cardio-renal-anaemia syndrome" /><category term="email" /><category term="maternal" /><category term="body mass index" /><category term="patient power" /><category term="chemoradiation therapy" /><category term="low blood counts" /><category term="science data" /><category term="webinar" /><category term="open communication" /><category term="clinical obstetrics and gynecology journal" /><category term="PET/CT.CT" /><category term="best practices" /><category term="whole genome expression profiling" /><category term="stage 1V ovarian cancer" /><category term="bereavement" /><category term="supportive care" /><category term="screening tests misuse" /><category term="advocate" /><category term="cancer insurance" /><category term="Sublingual administration" /><category term="monoclonal antibody" /><category term="autonomy" /><category term="chelation" /><category term="anti cancer" /><category term="immunohistochemical staining" /><category term="research priorities" /><category term="?" /><category term="British Columbia" /><category term="cancer control measurements" /><category term="inappropriate care" /><category term="smart" /><category term="C-reactive protein" /><category term="quote" /><category term="kennedy" /><category term="Gadovist" /><category term="wounds" /><category term="diagnostic radiation" /><category term="preclinical studies" /><category term="Scotland" /><category term="transgender cancer risks" /><category term="international cancer benchmarking" /><category term="pleuropulmonary blastoma" /><category term="tumor rupture" /><category term="paternalism" /><category term="PACE study" /><category term="personalised medicine" /><category term="phytoestrogens" /><category term="SNPs" /><category term="maintenance" /><category term="interval debuling" /><category term="nocc" /><category term="heptibiliary" /><category term="Interferon" /><category term="da Vinci" /><category term="antiproliferation" /><category term="teaching" /><category term="centralization" /><category term="minor allele" /><category term="charts" /><category term="national patient stakeholder dialogue" /><category term="peritoneal" /><category term="progesterone receptor" /><category term="peritoneum" /><category term="mesothelial" /><category term="epithelial ovarian cancer" /><category term="older adults" /><category term="late recurrences" /><category term="metabolism" /><category term="U.S. cancer statistics" /><category term="U.S. cost cancer 2010" /><category term="Sorafenib" /><category term="interpreting" /><category term="compliance" /><category term="Li Fraumeni" /><category term="colony-stimulating factor" /><category term="early phase" /><category term="tea" /><category term="Eyelea" /><category term="pledge" /><category term="primary care" /><category term="mucinous ovarian cancer" /><category term="clinician rights" /><category term="signet ring cell" /><category term="communication skills" /><category term="overuse" /><category term="u.s. annual cancer report" /><category term="web" /><category term="rights" /><category term="kidney" /><category term="Trastuzumab" /><category term="hospice" /><category term="controversy" /><category term="orphan drugs" /><category term="intensity-modulated radiation therapy" /><category term="BRAF mutation" /><category term="colorectal cancer syndromes" /><category term="altruism" /><category term="U.S. Medicare" /><category term="quackery" /><category term="endometrial cancer" /><category term="secrecy" /><category term="patient records" /><category term="propranolol hydrochloride" /><category term="Vorinostat" /><category term="AZD2281) cochrane" /><category term="steretactic body radiation" /><category term="hospice care" /><category term="aspirin in lynch syndrome" /><category term="First Canary Foundation" /><category term="Low grade histopathology; BRCA1; BRCA2; Risk assessment; Hereditary breast and ovarian cancer" /><category term="FDG)-PET" /><category term="depression" /><category term="contamination" /><category term="psychotherapy" /><category term="TNM" /><category term="regulatory T-cells" /><category term="ovarian cancer awareness" /><category term="flaxseed" /><category term="nonepithelial ovarian cancer" /><category term="rare ovarian cancer" /><category term="ERT" /><category term="low dose daily aspring" /><category term="oncolink" /><category term="Prof Calvert" /><category term="familial colorectal cancer" /><category term="OS" /><category term="ACRIN" /><category term="tumor diameter" /><category term="survivorship care plans" /><category term="DOD ovarian cancer outcomes consortium" /><category term="patients safety" /><category term="metformin" /><category term="family health" /><category term="CT" /><category term="lancet" /><category term="absolute risk" /><category term="Susan" /><category term="aging" /><category term="grey literature" /><category term="broken heart syndrome" /><category term="chronic inflammation" /><category term="medical technology" /><category term="deletions" /><category term="non-adherence" /><category term="radiation oncology guidelines" /><category term="dr robert ozols" /><category term="genetic risk prediction studies" /><category term="best countries" /><category term="contralateral breast cancer" /><category term="representatives" /><category term="birth defects" /><category term="Her-2/neu" /><category term="dabigatran" /><category term="patient" /><category term="over promise" /><category term="cam. complimentary and alternative medicine" /><category term="owhn" /><category term="radioisotopes" /><category term="e-records" /><category term="California" /><category term="views" /><category term="fred hutchinson research" /><category term="msi-h" /><category term="Hematology" /><category term="PROCEED clinical trial" /><category term="petition" /><category term="medical emergencym misdiagnosis" /><category term="student" /><category term="Herod" /><category term="research works act" /><category term="long term survivors" /><category term="surgical pathology" /><category term="caution" /><category term="FDG PET-CT" /><category term="hpv" /><category term="pipa" /><category term="clinical trial" /><category term="never-event" /><category term="Topotecan" /><category term="vitmain d" /><category term="overdose" /><category term="university of health network toronto" /><category term="miRNA" /><category term="patient views" /><category term="medical notes" /><category term="GDC-0449" /><category term="treatment related mortality" /><category term="WAR" /><category term="ERK" /><category term="MiSS" /><category term="neoplasia" /><category term="angiogenesis inhibitors" /><category term="WiT" /><category term="antimicrobiotics" /><category term="low body temperature" /><category term="radiation. self medicating" /><category term="mastectomies" /><category term="stats canada" /><category term="search site" /><category term="personalized treatments" /><category term="unknown significance" /><category term="cytogenetics" /><category term="priority" /><category term="GnRH agonist treatment" /><category term="dasatinib" /><category term="iron" /><category term="reassessment" /><category term="cancer cachexia" /><category term="tumors" /><category term="definition" /><category term="breast cancer screening" /><category term="infant tylenol recall" /><category term="vitmains" /><category term="health care spending" /><category term="MSH2" /><category term="combination therapy" /><category term="infographic" /><category term="Roche" /><category term="Angiotensin 1-7" /><category term="Oxaliplatin" /><category term="new doctors" /><category term="DTA-H19" /><category term="nominations" /><category term="facts" /><category term="ifosfamide" /><category term="vermillion" /><category term="distinct" /><category term="MSH1" /><category term="laymen terms" /><category term="preoperative assessment" /><category term="England" /><category term="ovarian cancer risk" /><category term="science journalism" /><category term="hospital infection rates" /><category term="Perioperative infection" /><category term="interleukin research" /><category term="patient centered care" /><category term="2011 asco" /><category term="oral drugs" /><category term="benign" /><category term="EPB41L3" /><category term="protocols" /><category term="speakerlink" /><category term="insurance costs" /><category term="oza" /><category term="biology" /><category term="grapefruit" /><category term="caBIG" /><category term="AMG386" /><category term="Margaret Railton" /><category term="ERRC1" /><category term="liability" /><category term="Avian; Gene expresion; animal models" /><category term="psychedlic" /><category term="Cyclophosphamide" /><category term="mutation prevalence" /><category term="post menopausal" /><category term="healthcare policy" /><category term="Nepal" /><category term="income" /><category term="carcinoma" /><category term="msi MLH1" /><category term="DOD" /><category term="disclosure" /><category term="stomach cancer" /><category term="media release" /><category term="cancer causes" /><category term="genetic syndromes" /><category term="molecular diagnostics" /><category term="cyclin E" /><category term="vergote" /><category term="PEM" /><category term="phase 1 clinical trial" /><category term="CAM" /><category term="cancerprogress. net" /><category term="tumor specimens" /><category term="ultrasounds" /><category term="Decitabine" /><category term="screening" /><category term="challenges" /><category term="multinodular goiter" /><category term="MSH6" /><category term="webcast" /><category term="second line therapy statistics" /><category term="lactase" /><category term="Giede" /><category term="radioembolization" /><category term="nanotechnology" /><category term="small cell ovarian" /><category term="NHANES" /><category term="young" /><category term="U.S. cancer screening" /><category term="notes" /><category term="future" /><category term="san diego" /><category term="radiosurgery" /><category term="SCT" /><category term="med students" /><category term="serotonin" /><category term="grief" /><category term="stromal tumors" /><category term="controversies" /><category term="germline mutations" /><category term="Azacitidine" /><category term="doctors and patients" /><category term="editor" /><category term="Stanford" /><category term="hastings center" /><category term="clinical trials finder" /><category term="non profits" /><category term="Picoplatin" /><category term="ovarian cancer and us blog" /><category term="authorship" /><category term="sugar" /><category term="work hour" /><category term="tyrosine kinases" /><category term="incidential findings" /><category term="WBRT" /><category term="FCCTX" /><category term="therapeutic advances" /><category term="accountable" /><category term="cochrane review" /><category term="prestige" /><category term="rebuttal" /><category term="asco abstracts 2011" /><category term="hyperestrogenism" /><category term="colorectal" /><category term="cancer drug cost" /><category term="gigascience" /><category term="non familial colorectal cancer" /><category term="how to ovarian cancer and us" /><category term="adhesions" /><category term="erthropoiesis-stimulating agents" /><category term="seeman" /><category term="knowledge deficit" /><category term="setting" /><category term="Carolyn" /><category term="lawsuit" /><category term="nagourey" /><category term="scandals" /><category term="simultaneous" /><category term="ICGC Australia" /><category term="ovarian cancer rare" /><category term="SCAR project" /><category term="Glutathione peroxidase 3" /><category term="allergy" /><category term="thrombolytic agents" /><category term="feline" /><category term="johns hopkins kimmel cancer center" /><category term="Gefitinib" /><category term="oncolytic virus therapy" /><category term="positive thinking" /><category term="employees" /><category term="thecoma" /><category term="pipeline" /><category term="concerns" /><category term="targeted therapies" /><category term="emerging drugs" /><category term="top women" /><category term="parents" /><category term="noncurative" /><category term="patient participation" /><category term="mira Dx" /><category term="hMLH1" /><category term="infection" /><category term="contrast agents" /><category term="protein MCPH1" /><category term="sandy rollman" /><category term="uncertainty" /><category term="SARS" /><category term="staging manual" /><category term="Armstrong" /><category term="low malignant potential" /><category term="AI" /><category term="cancer surgery" /><category term="blood infections" /><category term="uterine serous papillary carcinoma.HER-2 neu" /><category term="anthropometric" /><category term="symptom research" /><category term="pets" /><category term="bone loss" /><category term="nuclear survivin expression" /><category term="line" /><category term="probability" /><category term="GI cancers" /><category term="first line therapy" /><category term="gastroenterology" /><category term="IMC-3G3" /><category term="altruisic" /><category term="patient navigation" /><category term="vus" /><category term="clinical data" /><category term="instability" /><category term="Adelson" /><category term="duration" /><category term="shirley and sadie" /><category term="heart" /><category term="Mesothelium. Ovarian cancer" /><category term="physician QOL" /><category term="hours" /><category term="advocacy groups" /><category term="Karolinska Institutet" /><category term="Oncologist" /><category term="online" /><category term="preview" /><category term="mortality reates" /><category term="nursing homes" /><category term="physical activity" /><category term="patient experience" /><category term="she the people" /><category term="social programs" /><category term="pegfilgrastim-induced bone pain" /><category term="reearch" /><category term="pelvic" /><category term="breast cancer guidelines" /><category term="antidiuretics" /><category term="founder muations" /><category term="cancer research" /><category term="cooking" /><category term="TGF-B" /><category term="enrolment" /><category term="non-ashkenazi" /><category term="treatment related malignancy" /><category term="precursor" /><category term="DCA" /><category term="medicare" /><category term="prevention" /><category term="election canada" /><category term="human genome project" /><category term="hope" /><category term="ear ringing" /><category term="telephone workshop" /><category term="risk patterns" /><category term="medical schools" /><category term="talc" /><category term="NGR-hTNF" /><category term="B12" /><category term="Hamilton" /><category term="Meigs Syndrome" /><category term="postmenopausal. osteoporosis" /><category term="polymorphism" /><category term="patient-user involvement" /><category term="abagovomab" /><category term="healthcare economies" /><category term="robotics" /><category term="death registry" /><category term="peerage of science" /><category term="time with patients" /><category term="tailored cancer care" /><category term="thoracoscopy" /><category term="simple inclusion cysts" /><category term="dying well" /><category term="mRNA" /><category term="CMA" /><category term="optimist" /><category term="R04929097" /><category term="vascular disrupting agents" /><category term="canary foundation newsletter" /><category term="genotype" /><category term="emergency department" /><category term="headaches" /><category term="ownership" /><category term="ovarian cancer biomarkers" /><category term="health news" /><category term="tears to transparency" /><category term="immune compromised" /><category term="molecular characteristic" /><category term="health" /><category term="postmenopausal" /><category term="refractory" /><category term="antiaging" /><category term="ovarian metastasis to breast" /><category term="blinded participants" /><category term="lymph node metastasis" /><category term="emergencies" /><category term="relationships" /><category term="Dr. Al-Hayki" /><category term="cancer genome" /><category term="Iniparib" /><category term="gastrostomy tube placement" /><category term="medical records" /><category term="genomes" /><category term="social determinents" /><category term="MORAb-003" /><category term="chronic" /><category term="encryption" /><category term="Marjorie Williams" /><category term="breast cancer survivor" /><category term="COSA" /><category term="dietary acrylamide" /><category term="pancreatic" /><category term="drug formulary" /><category term="performance" /><category term="memo" /><category term="cell type" /><category term="neurotoxicity" /><category term="story" /><category term="breast cancer genetics" /><category term="confidence" /><category term="electronic health devices" /><category term="surgical prevention" /><category term="CML" /><category term="immature ovarian teratoma" /><category term="gynaecologic cancer survivours" /><category term="biopsy" /><category term="patient conference" /><category term="correspondence breast cancer guidelines" /><category term="thermal imaging" /><category term="Meig's syndrome" /><category term="exon 2" /><category term="disruptive women" /><category term="DepoVax™" /><category term="betty" /><category term="users" /><category term="ask" /><category term="Levothyroxine" /><category term="Donna Trussell" /><category term="debulking" /><category term="bilateral tumors" /><category term="genetic counselors" /><category term="Dr Henry Lynch" /><category term="help" /><category term="healthcare access" /><category term="OHA" /><category term="monique" /><category term="targeted therapy" /><category term="patients stories" /><category term="clinical trials search" /><category term="nasal perforation" /><category term="japanese women" /><category term="genetic variations" /><category term="zofran" /><category term="Gynecologic cancer; Symptoms; early detection" /><category term="old" /><category term="Anaphylactic reactions" /><category term="biomed" /><category term="patient safety oncology" /><category term="family caregivers" /><category term="black women" /><category term="clear cell" /><category term="mouse research" /><category term="suboptimal surgery" /><category term="face" /><category term="PTK6" /><category term="cancer patients" /><category term="dollars" /><category term="4rh international symposium" /><category term="stand up to cancer clinical trial search" /><category term="hospital sanitation" /><category term="mortality statistics" /><category term="granulosa" /><category term="SRS" /><category term="chemosensitization" /><category term="family member" /><category term="volunteers" /><category term="six figure salaries" /><category term="APC" /><category term="preparing for surgery" /><category term="moderate risk" /><category term="preidsposition" /><category term="laparascopic institute" /><category term="fraser institute" /><category term="progesterone" /><category term="inheritance" /><category term="audio" /><category term="underfunding" /><category term="generic descriptors" /><category term="CHR-3996" /><category term="researchers" /><category term="ovarian cancer outcomes" /><category term="borderline tumor;gastrointestinal type;malignant transformation; mature cystic teratoma; ovary" /><category term="gall bladder" /><category term="molecular pathology" /><category term="reclassifications" /><category term="health news reviews" /><category term="lilly oncology" /><category term="end-of-life" /><category term="liposomal encapsulated doxorubicin" /><category term="hurricanes" /><category term="where" /><category term="undifferentiated" /><category term="mouse models" /><category term="industry" /><category term="drug shortages" /><category term="U.S. cancer rates" /><category term="relocation" /><category term="breast cancer prevention" /><category term="incomplete" /><category term="ovarian blog" /><category term="terms" /><category term="e-health" /><category term="tweets" /><category term="kidneys" /><category term="mmrpro" /><category term="estradiol" /><category term="journal of cancer" /><category term="KLK" /><category term="chicken" /><category term="RAF inhibitors" /><category term="cancer unknown primary" /><category term="PD 407824" /><category term="pregnancy" /><category term="PDK" /><category term="sporadic ovarian cancer" /><category term="ultraradical" /><category term="support" /><category term="ICON7" /><category term="eye on dna" /><category term="acetaminiphen" /><category term="conjugates" /><category term="serrated polyposis" /><category term="palliative radiotherapy" /><category term="advocacy" /><category term="gray market drugs" /><category term="self concept" /><category term="dna colorectal cancer testing" /><category term="immunohistochemical" /><category term="paraneoplastic thrombocytosis" /><category term="cancer treatment induced bone loss" /><category term="second breast cancer" /><category term="Fentanyl" /><category term="9/11" /><category term="molecular events" /><category term="C-difficile" /><category term="vaccination" /><category term="realism" /><category term="CDC cancer prevention and control" /><category term="Lancet student" /><category term="strategies" /><category term="neuroendocrine" /><category term="delayed diagnoses" /><category term="Lynch Syndrome" /><category term="Alberta" /><category term="haemopoietic growth factors" /><category term="mutation" /><category term="low penetrance mutations" /><category term="serum" /><category term="chromsome" /><category term="oral kinase inhibitors" /><category term="stem cell markers" /><category term="men" /><category term="emergency" /><category term="IMRT" /><category term="disturbances" /><category term="ob gyns" /><category term="MAB monoclonal antibodies" /><category term="pain medications" /><category term="discussion" /><category term="blood tests" /><category term="Erbitux" /><category term="first birth" /><category term="12 cycles" /><category term="smart pills" /><category term="it's our time" /><category term="bisphosphosphonates" /><category term="blogger stats" /><category term="junk dna" /><category term="values" /><category term="kinase" /><category term="Ovature" /><category term="conversations" /><category term="research findings" /><category term="biobanking" /><category term="cancer predisposition" /><category term="inequities" /><category term="partnership against cancer canada" /><category term="utilization of services" /><category term="volatile" /><category term="cancer-related infertility" /><category term="platinum resistant" /><category term="mammogram screening" /><category term="response to treatment" /><category term="average risk colorectal cancer" /><category term="Symptoms; australia" /><category term="american association for cancer research" /><category term="dogs" /><category term="U.S. Preventive Services Task Force" /><category term="breast cme" /><category term="models" /><category term="serbia" /><category term="EGAPP recommendations" /><category term="drug effectiveness" /><category term="african american" /><category term="ESR1" /><category term="IOERT" /><category term="cancer pain" /><category term="cutaneous skin diseases" /><category term="emergency planning" /><category term="history of cancer" /><category term="surrogate" /><category term="early vs delayed" /><category term="mucositis" /><category term="irridation" /><category term="first line treatment" /><category term="ovarian low grade serous" /><category term="healthcare costs" /><category term="pedigree" /><category term="hyperthermia" /><category term="chronic fatigue syndrome" /><category term="wiki" /><category term="oncologist compensation" /><category term="protocol. eligibility" /><category term="sponsorship" /><category term="premature birth" /><category term="saliva test" /><category term="pelvis" /><category term="variants" /><category term="CINV" /><category term="Cryotherapy" /><category term="test results" /><category term="earthquake" /><category term="chemo brain" /><category term="thermal injury" /><category term="approach" /><category term="issues" /><category term="; Survival" /><category term="MammaPrint" /><category term="cancer-genetic testing" /><category term="tumor freezing" /><category term="hapmap" /><category term="MPV" /><category term="polymorphisms" /><category term="Tanzania" /><category term="science" /><category term="enoxaparin" /><category term="neurology" /><category term="prose database" /><category term="oncology healthcare resources" /><category term="doctor ratings" /><category term="risk reducing surgery" /><category term="cancer chemprevention" /><category term="kidney disease" /><category term="gynaecologic cancer care" /><category term="Gilles Frydman" /><category term="national cost of cancer care" /><category term="dairy" /><category term="gynecologic cancers" /><category term="counterfeit drugs" /><category term="endometrial carcinoma; ovarian carcinoma; intraepithelial" /><category term="shared decision making" /><category term="population-based" /><category term="natural menopause" /><category term="Toronto LHIN" /><category term="colon" /><category term="Paul" /><category term="partners" /><category term="transgender" /><category term="renal" /><category term="primar surgery" /><category term="world oncology" /><category term="ACLU" /><category term="ontario cancer care" /><category term="NSAID" /><category term="ocean trial" /><category term="recurrent germline mutations" /><category term="patient centered medicine" /><category term="healthcare seeking" /><category term="interruptions" /><category term="marales" /><category term="dying at home expenses" /><category term="latin america" /><category term="blood thinners" /><category term="pathology review" /><category term="bee" /><category term="expectations" /><category term="Catumaxomab" /><category term="anti-inflammatory agents" /><category term="generalist cancer care" /><category term="ovarian cancer diagnosis" /><category term="gas" /><category term="Gabapentin" /><category term="cadherins" /><category term="brain metastses" /><category term="fellowships" /><category term="drug combinations" /><category term="trial results" /><category term="anorexia" /><category term="peritoneal carcnomatosis" /><category term="Rustin" /><category term="erythropoietin; recombinant; ovarian neoplasms; anemia" /><category term="Olaparib" /><category term="moca" /><category term="screening Lynch Syndrome" /><category term="uncertain significance" /><category term="charity intelligence canada" /><category term="Florida" /><category term="diethyldithiocarbamate" /><category term="pancreatic syndrome" /><category term="consolidation" /><category term="countries" /><category term="innovation" /><category term="life after cancer" /><category term="post menopause" /><category term="statistics" /><category term="open access journal" /><category term="Merck" /><category term="rare disorders" /><category term="early ovarian cancer" /><category term="dr monk" /><category term="annamarie" /><category term="triple negative ovarian cancer" /><category term="zone" /><category term="Correlogic Systems" /><category term="HERA" /><category term="Lasofoxifene" /><category term="wijnenlynch syndrome" /><category term="sedation" /><category term="silver" /><category term="response" /><category term="patient care" /><category term="Losartan" /><category term="ovarian cancer signs and symptoms" /><category term="journal gynecologic oncology" /><category term="hematopoietic colony-stimulating factors" /><category term="India" /><category term="early stage breast" /><category term="gay" /><category term="coverage" /><category term="bone pain" /><category term="KRN5500" /><category term="pelvic mass" /><category term="understanding studies" /><category term="X-ray" /><category term="Polymorphism; Genetics" /><category term="stamp" /><category term="vascular" /><category term="factor" /><category term="GOC" /><category term="medical harm" /><category term="canine" /><category term="pelvic radiation disease" /><category term="food-drug interactions" /><category term="defining value" /><category term="patients rights" /><category term="endometrial carcinoma; ovarian carcinoma; PPP2R1A; PP2A; high-grade serous;mutations" /><category term="robotic assisted surgery" /><category term="lymphadenectomyy" /><category term="complications" /><category term="Brazil" /><category term="aacr clinical trial finder" /><category term="research papers" /><category term="meida" /><category term="DSHEA" /><category term="chemotherapy secondary adverse effects" /><category term="gestational trophoblastic" /><category term="early detection and screening" /><category term="medical admissions test for physicians" /><category term="publications" /><category term="immune modulation" /><category term="breaking bad news" /><category term="mucin" /><category term="liz mane" /><category term="Herceptin" /><category term="health canada" /><category term="geriatric oncology" /><category term="art" /><category term="gyn oncologist" /><category term="abstracts" /><category term="OvPlex" /><category term="Sunnybrook" /><category term="psychological adjustments" /><category term="dna repair" /><category term="cancer awareness" /><category term="PLOS" /><category term="journal" /><category term="family" /><category term="familial" /><category term="inherited mutations" /><category term="statin cancer risk" /><category term="drug sensitivity" /><category term="drug delivery" /><category term="act network" /><category term="anticancer" /><category term="unclassified variants" /><category term="gynecologic oncologist" /><category term="abdominal mass" /><category term="general surgeons" /><category term="early stage ovarian" /><category term="Brenner" /><category term="cytology" /><category term="surgery tips" /><category term="Benevigna" /><category term="helen palmquist" /><category term="Mylan-Minocycline" /><category term="GOG" /><category term="metastatic" /><category term="excess" /><category term="double mutations" /><category term="Varian Medical Systems" /><category term="spanish women" /><category term="Interleukins" /><category term="residents" /><category term="MuGard" /><category term="sarcoma" /><category term="Greece" /><category term="second cancers" /><category term="hydroxychloroquine" /><category term="social" /><category term="journal of negative results" /><category term="metastasectomy" /><category term="canadian medical association journal" /><category term="delayed vomiting" /><category term="financial" /><category term="social networking" /><category term="patient assistance programs" /><category term="asymptomatic ovarian" /><category term="community oncology alliance" /><category term="large bowel obstruction" /><category term="micrometastatic" /><category term="ovarian cancer stem cells" /><category term="recurrence rates" /><category term="chromosomes" /><category term="prognostic factor" /><category term="patients voices" /><category term="rxlist" /><category term="tool" /><category term="2013 genetics conference" /><category term="origin" /><category term="medical errors" /><category term="rate" /><category term="ovarian cancer followup" /><category term="adverse effects" /><category term="aggressive" /><category term="GOG 218" /><category term="concentrated formula" /><category term="Danish" /><category term="conventional" /><category term="ME-143" /><category term="international database" /><category term="cancer drugs" /><category term="molecular scores" /><category term="herzog" /><category term="patient website" /><category term="2012 canadian cancer statistics" /><category term="inflammatory" /><category term="rsearch methodology" /><category term="AZD6244" /><category term="calgary" /><category term="primary care doctorssurvivorship" /><category term="Youtube" /><category term="inherited cancers" /><category term="palliative chemotherapy" /><category term="champions" /><category term="NICE;  UK" /><category term="hospital procedure" /><category term="antioxidants" /><category term="overtreatment" /><category term="Randomized controlled trials; Recruitment; Patient information; Primary care; Research methods; Trial design" /><category term="operating time" /><category term="physician preferences" /><category term="research access" /><category term="Hatlie" /><category term="cancer progression" /><category term="multidrug resistance" /><category term="medical" /><category term="taxanes" /><category term="postmarketing" /><category term="nccn breast cancer" /><category term="combinations" /><category term="booklet" /><category term="small intestine" /><category term="executive director" /><category term="journal index" /><category term="high risk breast cancer" /><category term="sunitinib" /><category term="canadian" /><category term="private practice" /><category term="etanercept" /><category term="canadian health care system" /><category term="increasing rates" /><category term="memory" /><category term="cyst" /><category term="employment" /><category term="TrueBeam" /><category term="obese" /><category term="2012 eso conference" /><category term="H3 Biomedicine" /><category term="symptom checking" /><category term="oophorectomy" /><category term="LMWH" /><category term="magazine article" /><category term="lack of evidence" /><category term="spirtual" /><category term="surgical treatment" /><category term="oxygen" /><category term="brain tumor clinical trials" /><category term="stem cell. research" /><category term="underdiagnosed" /><category term="anastomotic leak" /><category term="small bowel obstruction" /><category term="IGFBP-4" /><category term="HIPEC" /><category term="super-specialization" /><category term="cancer improvement act" /><category term="microscopic bubbles" /><category term="intraperitoneal spillage" /><category term="Norway" /><category term="alternative therapy" /><category term="movement" /><category term="molecular classification" /><category term="Docetaxel" /><category term="cancer disparities" /><category term="QOL. clinical trials" /><category term="skin toxicity" /><category term="new cancer center" /><category term="results" /><category term="patient outcomes" /><category term="ismycancerdifferent?" /><category term="primary chemotherapy" /><category term="triage" /><category term="telomere" /><category term="advertisements" /><category term="DEcIDE" /><category term="PARP inhibitors" /><category term="ovarian cell types" /><category term="FDA warning" /><category term="pharmacist" /><category term="litigation" /><category term="Tamoxifen" /><category term="medical school" /><category term="colorectal cancer genetics" /><category term="fertility sparing surgery" /><category term="non carriers" /><category term="pay per view" /><category term="skin" /><category term="access to information" /><category term="dignity" /><category term="antioxidative" /><category term="complete responses" /><category term="shannon" /><category term="PCP" /><category term="radiation oncology" /><category term="dna sequencing" /><category term="WRHA" /><category term="Velcade" /><category term="abdominal" /><category term="world cancer congress" /><category term="cancer support" /><category term="lab tests" /><category term="inherited markers" /><category term="St Louis" /><category term="humanitarianism" /><category term="elastic compression" /><category term="needs assessment" /><category term="educational materials" /><category term="clear cell endometrial" /><category term="Halifax" /><category term="assay" /><category term="test" /><category term="Indonesia" /><category term="tips" /><category term="microenvironment research" /><category term="Amifostine" /><category term="neoadjuvant chemotherapy" /><category term="asian americans" /><category term="copy number" /><category term="benefit" /><category term="afebrile neutropenia" /><category term="interns" /><category term="epatients" /><category term="cdc" /><category term="imaging results" /><category term="palliation" /><category term="radiation-induced" /><category term="advanced cancer" /><category term="Romidepsin" /><category term="high risk breast" /><category term="Ovarian cancer; Biomarker; Autoantibody; p53; CA125" /><category term="Extraperitoneal metastases" /><category term="streamlining" /><category term="endocrine policy statement" /><category term="clear cell ovarian" /><category term="spiritual care" /><category term="alberta guidelines ovarian cancer" /><category term="quality" /><category term="poly ADP-ribose polymerase" /><category term="AUra" /><category term="mouth" /><category term="patient advocate" /><category term="informed consent" /><category term="2012 annual conference" /><category term="ovarian cancer; symptoms" /><category term="PARP" /><category term="retrospective data" /><category term="genetic signature" /><category term="death ratios" /><category term="patient pages asco" /><category term="hospital admissions" /><category term="Asia" /><category term="individualized treatment of patients with advanced stage ovarian cancer" /><category term="ecancer" /><category term="esgo" /><category term="company sponsored" /><category term="modified treatment plan" /><category term="disability" /><category term="mothers" /><category term="medical record access" /><category term="primary mucinous" /><category term="aranesp" /><category term="comparison" /><category term="high blood pressure" /><category term="response shift" /><category term="internet" /><category term="whole genome testing" /><category term="colectomy" /><category term="CNS" /><category term="complimentary and alternative medicine" /><category term="family physicians" /><category term="port" /><category term="glaxosmithkline" /><category term="biomarker" /><category term="oral supplements" /><category term="grants" /><category term="women" /><category term="OvaGene" /><category term="ARIDIA" /><category term="pathways" /><category term="patient involvement" /><category term="financial costs" /><category term="intraperitoneal chemotherapy" /><category term="prophylactic vaginal dilators" /><category term="ribbon" /><category term="spleen" /><category term="comorbidity" /><category term="non specialists" /><category term="Ovarian Cancer Action" /><category term="parenteral nutrition" /><category term="Percutaneous" /><category term="optimism" /><category term="drug resistance" /><category term="COTI" /><category term="loneliness" /><category term="e medical" /><category term="firefighters" /><category term="persistent disease" /><category term="molecular testing" /><category term="Clare" /><category term="gene specific risk" /><category term="pain specialists" /><category term="struma ovarii" /><category term="foundation for women's cancer" /><category term="fallopian tube cancer" /><category term="skin testing" /><category term="medication errors" /><category term="IMGN853" /><category term="early detection test" /><category term="primary peritoneal cancer" /><category term="fraud" /><category term="FAR-131" /><category term="New York" /><category term="vital signs" /><category term="Lab Corp" /><category term="policy" /><category term="legal" /><category term="literacy" /><category term="individualized care" /><category term="capsule rupture" /><category term="interview" /><category term="reproductive technology" /><category term="primary treatment" /><category term="cognitive" /><category term="power" /><category term="OCNA" /><category term="subscriptions" /><category term="figure" /><category term="Maspin" /><category term="bloggers" /><category term="surgical oncology" /><category term="Precision Therapeutics" /><category term="anthracyclines" /><category term="reuters" /><category term="genetic risk small cell ovary" /><category term="incompetence" /><category term="patient safety network" /><category term="dalteparin" /><category term="UK biobank" /><category term="patient advocacy" /><category term="trailer" /><category term="spirit" /><category term="interval debulking surgery" /><category term="antibiotics" /><category term="nurse led" /><category term="transitions" /><category term="integrated genomic based approach" /><category term="podcasts" /><category term="gastrointestinal complications" /><category term="CVac" /><category term="molecular markers" /><category term="health advocacy organizations" /><category term="palliative" /><category term="Genentech" /><category term="Marilyn" /><category term="Peutz-Jeghers Syndrome" /><category term="willingness to pay" /><category term="tracey gorden" /><category term="plants" /><category term="platinum" /><category term="Teal Toes" /><category term="MAPK" /><category term="principles" /><category term="subtotal colectomy" /><category term="menopause" /><category term="Yi" /><category term="Wistar Institute" /><category term="siblings" /><category term="BC Cancer Agency" /><category term="3M™ Coban™ 2" /><category term="ABT-888" /><category term="Daunorubicin" /><category term="PTEN" /><category term="Ignace Vergote" /><category term="doctor reviews" /><category term="social media" /><category term="canadian scientists" /><category term="geriatrics" /><category term="Lynch Syndrome clinical trial" /><category term="dysgerminoma" /><category term="genes" /><category term="knowledge genetics family history" /><category term="calcium" /><category term="radiation therapy" /><category term="premature menopause" /><category term="interleukin-6" /><category term="self-define symptoms" /><category term="carcinoid" /><category term="self care" /><category term="ZNF365" /><category term="cardiotoxicity" /><category term="contrast-enhanced" /><category term="sorry" /><category term="followup care" /><category term="expert patients" /><category term="rankings" /><category term="DPX-Survivac" /><category term="primary" /><category term="palliative sedation" /><category term="early breast cancer" /><category term="gabapentin enacarbil" /><category term="patient computer dialogue" /><category term="cancer care delivery" /><category term="public health" /><category term="skinner" /><category term="human dignity" /><category term="health evidence network" /><category term="risk-benefit" /><category term="bisphenoal A" /><category term="Histone deacetylase (HDAC) inhibitors" /><category term="needs" /><category term="HDAC inhibitors" /><category term="undiagnosed diseases" /><category term="assay testing" /><category term="male brca screening" /><category term="radiology" /><category term="DcR3" /><category term="conditional survival rates" /><category term="stories" /><category term="journal club" /><category term="medical training" /><category term="health care delivery; informed consent; professional-patient relationship; right to health care" /><category term="journalism" /><category term="progression" /><category term="burden" /><category term="Amsterdam" /><category term="necrosis" /><category term="isolation" /><category term="genome grants" /><category term="CEA" /><category term="reputation" /><category term="AICR" /><category term="charities" /><category term="letter to the editor" /><category term="statistics canada" /><category term="PreOvar test" /><category term="patients experience" /><category term="AGR2" /><category term="paywalled" /><category term="cancer specific stress" /><category term="non invasive" /><category term="gilda's club" /><category term="natural health products" /><category term="institituion" /><category term="assumptions" /><category term="uncommon histology" /><category term="Mimosa" /><category term="Ferrandina" /><category term="asian medicine" /><category term="science journalsim" /><category term="implants" /><category term="faulty logic" /><category term="SQUID technology" /><category term="Gadavist" /><category term="Dr Benivegan" /><category term="Berwick" /><category term="death rates" /><category term="monitoring" /><category term="website" /><category term="OVAR-IMRT" /><category term="high volume" /><category term="IGCS" /><category term="toxicities" /><category term="squamous cell ovarian cancer; endometriosis" /><category term="sporadic" /><category term="Update" /><category term="ovatax" /><category term="dilemmas" /><category term="grading systems" /><category term="drainage tube" /><category term="power study" /><category term="Onko-Sure" /><category term="indigenous people" /><category term="Anxiety; Decision-making" /><category term="guidelines" /><category term="understand" /><category term="hospital bills" /><category term="study design" /><category term="gog 262" /><category term="quest pharma" /><category term="healthy lifestype" /><category term="amlodipine" /><category term="survivorship plans" /><category term="romanow commission" /><category term="safety" /><category term="drug mishap" /><category term="tyrosine kinase receptors" /><category term="truth" /><category term="toxicity" /><category term="inflammatory breast cancer" /><category term="ErbB" /><category term="prairie" /><category term="medical students; peer learning; surgical skills" /><category term="survivours debate" /><category term="virtual" /><category term="serum creatinine levels" /><category term="conflicts of interest" /><category term="non-steroid anti-inflammatory" /><category term="Clomiphene" /><category term="pregnancy in cancer" /><category term="breast" /><category term="surgical qualifications" /><category term="tumor progression" /><category term="rheumatoid arthritis" /><category term="Cancer Cell Line Encyclopedia" /><category term="gynecologic cancer care" /><category term="cancers" /><category term="clincial trials" /><category term="ambiguous" /><category term="rnai" /><category term="ureteral" /><category term="Michelle Robinson" /><category term="histone deacetylase inhibitors" /><category term="clear cell uterine" /><category term="universal health care" /><category term="unfunded" /><category term="referral patterns" /><category term="interleukin-2" /><category term="serous" /><category term="pet registry" /><category term="prophylactic surgery" /><category term="honesty" /><category term="pulmonary embolism" /><category term="international women's day" /><category term="underestimates" /><category term="TGFß1 mRNA" /><category term="falsification" /><category term="sequential" /><category term="breast conserving surgery" /><category term="hypermethylation" /><category term="Chicago" /><category term="surgical site infections" /><category term="ALOX5" /><category term="susan g komen" /><category term="OGX-011" /><category term="unclassified" /><category term="learning" /><category term="U.S. healthcare" /><category term="dextran" /><category term="lung cancer" /><category term="international cancer genome consortium" /><category term="Montreal" /><category term="CSF" /><category term="Taxotere" /><category term="GM-CSF" /><category term="musculoskeletal" /><category term="speaker" /><category term="ESMO. conference" /><category term="indices" /><category term="post" /><category term="rectum" /><category term="pelvic veins" /><category term="clinical practice guidelines" /><category term="physical examinations" /><category term="readmissions" /><category term="end points" /><category term="insomnia" /><category term="harms" /><category term="low oxygen" /><category term="awards" /><category term="observational studies" /><category term="peripheral blood" /><category term="Org 2766" /><category term="ovarian cancer target therapies" /><category term="familial breast cancer" /><category term="familial non-syndromic" /><category term="long term distress" /><category term="hereditary breast ovarian" /><category term="CER" /><category term="apoptosis" /><category term="long term cancer survivors" /><category term="fertility counseling" /><category term="national cancer genomic medicine" /><category term="LFS" /><category term="public documents" /><category term="trends" /><category term="elderly cancer patients" /><category term="emotion" /><category term="immunocellular therapeutics" /><category term="pain management" /><category term="Canada" /><category term="Akts" /><category term="subtypes" /><category term="cochrane" /><category term="low grade serous ovarian" /><category term="bladder carcinoma" /><category term="miR-645" /><category term="stem cell therapies" /><category term="clearity foundation" /><category term="Microscopic Hematuria" /><category term="HER2/neu" /><category term="germline" /><category term="excercise" /><category term="cancer politics" /><category term="sequence" /><category term="decatumumab" /><category term="high penetrance mutations" /><category term="cancer control" /><category term="Gynecologic cancer; Symptoms; Assessment; Ovarian cancer; Cervical cancer; Vulvar cancer" /><category term="herbal use" /><category term="kindred" /><category term="labels" /><category term="target based" /><category term="the oncologist free app" /><category term="kidney cancer" /><category term="PPP2R1A" /><category term="TIF" /><category term="coping" /><category term="BNP1350" /><category term="lymphoedema" /><category term="time allocation" /><category term="gene maps" /><category term="colonoscopies" /><category term="chemo-resistant ovarian cancer" /><category term="interpret" /><category term="drug induced damage" /><category term="ASGO" /><category term="; NICE; CA125" /><category term="open access publishing" /><category term="tarceva" /><category term="cyst rupture" /><category term="zoledronic acid" /><category term="anthracycline" /><category term="endometriosis" /><category term="health inovation" /><category term="bilary tract" /><category term="nci cancer bulletin" /><category term="registries" /><category term="integrative cancer therapies" /><category term="ovarian cancer survivor" /><category term="bladder cancer" /><category term="agonists" /><category term="breast cancer genetic management" /><category term="taste alterations" /><category term="recruitment" /><category term="online prescriptions" /><category term="stage 1V ovarian cancer survival" /><category term="FIPPA" /><category term="single port" /><category term="MuGuard" /><category term="doctors for medicare" /><category term="editors" /><category term="WT1" /><category term="mice" /><category term="options" /><category term="ovarian cancer ICGC" /><category term="neoadjuvant therapy" /><category term="social support" /><category term="dictionary" /><category term="cystotomy" /><category term="diagnostic testing" /><category term="free speech" /><category term="mutch" /><category term="drugs" /><category term="distribution" /><category term="medicine" /><category term="pathologist" /><category term="medical devices" /><category term="hospital staff" /><category term="circulating miRNA biomarkers" /><category term="predictive factor" /><category term="salaries" /><category term="unmet needs" /><category term="PI3K/mTOR-pathway inhibitors" /><category term="difficult patient" /><category term="surgical adhesions" /><category term="older women" /><category term="fingerprint loss" /><category term="pathogenesis" /><category term="elderly" /><category term="consumers" /><category term="assessments" /><category term="dying" /><category term="virginia" /><category term="Family communication" /><category term="best care" /><category term="munk debates" /><category term="relative survival" /><category term="hypersensitivy" /><category term="suppportive care" /><category term="advocates" /><category term="bloody stools" /><category term="ecco" /><category term="atlas" /><category term="self reported health" /><category term="variables" /><category term="astrazeneca" /><category term="cpsi" /><category term="ovarian cancer diagnostics" /><category term="compensation" /><category term="schedule" /><category term="llaparoscopy" /><category term="granisetron" /><category term="anticancer drugs" /><category term="enema" /><category term="government" /><category term="disease drug comparisons" /><category term="experimental drug" /><category term="blog terms" /><category term="symptoms menopause" /><category term="type D personality" /><category term="clear cell ovarian survival" /><category term="physician burnout" /><category term="EMSY" /><category term="mmr" /><category term="bad news" /><category term="platinum resistance" /><category term="cancer research algorithms" /><category term="systematic  reviews" /><category term="high stage" /><category term="journalists" /><category term="nightshift" /><category term="diciplinarian action" /><category term="holistic medicine" /><category term="technology" /><category term="blood stool test" /><category term="hostility" /><category term="MUC1" /><category term="genetic test" /><category term="tort reform" /><category term="anastrozole" /><category term="pools" /><category term="glutathione" /><category term="dr oz show" /><category term="consent" /><category term="origins" /><category term="ERCC1" /><category term="1C" /><category term="tedmed" /><category term="gcf" /><category term="ovarian cancer cell types" /><category term="canadian hospitals" /><category term="Becoming a Radiologist" /><category term="recurrent" /><category term="treatment outcomes" /><category term="inherited" /><category term="gastrointestinal tract" /><category term="water" /><category term="third chemotherapy" /><category term="september" /><category term="breast brachytherapy" /><category term="IL1A rs17561" /><category term="endocrinology" /><category term="multiple cancers" /><category term="childhood cancer survivors" /><category term="parental cancer" /><category term="pre menopausal" /><category term="health care services" /><category term="Colorado" /><category term="pic lines" /><category term="self diagnosis" /><category term="world health organization" /><category term="K618A" /><category term="cancerrxgene" /><category term="signmoidoscopy" /><category term="intimidation" /><category term="CD30" /><category term="Radiologist" /><category term="mathematics" /><category term="malinda teel" /><category term="coffee" /><category term="green tea" /><category term="oncologists" /><category term="death certificates" /><category term="fda.genetic testing" /><category term="journals" /><category term="dose-dense" /><category term="magazine" /><category term="barriers" /><category term="relationship" /><category term="retraction" /><category term="radiation" /><category term="second cytoreductive surgery" /><category term="digital divide" /><category term="canadian government" /><category term="PET/CT" /><category term="Carboplatin-PLD" /><category term="mental health" /><category term="thromboembolism" /><category term="Carboplating" /><category term="wisdom of crowds" /><category term="multidisciplinary care" /><category term="risk reducing mastectomy" /><category term="chemotherapy advisor" /><category term="OCIAD2; ovarian mucinous tumor" /><category term="doctor-patient communication" /><category term="multicentre" /><category term="planner" /><category term="multiple serrated polyps" /><category term="50+ yr" /><category term="review" /><category term="robert a nagourney" /><category term="ovarian surgery" /><category term="doctor" /><category term="fallopian tubes" /><category term="female" /><category term="nevada genetic testing" /><category term="oncology" /><category term="2011 asco abstracts" /><category term="college" /><category term="CSFs" /><category term="blog posts" /><category term="front line therapy" /><category term="alcohol" /><category term="neurologic" /><category term="FIGO staging endometrial cancer" /><category term="cytotoxic drug errors" /><category term="superstition" /><category term="Ovacome" /><category term="vegetables" /><category term="self identified" /><category term="research centers" /><category term="adenoviruses" /><category term="endometrioid ovarian" /><category term="CA125 Antigen; Surveillance; nadir" /><category term="toremifene" /><category term="public" /><category term="federal government" /><category term="Early integration" /><category term="patients" /><category term="slovenia" /><category term="photos" /><category term="VEGF Trap" /><category term="Cisplatin" /><category term="palliative homecare" /><category term="leiomyosarcoma" /><category term="U.S. ovarian cancer ICGC" /><category term="dietary supplements" /><category term="private health care canada" /><category term="cancer spread" /><category term="post surgery" /><category term="problem detection study" /><category term="patient participants" /><category term="patrick dempsey" /><category term="deficiency" /><category term="brca genetic testing" /><category term="commonwealth fund" /><category term="gynecology" /><category term="biochemistry" /><category term="clear cell ovarian cancer" /><category term="cathy chapman" /><category term="genetic instability" /><category term="CPT-P" /><category term="perspectives" /><category term="spirituality" /><category term="ondansetron" /><category term="Urogynocolgy" /><category term="overweight" /><category term="Karlan" /><category term="DCIS" /><category term="photodynamic therapy" /><category term="taxane chemotherapy" /><category term="Cochrane Collaboration" /><category term="pelvic exams" /><category term="merger" /><category term="ovarian cancer biology" /><category term="scar tissue" /><category term="cancer survivorship health behaviours" /><category term="MYH associated polyposis" /><category term="nonprofit" /><category term="clarity" /><category term="FDA" /><category term="cleaning products" /><category term="pixantrone fda" /><category term="gastrointestinal cancers" /><category term="A6" /><category term="healthcare act" /><category term="survivor award" /><category term="vegatables" /><category term="peglylated liposomal doxorubicin" /><category term="OPT-821" /><category term="urothelial bladder cancer" /><category term="international healthcare" /><category term="regret" /><category term="life support" /><category term="mycare" /><category term="Symptom control" /><category term="Fortitude" /><category term="commercializtion" /><category term="ovarian endocrine" /><category term="information" /><category term="adrenocortical" /><category term="guidance report" /><category term="gene signatures" /><category term="luck" /><category term="human genome" /><category term="gi dna testing fecal biomarkers" /><category term="monk" /><category term="stents" /><category term="research misconduct" /><category term="tongue" /><category term="measles virus vaccine" /><category term="Gynaecology" /><category term="pediatric cancer survivors" /><category term="Therapy-related myeloid leukemia" /><category term="EUAS" /><category term="chinese" /><category term="melatonin" /><category term="feeds" /><category term="bone health" /><category term="patients first" /><category term="clinical trial enrolment" /><category term="wine" /><category term="fraser report" /><category term="critical illness" /><category term="hnppc" /><category term="international gynecologic cancer society" /><category term="renal impairment" /><category term="ulceration" /><category term="pharmaceutical industry" /><category term="Mendoza" /><category term="cognitive abilities" /><category term="CTC" /><category term="surgical centers" /><category term="distress" /><category term="inadequate surgery" /><category term="hospital care" /><category term="genetic counseling" /><category term="no needless list" /><category term="powerful patients" /><category term="oopherectomy" /><category term="Reovirus" /><category term="cellsearch" /><category term="opinions" /><category term="contrast enhanced" /><category term="public health genomics" /><category term="shared environment" /><category term="immunoglobulin" /><category term="sincerity" /><category term="herpes zoster vaccine" /><category term="molecular subtypes" /><category term="PSD95 inhibitor" /><category term="A4" /><category term="morality" /><category term="laparoscopic" /><category term="immunization schedule" /><category term="bio markers" /><category term="free access" /><category term="alteratives" /><category term="doctors" /><category term="the oncologist" /><category term="caring" /><category term="clinical care options" /><category term="Temsirolimus" /><category term="neovascular" /><category term="in vitro fertilization" /><category term="oocyte" /><category term="cost" /><category term="heart attack" /><category term="end of life" /><category term="VEGFR2" /><category term="tissue" /><category term="pilot program" /><category term="anticoagulants" /><category term="interactions" /><category term="ovarian cancer survival Europe" /><category term="mismatch repair genes" /><category term="suffering" /><category term="bias" /><category term="futility" /><category term="political oncology" /><category term="SGO" /><category term="horse" /><category term="microbubble" /><category term="patient safety" /><category term="etiologic link" /><category term="antiangiogenic" /><category term="breast cancer metastasis" /><category term="European Cancer Resolution" /><category term="McMaster" /><category term="Gemcitabine" /><category term="skeptical" /><category term="integrated cancer care" /><category term="outcome research" /><category term="familial syndrome" /><category term="Conejo-Garcia" /><category term="FDG" /><category term="Assisted reproductive technology" /><category term="user involvement" /><category term="testing" /><category term="terry fox foundation" /><category term="trabectedin" /><category term="platinum retreatment" /><category term="others" /><category term="humans" /><category term="Nektar" /><category term="genomics in drug sensitivity" /><category term="breast reconstruction" /><category term="WORD" /><category term="post-operative" /><category term="online tools" /><category term="concensus" /><category term="keystone" /><category term="ovarian cancer survival" /><category term="chinese-americans" /><category term="AHRQ" /><category term="treatment responses" /><category term="Commonweath Fund" /><category term="drug advertising" /><category term="lawsuit oncologist physician canada cancer ovarian gynecology" /><category term="low stage" /><category term="nomogram" /><category term="rectal cancer" /><category term="autoimmune" /><category term="univerity of alberta" /><category term="canadian ovarian guidelines" /><category term="fibromyalgia" /><category term="SOX11" /><category term="Roxiane" /><category term="recto-sigmoid" /><category term="drug approvals" /><category term="breast cancer risk" /><category term="moderated" /><category term="ovarian cancer CANO presentation conference St John's" /><category term="telephone" /><category term="gastrointestinal bleeding" /><category term="PI3K" /><category term="office" /><category term="AML" /><category term="P349L" /><category term="needless" /><category term="lack of understanding" /><category term="interpretation" /><category term="gastrointestinal" /><category term="yolk sac" /><category term="non invasive colorectal cancer screening" /><category term="CHEMSAS" /><category term="risk assessment" /><category term="comparative effectiveness" /><category term="access to care" /><category term="hours of service" /><category term="surveys" /><category term="vrca" /><category term="mimicking" /><category term="Tipper" /><category term="ehealth" /><category term="ovarian cancer case reports" /><category term="pancreatic cancer" /><category term="treatment related side effects" /><category term="cancer journal" /><category term="faltering cancer trials" /><category term="protocol" /><category term="cecum" /><category term="NS" /><category term="Nidogen-2" /><category term="world cancer research fund" /><category term="identification" /><category term="medical tests" /><category term="calcitriol" /><category term="9p22.2" /><category term="selenium" /><category term="evidence updates" /><category term="CCO" /><category term="low-risk women" /><category term="Horizon Discovery" /><category term="atlas of genetics" /><category term="freezing ovarian tissue" /><category term="bladder injury" /><category term="your guide to taking control" /><category term="cancer specific" /><category term="imaging technology" /><category term="UK guidelines" /><category term="mean platelet volume" /><category term="poradic ovarian cancer" /><category term="cancer care" /><category term="bone turnover" /><category term="Stimuvax" /><category term="morphine" /><category term="engagement" /><category term="early age diagnosis" /><category term="open medicine" /><category term="kitten" /><category term="integrated optical coherence tomography" /><category term="chris carr" /><category term="first relapse" /><category term="diagnostics; HE4" /><category term="MMS" /><category term="board certified" /><category term="low penetrance genes" /><category term="thrombocytosis" /><category term="donors" /><category term="indianapolis" /><category term="prescription costs canada" /><category term="duodenal" /><category term="patient survey" /><category term="ATAC" /><category term="digital mammography" /><category term="nodules" /><category term="hypersensitivity" /><category term="opportunities" /><category term="Patient-Centered Outcomes Research Institute" /><category term="healthy volunteers" /><category term="randomised trials" /><category term="dna stool testing" /><category term="CD3" /><category term="patient goals" /><category term="male" /><category term="Patupilone" /><category term="arrayit diagnostics" /><category term="EC145" /><category term="HuGENet" /><category term="Latinos" /><category term="Edmonton Symptom Assessment Scale" /><category term="weekly taxol" /><category term="limited" /><category term="granulocyte colone stimulating" /><category term="NAFC" /><category term="hormone contraceptive" /><category term="compare" /><category term="personality type d" /><category term="report card" /><category term="patients' association of canada" /><category term="patient harm" /><category term="NIH" /><category term="pills" /><category term="ovarian cancer in chinese women" /><category term="EORTC" /><category term="astro" /><category term="EGAPP" /><category term="brca muation testing" /><category term="scale" /><category term="hospital cleanliness" /><category term="ESO" /><category term="inhibitorsmutations" /><category term="laparoscopic surgery" /><category term="slide presentation" /><category term="brca decision tool" /><category term="dna" /><category term="bahamas" /><category term="proctectomy" /><category term="CD4" /><category term="stage 1V" /><category term="pay for performance" /><category term="sdoh" /><category term="foundation" /><category term="bufferin" /><category term="plant based" /><category term="68Ga-DOTATATE" /><category term="film" /><category term="surgical costs" /><category term="risk of malignancy index" /><category term="negative study" /><category term="ovarian cancer research" /><category term="patients voice drug safety" /><category term="CA4P" /><category term="Chronix Biomedical" /><category term="boards" /><category term="genetic research" /><category term="risk management" /><category term="ovarian cancer surveillance" /><category term="amgen" /><category term="secondary surgery" /><category term="immunostaining" /><category term="NL" /><category term="survival" /><category term="rare tumor types" /><category term="gtube" /><category term="breast cancer subtypes" /><category term="Karen Klok Anderegg" /><category term="weekly topotecan" /><category term="diabetic" /><category term="cancer care Europe" /><category term="Elisa" /><category term="U.S. cancer report 2012" /><category term="Tetranectin" /><category term="CHOP" /><category term="elsevier journals" /><category term="nonsteroid anti-inflammatory" /><category term="precancer" /><category term="patients opinion" /><category term="most popular posts" /><category term="claims" /><category term="malnutrition" /><category term="histotype" /><category term="ovarian cancer hope" /><category term="overdiagnosis" /><category term="flowers" /><category term="germ cell" /><category term="Women's Health Initiative" /><category term="legislation" /><category term="Breakthrough pain" /><category term="perceptions" /><category term="MYC" /><category term="invisible" /><category term="paraneoplastic cerebellar degeneration" /><category term="metastatic ovarian cancer" /><category term="rare ovarian tumors" /><category term="critical thinking" /><category term="health centers" /><category term="emergency medicine" /><category term="18F-FDG PET-CT" /><category term="lesions" /><category term="influences" /><category term="stage 1" /><category term="Primary tumourdebulking; Secondary tumourdebulking; Tumour dissemination; Tumour residuals; Outcome" /><category term="clinique" /><category term="sabotage" /><category term="ovarian primary peritoneal cancer" /><category term="postsurgical" /><category term="CPU" /><category term="dose dense" /><category term="sun exposure" /><category term="plain language" /><category term="serms" /><category term="nations" /><category term="seeding trials" /><category term="teleconference" /><category term="stage 2" /><category term="acetylcysteine" /><category term="Mount Sinai" /><category term="platinum based chemotherapy" /><category term="adnexal masses" /><category term="sharing" /><category term="Prealbumin; Transthyretin; CA 125; Ovarian neoplasms; Pelvic mass" /><category term="dermatology" /><category term="canada gastroenterology" /><category term="subspecialization" /><category term="circulating miRNA" /><category term="host factors" /><category term="SEER" /><category term="trialcheck" /><category term="early stage" /><category term="patient education" /><category term="model" /><category term="delayed diagnosis" /><category term="cancer patient care" /><category term="distrupted lives" /><category term="ecstacy" /><category term="peritoneal mesothelioma" /><category term="non epithelial ovarian" /><category term="erlotinib" /><category term="tools" /><category term="informed decisions" /><category term="cancer oncology alternatives complimentary medicine Canada U.S." /><category term="specialist care" /><category term="insulin" /><category term="online pharmacy" /><category term="conflicts" /><category term="hormone replacement therapy" /><category term="folate vaccine" /><category term="nasal" /><category term="ummunovaccine" /><category term="training" /><category term="pre-diagnosis" /><category term="inconclusive" /><category term="deaths" /><category term="upper limb" /><category term="jama" /><category term="advanced stage" /><category term="fda alert" /><category term="cystic tumors" /><category term="patient's perspective" /><category term="oscillation" /><category term="brain" /><category term="physician" /><category term="cancer medical oncologist" /><category term="family doctor" /><category term="vitamin D. less common" /><category term="tumor spread" /><category term="Methylene blue" /><category term="contagious cancer" /><category term="ureteral injury" /><category term="unemployment" /><category term="TA-65" /><category term="NHS" /><category term="CA19.9" /><category term="ovarian cancer" /><category term="prognostic" /><category term="patient impact" /><category term="rateMDs" /><category term="comment" /><category term="dnr" /><category term="nutrition" /><category term="sgo annual meeting" /><category term="low risk" /><category term="folate receptors" /><category term="physicial" /><category term="pathologists" /><category term="NICE" /><category term="coercive" /><category term="reproduction" /><category term="treatment" /><category term="risk" /><category term="inspiration" /><category term="herbal products" /><category term="dehumanization" /><category term="Leape" /><category term="AIDS" /><category term="permanent hair loss" /><category term="thank you" /><category term="hinder" /><category term="immunotherapeutic" /><category term="survivours" /><category term="Singapore" /><category term="Ortiz" /><category term="2012 japanese medical oncology conference" /><category term="2009 Italy" /><category term="next generation sequencing" /><category term="flaherty" /><category term="cell lines" /><category term="Enzastaurin" /><category term="cancer care systems" /><category term="early ovarian cancer detection" /><category term="thalidomide" /><category term="white light" /><category term="Edinburgh" /><category term="patient advocates" /><category term="statements" /><category term="cytoreductive surgery" /><category term="Taxol" /><category term="publishing" /><category term="literature" /><category term="cystic mass" /><category term="radiation exposure" /><category term="sequencing" /><category term="google search" /><category term="Rocco" /><category term="dissemination" /><category term="missing data" /><category term="outpatient" /><category term="Hirte" /><category term="ESA" /><category term="physician assistants" /><category term="acupuncture" /><category term="falsifying" /><category term="targeted" /><category term="ontario womens health network" /><category term="long term side effects" /><category term="Gynecologic Oncologists of Canada" /><category term="phase 11 clinical trial" /><category term="EHR" /><category term="gynaecologic oncologist" /><category term="BRCA1" /><category term="dynamic  fmri" /><category term="stimatization" /><category term="FBW7" /><category term="magnetic nanoparticles" /><category term="reproductive medicine" /><category term="debate presentation" /><category term="Docetaxel; Abdominal radiation; Chemosensitizer; CT" /><category term="patient values" /><category term="non-cancer patients" /><category term="internet strike" /><category term="naturopathy" /><category term="common pathways" /><category term="healthcare denial" /><category term="advanced care planning" /><category term="appendicitis" /><category term="institutions" /><category term="personhood" /><category term="colorectal cancer risks" /><category term="statistical model" /><category term="fecal accult blood tests" /><category term="generic drugs" /><category term="game" /><category term="vegfr inhibitors" /><category term="medical journalism" /><category term="movie" /><category term="taxpayer funded reserch" /><category term="non genital tract" /><category term="non toxic" /><category term="computerized system patent" /><category term="CD8" /><category term="aspiration" /><category term="pleurodesis" /><category term="bilary" /><category term="abnormal lipids" /><category term="Archexin" /><category term="patient centred care" /><category term="injectable depots" /><category term="primary health care" /><category term="asco 2012 award" /><category term="ileoanal pouch" /><category term="Denmark" /><category term="intereactive" /><category term="current oncology" /><category term="CD34" /><category term="evidence" /><category term="appendix" /><category term="vaccine" /><category term="pleural malignancy" /><category term="science and healing" /><category term="hospitals" /><category term="sex cord stromal tumors" /><category term="dna damage" /><category term="uroepithelial" /><category term="portuguese" /><category term="BRCA2" /><category term="weekly stats" /><category term="hypercalcemia" /><category term="mri clinical trial" /><category term="science research" /><category term="voluntary" /><category term="OTUB1" /><category term="canvas art" /><category term="life sustaining treatments" /><category term="non serous" /><category term="integrative medicine" /><category term="mesothelin" /><category term="hernia" /><category term="cancer journals" /><category term="beva" /><category term="upper GI" /><category term="surgical clamps" /><category term="Oregon" /><category term="privacy" /><category term="septal" /><category term="patient safety. surgery" /><category term="collaborations" /><category term="screemomg" /><category term="low grader serous ovarian cancer" /><category term="hormone therapy" /><category term="Dr Lynch" /><category term="clincial trials mailing list healthcare" /><category term="personality" /><category term="patient input" /><category term="gynecologic cancer webinar" /><category term="useful information" /><category term="clinics" /><category term="over treatment" /><category term="patients association canada" /><category term="ROMA" /><category term="health states" /><category term="metastatectomy" /><category term="middletown" /><category term="lymph nodes" /><category term="squamous cell" /><category term="NET's" /><category term="reforms" /><category term="thrombosis" /><category term="votrient" /><category term="patiuents" /><category term="L1CAM" /><category term="estrogen receptor polymorphisms" /><category term="extraovarian" /><category term="procedure" /><category term="plain english" /><category term="weighte" /><category term="healthcare comparisons" /><category term="art of oncology" /><category term="hospital systems" /><category term="patents" /><category term="Modern Healthcare" /><category term="cancer risk" /><category term="prophylatic surgery" /><category term="late effects" /><category term="dietary fat" /><category term="immune" /><category term="Mexico" /><category term="RAD51 assay" /><category term="Netherlands" /><category term="google" /><category term="Contralateral Prophylactic Mastectomy" /><category term="early onset" /><category term="martin luther king jr" /><category term="malnourished" /><category term="heart attack risk" /><category term="user fees" /><category term="New Zealand" /><category term="breast cancer recurrence" /><category term="students for medicare" /><category term="Ashkenazi Jew pancreatic" /><category term="preventable" /><category term="epirubicin" /><category term="farlow" /><category term="Steve Jobs" /><category term="cancer genomics" /><category term="canadian health policy" /><category term="soul" /><category term="biopsies" /><category term="sleepiness" /><category term="cancer test" /><category term="sexuality" /><category term="burgers" /><category term="chat sessions" /><category term="cancer oncology" /><category term="Washington" /><category term="longevity" /><category term="citations" /><category term="histone deacetylase inhibitor" /><category term="6-thioguanine" /><category term="colony-stimulating factors" /><category term="program" /><category term="brca2 c.156_157insAlu" /><category term="size" /><category term="2012 annual conference cochrane" /><category term="oprah" /><category term="rob lamberts blog" /><category term="words" /><category term="double gloved" /><category term="emergency care" /><category term="ARID1A" /><category term="lymph note" /><category term="communications" /><category term="Melbourne" /><category term="squamous cell carcinoma" /><category term="purgatives" /><category term="synergy" /><category term="arteriosclerosis" /><category term="genetic testing registry" /><category term="gynecologic conference" /><category term="ostomy" /><category term="sickness certificates" /><category term="ERBB2" /><category term="Palmar–plantar erythrodysesthesia" /><category term="liposomal" /><category term="Prealbumin; Transthyretin; CA 125;  Pelvic mass" /><category term="blood test" /><category term="urogynecology" /><category term="e-communication" /><category term="Mylan-Amlodipine" /><category term="heart disease" /><category term="stage 11" /><category term="artist" /><category term="peritoneal fibrosis" /><category term="Cowden Syndrome" /><category term="paracentesis" /><category term="resveratrol" /><category term="mucinous" /><category term="group dynamics" /><category term="Ocrelizumab" /><category term="RFI" /><category term="scientific" /><category term="cervical cancer screening" /><category term="carcinogens" /><category term="herpes zoster" /><category term="wound complications" /><category term="OVA1" /><category term="microwave thermotherapy" /><category term="research quality" /><category term="lung metastases" /><category term="vemurafenib" /><category term="higher spending hospitals" /><category term="financial conflicts of interest" /><category term="seniors" /><category term="malignant effusion" /><category term="priorities" /><category term="Globe and Mail" /><category term="cancer therapies" /><category term="Clinical Oncological Society" /><category term="brain metastases; Central nervous system metastases; Ovarian cancer; Survival" /><category term="Temisirolimus" /><category term="UHN" /><category term="mexican women" /><category term="trust" /><category term="persuasion" /><category term="navigators" /><category term="treatment related secondary primary" /><category term="patients views" /><category term="MiCK" /><category term="Cyberknife" /><category term="expenditures" /><category term="difficult patients" /><category term="lancet oncology" /><category term="bill C-38" /><category term="class" /><category term="ovarian cancer blog" /><category term="genomics" /><category term="NanoKnife" /><category term="misinterpreted" /><category term="antibody drug conjugates" /><category term="yolk sac ovarian" /><category term="pelvic floor prolapse" /><category term="internet explorer" /><category term="durhane wong-rieger" /><category term="non epithelial" /><category term="national pharmacare" /><category term="PFS" /><category term="Gorden" /><category term="physician survey" /><category term="chemo response" /><category term="abdominopelvic" /><category term="small study" /><category term="minerals" /><category term="tests" /><category term="pathology" /><category term="laparotomy" /><category term="hormone replace therapy" /><category term="knowledge gap" /><category term="cochrane journal club" /><category term="personalized cancer therapies" /><category term="CA125; surgery" /><category term="MR" /><category term="physician payments ontario" /><category term="psychosocial oncology" /><category term="nurse practitioner" /><category term="survivors" /><category term="Jerusalem" /><category term="necrotic tissue" /><category term="risk-reducing oophorectomy" /><category term="cysts" /><category term="minor children" /><category term="adjuvant hormonal therapy" /><category term="immunology" /><category term="FOXL2 c.402C G" /><category term="rare diseases" /><category term="android app" /><category term="omental masses" /><category term="inhibitors" /><category term="second-line" /><category term="immunosuppression" /><category term="lower limb" /><category term="silicone breast implants" /><category term="cancer theme issue" /><category term="meta-analysis" /><category term="let-7" /><category term="radiation resistant" /><category term="malignant" /><category term="guardians" /><category term="cervical cancer" /><category term="agenda" /><category term="collateral damage" /><category term="stage 1C" /><category term="resident physicians" /><category term="injury" /><category term="media critique" /><category term="ovariancancerandus" /><category term="SEPTRIS" /><category term="cochrane consumer network" /><category term="chemoresistance" /><category term="freezing" /><category term="not flashes" /><category term="plasminogen activator inhibitor-1" /><category term="alvarez" /><category term="DMS" /><category term="physican" /><category term="restless leg" /><category term="treatment related" /><category term="referrals" /><category term="mesothelin antibodies" /><category term="salpingo-oophorectomy" /><category term="citalopram" /><category term="efficiency" /><category term="patient-centered care" /><category term="laparoscopy" /><category term="research ethics" /><category term="HTX005" /><category term="symptoms ovarian cancer" /><category term="brain mets" /><category term="metastases" /><category term="CRF" /><category term="hypoxia" /><category term="nephrotoxicity" /><category term="polish" /><category term="family history" /><category term="socioeconomic status" /><category term="Hispanic" /><category term="birrer" /><category term="gynecologic cancer drug monograms" /><category term="Cameroon" /><category term="hand hygiene" /><category term="prejudices" /><category term="hyperthermic Intraperitoneal Chemotherapy" /><category term="Wyeth" /><category term="dollar a day" /><category term="partnership" /><category term="morbidity" /><category term="BluePrint" /><category term="remote" /><category term="CD47" /><category term="families" /><category term="doubling time" /><category term="diathermy" /><category term="canadian cancer society" /><category term="direct to consumer genetic testing" /><category term="health plans" /><category term="Inderal" /><category term="drug therapy;antineoplastic agents" /><category term="cancer-related anaemia" /><category term="onko sure" /><category term="slideshow" /><category term="ancient times" /><category term="Coukos" /><category term="in situ" /><category term="Europe" /><category term="IL-12 gene" /><category term="antiestrogens" /><category term="L-Glutamine" /><category term="ACE inhibitors" /><category term="suboptimal" /><category term="medical imaging" /><category term="easter bunny" /><category term="ECOG" /><category term="APC gene" /><category term="reproductive organs" /><category term="doctors 2.0" /><category term="phase 111" /><category term="genetic counselling" /><category term="primare" /><category term="CRC" /><category term="roles" /><category term="provinces" /><category term="dirty hospitals" /><category term="Denise" /><category term="guideline" /><category term="never events" /><category term="complex care" /><category term="ovarian cell" /><category term="oregovomab" /><category term="FOLR1" /><category term="interactive" /><category term="tHE ART of the Matter" /><category term="LXS Oral Powder" /><category term="NHA" /><category term="miratazapine" /><category term="clinical cancer advances" /><category term="cloud" /><category term="agency" /><category term="molecular analysis" /><category term="patient safety surgical site infections" /><category term="Complementary and Alternative Medicine" /><category term="nordic countries" /><category term="alpha-tocopherol" /><category term="stigma" /><category term="Japan" /><category term="human genetics" /><category term="microsatellite instability" /><category term="ColoMarker" /><category term="ovarian cancer international cancer genome consortium" /><category term="truth telling" /><category term="cancer related fatigue" /><category term="healthcare system" /><category term="stage 1A" /><category term="patient costs" /><category term="international group" /><category term="diaphragmatic surgery" /><category term="Sutent" /><category term="myriad genetics" /><category term="ignorance" /><category term="medical care" /><category term="antidepressants" /><category term="Latino" /><category term="cancer canada" /><category term="dormancy" /><category term="cryoablation" /><category term="high dose vitamin c" /><category term="Ontario" /><category term="bill gates" /><category term="Nichol" /><category term="ChemoFx" /><category term="statins" /><category term="screening tests" /><category term="cancer symptom reporting" /><category term="tweet cloud" /><category term="Darbepoetin Alfa" /><category term="fertility counselling" /><category term="stress" /><category term="call for abstracts" /><category term="bowel obstruction" /><category term="understanding your lab tests" /><category term="in person genetic testing" /><category term="Wellcome Trust" /><category term="blog" /><category term="delayed care" /><category term="patient guide" /><category term="triple-negative breast" /><category term="genomic data" /><category term="caregiving" /><category term="myalgia" /><category term="ovarian stimulation" /><category term="MolMed" /><category term="subspecialty care" /><category term="phase 0 clinical trials" /><category term="turning up the volume" /><category term="fdurd" /><category term="BRCAness" /><category term="whole brain radiotherapy" /><category term="metastatic gynecologic cancers" /><category term="u.s. healthcare systems" /><title type="text">OVARIAN CANCER and US</title><subtitle type="html">“We can't solve problems by using the same kind of thinking we used when we created them.”..........“Not everything that can be counted counts and not everything that counts can be counted.” 

Albert Einstein</subtitle><link rel="http://schemas.google.com/g/2005#feed" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/posts/default" /><link rel="alternate" type="text/html" href="http://ovariancancerandus.blogspot.com/" /><link rel="next" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default?start-index=26&amp;max-results=25" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><generator version="7.00" uri="http://www.blogger.com">Blogger</generator><openSearch:totalResults>8965</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/atom+xml" href="http://feeds.feedburner.com/OvarianCancerAndUs" /><feedburner:info uri="ovariancancerandus" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><link rel="license" type="text/html" href="http://creativecommons.org/licenses/by-nc-nd/3.0/" /><logo>http://creativecommons.org/images/public/somerights20.gif</logo><feedburner:emailServiceId>OvarianCancerAndUs</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><entry><id>tag:blogger.com,1999:blog-9029913.post-5042777516517658175</id><published>2012-05-29T06:13:00.000-04:00</published><updated>2012-05-29T06:13:28.601-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Canada" /><category scheme="http://www.blogger.com/atom/ns#" term="partnership against cancer canada" /><title type="text">SUSTAINING ACTION TOWARD A SHARED VISION - 2012–2017  Strategic Plan - Partnership Against Cancer Canada (does not include ovarian/gyn)</title><content type="html">Blogger's Note: search of 'ovarian'/'ovary'/'gyn' yields null results

SUSTAINING ACTION TOWARD A SHARED VISION - 2012–2017&amp;nbsp; Strategic Plan - Canada 

CONTENTS
2 MESSAGE FROM THE CHAIR AND CEO
4...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=WQfjwO3aE-k:KkldZkZAB1M:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=WQfjwO3aE-k:KkldZkZAB1M:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=WQfjwO3aE-k:KkldZkZAB1M:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=WQfjwO3aE-k:KkldZkZAB1M:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/WQfjwO3aE-k" height="1" width="1"/&gt;</content><link rel="related" href="http://www.partnershipagainstcancer.ca/wp-content/uploads/Sustaining-Action-Toward-A-Shared-Vision_web.pdf" title="SUSTAINING ACTION TOWARD A SHARED VISION - 2012–2017  Strategic Plan - Partnership Against Cancer Canada (does not include ovarian/gyn)" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/5042777516517658175/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/sustaining-action-toward-shared-vision.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5042777516517658175" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5042777516517658175" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/WQfjwO3aE-k/sustaining-action-toward-shared-vision.html" title="SUSTAINING ACTION TOWARD A SHARED VISION - 2012–2017  Strategic Plan - Partnership Against Cancer Canada (does not include ovarian/gyn)" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/sustaining-action-toward-shared-vision.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-5463235223178889573</id><published>2012-05-29T05:20:00.001-04:00</published><updated>2012-05-29T05:20:07.173-04:00</updated><title type="text">Ovarian Cancer and Us - blogger's note</title><content type="html">short sabbatical - blog postings to return in ~ one week - thanks!http://ovariancancerandus.blogspot.com/feeds/posts/default&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=sJ_7yxWX4V8:MT4lz9ak7nw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=sJ_7yxWX4V8:MT4lz9ak7nw:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=sJ_7yxWX4V8:MT4lz9ak7nw:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=sJ_7yxWX4V8:MT4lz9ak7nw:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/sJ_7yxWX4V8" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/5463235223178889573/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/ovarian-cancer-and-us-bloggers-note.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5463235223178889573" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5463235223178889573" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/sJ_7yxWX4V8/ovarian-cancer-and-us-bloggers-note.html" title="Ovarian Cancer and Us - blogger's note" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/ovarian-cancer-and-us-bloggers-note.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-6275953233856328179</id><published>2012-05-29T04:46:00.000-04:00</published><updated>2012-05-29T04:46:24.590-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="treatment related side effects" /><category scheme="http://www.blogger.com/atom/ns#" term="skin toxicity" /><category scheme="http://www.blogger.com/atom/ns#" term="side effects" /><category scheme="http://www.blogger.com/atom/ns#" term="adverse effects" /><title type="text">Journal of Experimental &amp; Clinical Cancer Research |- Chemotherapy and skin reactions</title><content type="html">Journal of Experimental &amp;amp; Clinical Cancer Research&amp;nbsp; Chemotherapy and skin reactions

Research

 Chemotherapy  and skin  reactions The complete article is available as a provisional PDF. The...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=NBi4hcdSSik:AMwKFPhfLuo:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=NBi4hcdSSik:AMwKFPhfLuo:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=NBi4hcdSSik:AMwKFPhfLuo:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=NBi4hcdSSik:AMwKFPhfLuo:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/NBi4hcdSSik" height="1" width="1"/&gt;</content><link rel="related" href="http://www.jeccr.com/content/31/1/50/abstract" title="Journal of Experimental &amp; Clinical Cancer Research |- Chemotherapy and skin reactions" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/6275953233856328179/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/journal-of-experimental-clinical-cancer.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6275953233856328179" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6275953233856328179" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/NBi4hcdSSik/journal-of-experimental-clinical-cancer.html" title="Journal of Experimental &amp; Clinical Cancer Research |- Chemotherapy and skin reactions" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/journal-of-experimental-clinical-cancer.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-6439164846886538629</id><published>2012-05-29T04:40:00.000-04:00</published><updated>2012-05-29T04:47:01.939-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="CPT-P" /><category scheme="http://www.blogger.com/atom/ns#" term="Cisplatin" /><category scheme="http://www.blogger.com/atom/ns#" term="clear cell" /><category scheme="http://www.blogger.com/atom/ns#" term="irinotecan" /><category scheme="http://www.blogger.com/atom/ns#" term="clear cell ovarian" /><title type="text">paywalled: Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line</title><content type="html">Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line chemotherapy

Article first published online: 28 MAY...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=3m2Cq5Cwn1w:UvBHs_w8STU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=3m2Cq5Cwn1w:UvBHs_w8STU:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=3m2Cq5Cwn1w:UvBHs_w8STU:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=3m2Cq5Cwn1w:UvBHs_w8STU:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/3m2Cq5Cwn1w" height="1" width="1"/&gt;</content><link rel="related" href="http://onlinelibrary.wiley.com/doi/10.1111/j.1447-0756.2012.01884.x/abstract;jsessionid=B7193179A83C14FDF9D4E08DFA595FCA.d02t04" title="paywalled: Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/6439164846886538629/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/paywalled-long-term-survival-in.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6439164846886538629" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6439164846886538629" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/3m2Cq5Cwn1w/paywalled-long-term-survival-in.html" title="paywalled: Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/paywalled-long-term-survival-in.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-8496548832552351245</id><published>2012-05-29T04:31:00.000-04:00</published><updated>2012-05-29T04:31:30.877-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="hormone replacement therapy" /><category scheme="http://www.blogger.com/atom/ns#" term="HRT" /><category scheme="http://www.blogger.com/atom/ns#" term="WHI" /><category scheme="http://www.blogger.com/atom/ns#" term="ERT" /><category scheme="http://www.blogger.com/atom/ns#" term="Women's Health Initiative" /><title type="text">HRT Risk Holds Steady Based on Updated Review - in OB/Gyn, HRT from MedPage Today</title><content type="html">HRT Risk Holds Steady Based on Updated Review - in OB/Gyn, HRT from MedPage Today


 Action Points
A  systematic review of papers published since 2002 (post-WHI study) found that the risks of ...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=0y92H1yznQo:SGMIPvf1ST4:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=0y92H1yznQo:SGMIPvf1ST4:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=0y92H1yznQo:SGMIPvf1ST4:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=0y92H1yznQo:SGMIPvf1ST4:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/0y92H1yznQo" height="1" width="1"/&gt;</content><link rel="related" href="http://www.medpagetoday.com/OBGYN/HRT/32952" title="HRT Risk Holds Steady Based on Updated Review - in OB/Gyn, HRT from MedPage Today" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/8496548832552351245/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/hrt-risk-holds-steady-based-on-updated.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/8496548832552351245" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/8496548832552351245" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/0y92H1yznQo/hrt-risk-holds-steady-based-on-updated.html" title="HRT Risk Holds Steady Based on Updated Review - in OB/Gyn, HRT from MedPage Today" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/hrt-risk-holds-steady-based-on-updated.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-6362150984500407532</id><published>2012-05-29T03:35:00.000-04:00</published><updated>2012-05-29T03:35:22.714-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="bone pain" /><category scheme="http://www.blogger.com/atom/ns#" term="bone loss" /><category scheme="http://www.blogger.com/atom/ns#" term="osteoporosis" /><category scheme="http://www.blogger.com/atom/ns#" term="side effects" /><category scheme="http://www.blogger.com/atom/ns#" term="adverse effects" /><title type="text">Earlier detection of bone loss may be in future</title><content type="html">Earlier detection of bone loss may be in future

“Right now, pain is usually the first indication that cancer is  affecting bones. If we could detect it earlier by an analysis of urine  or blood in...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=_at30XXxxdc:0x-6B7I4v9M:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=_at30XXxxdc:0x-6B7I4v9M:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=_at30XXxxdc:0x-6B7I4v9M:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=_at30XXxxdc:0x-6B7I4v9M:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/_at30XXxxdc" height="1" width="1"/&gt;</content><link rel="related" href="http://www.alphagalileo.org/ViewItem.aspx?ItemId=120598&amp;CultureCode=en" title="Earlier detection of bone loss may be in future" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/6362150984500407532/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/earlier-detection-of-bone-loss-may-be.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6362150984500407532" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6362150984500407532" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/_at30XXxxdc/earlier-detection-of-bone-loss-may-be.html" title="Earlier detection of bone loss may be in future" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/earlier-detection-of-bone-loss-may-be.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-5704932737390102878</id><published>2012-05-28T10:08:00.000-04:00</published><updated>2012-05-28T10:08:51.784-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Canada" /><category scheme="http://www.blogger.com/atom/ns#" term="bill C-38" /><category scheme="http://www.blogger.com/atom/ns#" term="canadian politics" /><category scheme="http://www.blogger.com/atom/ns#" term="healthcare canada" /><title type="text">Bill C-38 protest has 13,000 websites going dark across Canada this June | Canada Politics - media (c-38 bill/Canadian healthcare)</title><content type="html">Bill C-38 protest has 13,000 websites going dark across Canada this June | Canada Politics

"When it comes to politics, Canadians are generally an  apathetic bunch. Often, a controversy will brew and...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=2AdWwlD1q6Y:ohhr2cknFdQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=2AdWwlD1q6Y:ohhr2cknFdQ:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=2AdWwlD1q6Y:ohhr2cknFdQ:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=2AdWwlD1q6Y:ohhr2cknFdQ:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/2AdWwlD1q6Y" height="1" width="1"/&gt;</content><link rel="related" href="http://ca.news.yahoo.com/blogs/canada-politics/bill-c-38-protest-13-000-websites-going-212703143.html" title="Bill C-38 protest has 13,000 websites going dark across Canada this June | Canada Politics - media (c-38 bill/Canadian healthcare)" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/5704932737390102878/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/bill-c-38-protest-has-13000-websites.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5704932737390102878" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5704932737390102878" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/2AdWwlD1q6Y/bill-c-38-protest-has-13000-websites.html" title="Bill C-38 protest has 13,000 websites going dark across Canada this June | Canada Politics - media (c-38 bill/Canadian healthcare)" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/bill-c-38-protest-has-13000-websites.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-6054836200761475938</id><published>2012-05-28T08:09:00.001-04:00</published><updated>2012-05-28T08:09:42.182-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="inflammation" /><category scheme="http://www.blogger.com/atom/ns#" term="IL-13Rα2" /><category scheme="http://www.blogger.com/atom/ns#" term="interleukin research" /><title type="text">IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer.</title><content type="html">IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer

"Taken together, IL-13Rα2 is involved in cancer metastasis through ...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=dzz1YdR4-Q8:w30q-aF_pmw:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=dzz1YdR4-Q8:w30q-aF_pmw:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=dzz1YdR4-Q8:w30q-aF_pmw:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=dzz1YdR4-Q8:w30q-aF_pmw:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/dzz1YdR4-Q8" height="1" width="1"/&gt;</content><link rel="related" href="http://ukpmc.ac.uk/abstract/MED/21858811?source=rss" title="IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer." /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/6054836200761475938/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/il-13-regulates-cancer-invasion-and.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6054836200761475938" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6054836200761475938" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/dzz1YdR4-Q8/il-13-regulates-cancer-invasion-and.html" title="IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancer." /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/il-13-regulates-cancer-invasion-and.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-7812717664257587127</id><published>2012-05-28T08:06:00.002-04:00</published><updated>2012-05-28T08:06:50.533-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="data" /><category scheme="http://www.blogger.com/atom/ns#" term="access" /><category scheme="http://www.blogger.com/atom/ns#" term="communications" /><title type="text">Health News - Enhanced data access to benefit cancer researchers and patients</title><content type="html">Health News - Enhanced data access to benefit cancer researchers and patientshttp://ovariancancerandus.blogspot.com/feeds/posts/default&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=Nh3n3kZ4zmE:ao13-QQzc_E:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=Nh3n3kZ4zmE:ao13-QQzc_E:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=Nh3n3kZ4zmE:ao13-QQzc_E:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=Nh3n3kZ4zmE:ao13-QQzc_E:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/Nh3n3kZ4zmE" height="1" width="1"/&gt;</content><link rel="related" href="http://www.healthcanal.com/cancers/29645-Enhanced-data-access-benefit-cancer-researchers-and-patients.html?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+healthnewshc%2FOxfp+%28Health+News+from+HealthCanal.com%29&amp;utm_content=Google+Reader" title="Health News - Enhanced data access to benefit cancer researchers and patients" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/7812717664257587127/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/health-news-enhanced-data-access-to.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/7812717664257587127" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/7812717664257587127" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/Nh3n3kZ4zmE/health-news-enhanced-data-access-to.html" title="Health News - Enhanced data access to benefit cancer researchers and patients" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/health-news-enhanced-data-access-to.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-6810365699434624833</id><published>2012-05-28T07:58:00.000-04:00</published><updated>2012-05-28T07:58:12.172-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="brain metastases" /><category scheme="http://www.blogger.com/atom/ns#" term="whole brain radiotherapy" /><category scheme="http://www.blogger.com/atom/ns#" term="WBRT" /><category scheme="http://www.blogger.com/atom/ns#" term="brain cancer" /><title type="text">Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment</title><content type="html">&amp;nbsp;Neurocognitive function impairment after wholebrain radiotherapy for brain metastases: actual assessment


&amp;nbsp;Conclusion
......The results of this review will enable physicians to...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=qmARMaPUw78:9CPmPAQMZlI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=qmARMaPUw78:9CPmPAQMZlI:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=qmARMaPUw78:9CPmPAQMZlI:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=qmARMaPUw78:9CPmPAQMZlI:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/qmARMaPUw78" height="1" width="1"/&gt;</content><link rel="related" href="http://www.ro-journal.com/content/pdf/1748-717X-7-77.pdf" title="Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/6810365699434624833/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/neurocognitive-function-impairment.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6810365699434624833" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6810365699434624833" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/qmARMaPUw78/neurocognitive-function-impairment.html" title="Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/neurocognitive-function-impairment.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-1328453728348177745</id><published>2012-05-28T07:15:00.000-04:00</published><updated>2012-05-28T07:15:10.169-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Avastin" /><category scheme="http://www.blogger.com/atom/ns#" term="Bevacizumab" /><category scheme="http://www.blogger.com/atom/ns#" term="perforations" /><category scheme="http://www.blogger.com/atom/ns#" term="mortality" /><category scheme="http://www.blogger.com/atom/ns#" term="gastrointestinal perforation" /><title type="text">paywalled: Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients</title><content type="html">Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients: 
Abstract
Aim
To present the gastrointestinal (GI) complications associated with...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=WxD2qPbZY4Y:Rh95VEgRUNM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=WxD2qPbZY4Y:Rh95VEgRUNM:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=WxD2qPbZY4Y:Rh95VEgRUNM:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=WxD2qPbZY4Y:Rh95VEgRUNM:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/WxD2qPbZY4Y" height="1" width="1"/&gt;</content><link rel="related" href="http://www.springerlink.com/content/10321r873rt1m206/" title="paywalled: Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/1328453728348177745/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/paywalled-bevacizumab-induced.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/1328453728348177745" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/1328453728348177745" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/WxD2qPbZY4Y/paywalled-bevacizumab-induced.html" title="paywalled: Bevacizumab-induced perforation of the gastrointestinal tract: clinical and radiographic findings in 11 patients" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/paywalled-bevacizumab-induced.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-3429108105290321378</id><published>2012-05-28T06:47:00.001-04:00</published><updated>2012-05-28T06:47:26.494-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="immunotherapy" /><category scheme="http://www.blogger.com/atom/ns#" term="chemotherapy" /><category scheme="http://www.blogger.com/atom/ns#" term="translational research" /><category scheme="http://www.blogger.com/atom/ns#" term="immune response" /><category scheme="http://www.blogger.com/atom/ns#" term="complete responses" /><category scheme="http://www.blogger.com/atom/ns#" term="regulatory T-cells" /><category scheme="http://www.blogger.com/atom/ns#" term="oscillation" /><category scheme="http://www.blogger.com/atom/ns#" term="common pathways" /><category scheme="http://www.blogger.com/atom/ns#" term="immune modulation" /><title type="text">Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation</title><content type="html">Complete clinical responses to cancer therapy caused by multiple diver


 Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=06uEDn_SI9U:jOgtbzgPDWI:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=06uEDn_SI9U:jOgtbzgPDWI:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=06uEDn_SI9U:jOgtbzgPDWI:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=06uEDn_SI9U:jOgtbzgPDWI:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/06uEDn_SI9U" height="1" width="1"/&gt;</content><link rel="related" href="http://www.dovepress.com/complete-clinical-responses-to-cancer-therapy-caused-by-multiple-diver-peer-reviewed-article-CMAR" title="Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/3429108105290321378/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/complete-clinical-responses-to-cancer.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/3429108105290321378" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/3429108105290321378" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/06uEDn_SI9U/complete-clinical-responses-to-cancer.html" title="Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/complete-clinical-responses-to-cancer.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-2624646038249876421</id><published>2012-05-28T06:28:00.000-04:00</published><updated>2012-05-28T06:28:00.941-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="single persons" /><category scheme="http://www.blogger.com/atom/ns#" term="alone" /><title type="text">Single people with cancer often face the toughest battle alone | Health | Macon.com</title><content type="html">Single people with cancer often face the toughest battle alone | Health | Macon.comhttp://ovariancancerandus.blogspot.com/feeds/posts/default&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=uGpyGCVIDwY:RE5OmXJ4kCY:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=uGpyGCVIDwY:RE5OmXJ4kCY:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=uGpyGCVIDwY:RE5OmXJ4kCY:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=uGpyGCVIDwY:RE5OmXJ4kCY:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/uGpyGCVIDwY" height="1" width="1"/&gt;</content><link rel="related" href="http://www.macon.com/2012/05/28/2040354/single-people-with-cancer-often.html#storylink=rss" title="Single people with cancer often face the toughest battle alone | Health | Macon.com" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/2624646038249876421/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/single-people-with-cancer-often-face.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/2624646038249876421" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/2624646038249876421" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/uGpyGCVIDwY/single-people-with-cancer-often-face.html" title="Single people with cancer often face the toughest battle alone | Health | Macon.com" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/single-people-with-cancer-often-face.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-5253401465544450668</id><published>2012-05-27T12:37:00.003-04:00</published><updated>2012-05-27T12:37:57.366-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="CA-125" /><category scheme="http://www.blogger.com/atom/ns#" term="HE4" /><category scheme="http://www.blogger.com/atom/ns#" term="CA125" /><category scheme="http://www.blogger.com/atom/ns#" term="2012 ASCO abstract" /><title type="text">Does HE4 have a role in the recurrence of ovarian cancer? | 2012 ASCO Annual Meeting Abstracts (+ links to related ovarian abstracts)</title><content type="html">Does HE4 have a role in the recurrence of ovarian cancer? | 2012 ASCO Annual Meeting Abstracts

Abstract:
Background:  Human epididymis protein 4 (HE4) has been recently  described as a new marker...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=FS-lJ-bvPcE:J6VSNEaGF6w:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=FS-lJ-bvPcE:J6VSNEaGF6w:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=FS-lJ-bvPcE:J6VSNEaGF6w:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=FS-lJ-bvPcE:J6VSNEaGF6w:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/FS-lJ-bvPcE" height="1" width="1"/&gt;</content><link rel="related" href="http://abstract.asco.org/AbstView_114_98512.html" title="Does HE4 have a role in the recurrence of ovarian cancer? | 2012 ASCO Annual Meeting Abstracts (+ links to related ovarian abstracts)" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/5253401465544450668/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/does-he4-have-role-in-recurrence-of.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5253401465544450668" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5253401465544450668" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/FS-lJ-bvPcE/does-he4-have-role-in-recurrence-of.html" title="Does HE4 have a role in the recurrence of ovarian cancer? | 2012 ASCO Annual Meeting Abstracts (+ links to related ovarian abstracts)" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/does-he4-have-role-in-recurrence-of.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-8524093351328167457</id><published>2012-05-27T07:08:00.000-04:00</published><updated>2012-05-27T07:08:32.748-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="recurrence" /><category scheme="http://www.blogger.com/atom/ns#" term="bmi" /><category scheme="http://www.blogger.com/atom/ns#" term="surgery" /><category scheme="http://www.blogger.com/atom/ns#" term="progression free survival" /><category scheme="http://www.blogger.com/atom/ns#" term="obesity" /><category scheme="http://www.blogger.com/atom/ns#" term="weight" /><title type="text">Time to Ovarian Cancer Return Not Tied to BMI - in Meeting Coverage, ASCO from MedPage Today</title><content type="html">Medical News: Time to Ovarian Cancer Return Not Tied to BMI - in Meeting Coverage, ASCO from MedPage Today


 Action Points
Note  that this study was published as an abstract and will be presented at...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=SHBaVM7rxck:-bve1VF37MU:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=SHBaVM7rxck:-bve1VF37MU:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=SHBaVM7rxck:-bve1VF37MU:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=SHBaVM7rxck:-bve1VF37MU:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/SHBaVM7rxck" height="1" width="1"/&gt;</content><link rel="related" href="http://www.medpagetoday.com/MeetingCoverage/ASCO/32949" title="Time to Ovarian Cancer Return Not Tied to BMI - in Meeting Coverage, ASCO from MedPage Today" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/8524093351328167457/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/time-to-ovarian-cancer-return-not-tied.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/8524093351328167457" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/8524093351328167457" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/SHBaVM7rxck/time-to-ovarian-cancer-return-not-tied.html" title="Time to Ovarian Cancer Return Not Tied to BMI - in Meeting Coverage, ASCO from MedPage Today" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/time-to-ovarian-cancer-return-not-tied.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-2487896639974864879</id><published>2012-05-26T11:26:00.000-04:00</published><updated>2012-05-26T11:26:19.854-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="mRNA" /><category scheme="http://www.blogger.com/atom/ns#" term="proteins" /><category scheme="http://www.blogger.com/atom/ns#" term="PITX2" /><category scheme="http://www.blogger.com/atom/ns#" term="high grade ovarian" /><category scheme="http://www.blogger.com/atom/ns#" term="clear cell ovarian" /><title type="text">PLoS ONE: Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer Progression (clear cell ovarian/high grade)</title><content type="html">PLoS ONE: Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer Progression

"....According to FIGO grading classification, high-grade ovarian tumor cells are usually...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=cQJ2ouGQkAE:_5_wtQ-GrBY:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=cQJ2ouGQkAE:_5_wtQ-GrBY:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=cQJ2ouGQkAE:_5_wtQ-GrBY:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=cQJ2ouGQkAE:_5_wtQ-GrBY:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/cQJ2ouGQkAE" height="1" width="1"/&gt;</content><link rel="related" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0037076#s4" title="PLoS ONE: Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer Progression (clear cell ovarian/high grade)" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/2487896639974864879/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/plos-one-increased-expression-of-pitx2.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/2487896639974864879" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/2487896639974864879" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/cQJ2ouGQkAE/plos-one-increased-expression-of-pitx2.html" title="PLoS ONE: Increased Expression of PITX2 Transcription Factor Contributes to Ovarian Cancer Progression (clear cell ovarian/high grade)" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/plos-one-increased-expression-of-pitx2.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-2853725763907155860</id><published>2012-05-26T11:17:00.002-04:00</published><updated>2012-05-26T11:17:24.684-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Olaparib" /><title type="text">see blogger's note: Medical News: More Good Data for PARP Blocker (Olaparib)  in Ovarian Ca - in Meeting Coverage, ASCO from MedPage Today</title><content type="html">Blogger's Note: see blog postings 'olaparib' (searchable) of March 27th and March 8th and others; also use NEJM search for more information on ovarian cancer/Olaparib 

Medical News: More Good Data...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=dseSfxeMRfc:Q3PKQ0sGcQs:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=dseSfxeMRfc:Q3PKQ0sGcQs:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=dseSfxeMRfc:Q3PKQ0sGcQs:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=dseSfxeMRfc:Q3PKQ0sGcQs:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/dseSfxeMRfc" height="1" width="1"/&gt;</content><link rel="related" href="http://www.medpagetoday.com/MeetingCoverage/ASCO/32927" title="see blogger's note: Medical News: More Good Data for PARP Blocker (Olaparib)  in Ovarian Ca - in Meeting Coverage, ASCO from MedPage Today" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/2853725763907155860/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/see-bloggers-note-medical-news-more.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/2853725763907155860" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/2853725763907155860" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/dseSfxeMRfc/see-bloggers-note-medical-news-more.html" title="see blogger's note: Medical News: More Good Data for PARP Blocker (Olaparib)  in Ovarian Ca - in Meeting Coverage, ASCO from MedPage Today" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/see-bloggers-note-medical-news-more.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-5866135654391121407</id><published>2012-05-26T05:33:00.000-04:00</published><updated>2012-05-26T05:33:47.644-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="vaccine" /><category scheme="http://www.blogger.com/atom/ns#" term="Cyclophosphamide" /><category scheme="http://www.blogger.com/atom/ns#" term="clinical trials" /><title type="text">not yet recruiting: Cyclophosphamide and Vaccine Therapy in Treating Patients With Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Full Text View - ClinicalTrials.gov</title><content type="html">Cyclophosphamide and Vaccine Therapy in Treating Patients With Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Full Text View - ClinicalTrials.gov

This study is not yet...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=75nxfMxkvPo:mTT21ZSZ7OE:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=75nxfMxkvPo:mTT21ZSZ7OE:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=75nxfMxkvPo:mTT21ZSZ7OE:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=75nxfMxkvPo:mTT21ZSZ7OE:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/75nxfMxkvPo" height="1" width="1"/&gt;</content><link rel="related" href="http://clinicaltrials.gov/ct2/show/NCT01606241?term=ovarian+cancer&amp;recr=Open&amp;lup_s=04%2F26%2F2012&amp;lup_d=30" title="not yet recruiting: Cyclophosphamide and Vaccine Therapy in Treating Patients With Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Full Text View - ClinicalTrials.gov" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/5866135654391121407/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/not-yet-recruiting-cyclophosphamide-and.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5866135654391121407" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/5866135654391121407" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/75nxfMxkvPo/not-yet-recruiting-cyclophosphamide-and.html" title="not yet recruiting: Cyclophosphamide and Vaccine Therapy in Treating Patients With Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Full Text View - ClinicalTrials.gov" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/not-yet-recruiting-cyclophosphamide-and.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-6436430779701762680</id><published>2012-05-26T05:27:00.001-04:00</published><updated>2012-05-26T05:27:41.660-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="end of life" /><category scheme="http://www.blogger.com/atom/ns#" term="communication" /><title type="text">Massachusetts Moves to Require End-of-Life Talks</title><content type="html">Mass. Moves to Require End-of-Life Talks:
WBUR radio and Kaiser Health News report that the Massachusetts Senate has quietly approved a measure requiring doctors and nurses to discuss end of life...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=ulCw2d9B6lw:aU3EUQ4JYPk:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=ulCw2d9B6lw:aU3EUQ4JYPk:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=ulCw2d9B6lw:aU3EUQ4JYPk:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=ulCw2d9B6lw:aU3EUQ4JYPk:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/ulCw2d9B6lw" height="1" width="1"/&gt;</content><link rel="related" href="http://www.forbes.com/sites/howardgleckman/2012/05/25/mass-moves-to-require-end-of-life-talks/" title="Massachusetts Moves to Require End-of-Life Talks" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/6436430779701762680/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/massachusetts-moves-to-require-end-of.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6436430779701762680" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6436430779701762680" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/ulCw2d9B6lw/massachusetts-moves-to-require-end-of.html" title="Massachusetts Moves to Require End-of-Life Talks" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/massachusetts-moves-to-require-end-of.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-4848898610587957822</id><published>2012-05-26T05:11:00.002-04:00</published><updated>2012-05-26T05:11:48.013-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Lynch Syndrome" /><title type="text">pdf: Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations</title><content type="html">pdf:&amp;nbsp; Family perspectives in lynch syndrome becoming afamily at risk, patterns of communication andinfluence on relations&amp;nbsp;http://ovariancancerandus.blogspot.com/feeds/posts/default&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=3VHmnfPZuFQ:OmyCmS4SGA8:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=3VHmnfPZuFQ:OmyCmS4SGA8:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=3VHmnfPZuFQ:OmyCmS4SGA8:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=3VHmnfPZuFQ:OmyCmS4SGA8:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/3VHmnfPZuFQ" height="1" width="1"/&gt;</content><link rel="related" href="http://www.hccpjournal.com/content/pdf/1897-4287-10-6.pdf" title="pdf: Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/4848898610587957822/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/pdf-family-perspectives-in-lynch.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/4848898610587957822" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/4848898610587957822" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/3VHmnfPZuFQ/pdf-family-perspectives-in-lynch.html" title="pdf: Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/pdf-family-perspectives-in-lynch.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-6826251172223978627</id><published>2012-05-26T05:09:00.000-04:00</published><updated>2012-05-26T05:09:21.545-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="Lynch Syndrome" /><title type="text">Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations</title><content type="html">Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations

 The complete article is available as a provisional PDF. The fully formatted PDF...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=L2AbTJbSvf8:wTdWeTCM_gg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=L2AbTJbSvf8:wTdWeTCM_gg:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=L2AbTJbSvf8:wTdWeTCM_gg:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=L2AbTJbSvf8:wTdWeTCM_gg:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/L2AbTJbSvf8" height="1" width="1"/&gt;</content><link rel="related" href="http://www.hccpjournal.com/content/10/1/6" title="Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/6826251172223978627/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/family-perspectives-in-lynch-syndrome.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6826251172223978627" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/6826251172223978627" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/L2AbTJbSvf8/family-perspectives-in-lynch-syndrome.html" title="Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/family-perspectives-in-lynch-syndrome.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-4025071873970923884</id><published>2012-05-26T04:58:00.001-04:00</published><updated>2012-05-26T04:58:21.540-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="brentuximab" /><category scheme="http://www.blogger.com/atom/ns#" term="CD30" /><title type="text">What's Hot at ASCO This Year? (Brentuximab/ovarian cancer/CD30)</title><content type="html">What's Hot at ASCO This Year?

".... Another study that builds on a previous breakthrough screened more than  1000 patients with nonlymphoma malignancies for high CD30 expression...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=a1X2vrhXC0Y:5FVEnWXVxQQ:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=a1X2vrhXC0Y:5FVEnWXVxQQ:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=a1X2vrhXC0Y:5FVEnWXVxQQ:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=a1X2vrhXC0Y:5FVEnWXVxQQ:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/a1X2vrhXC0Y" height="1" width="1"/&gt;</content><link rel="related" href="http://www.medscape.com/viewarticle/764556?src=rss" title="What's Hot at ASCO This Year? (Brentuximab/ovarian cancer/CD30)" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/4025071873970923884/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/whats-hot-at-asco-this-year.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/4025071873970923884" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/4025071873970923884" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/a1X2vrhXC0Y/whats-hot-at-asco-this-year.html" title="What's Hot at ASCO This Year? (Brentuximab/ovarian cancer/CD30)" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/whats-hot-at-asco-this-year.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-8391094762689882124</id><published>2012-05-26T04:52:00.002-04:00</published><updated>2012-05-26T04:54:02.726-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="kittens" /><title type="text">Physician Group Says No to Kittens in Medical Training</title><content type="html">Physician Group Says No to Kittens in Medical Training

&amp;nbsp;The group, the Physicians Committee for Responsible Medicine (PCRM),  asked a branch of the US Department of Agriculture (USDA) yesterday...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=4KeOcnr5Y74:QDVZzMpzvYM:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=4KeOcnr5Y74:QDVZzMpzvYM:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=4KeOcnr5Y74:QDVZzMpzvYM:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=4KeOcnr5Y74:QDVZzMpzvYM:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/4KeOcnr5Y74" height="1" width="1"/&gt;</content><link rel="related" href="http://www.medscape.com/viewarticle/764587?src=rss" title="Physician Group Says No to Kittens in Medical Training" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/8391094762689882124/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/physician-group-says-no-to-kittens-in.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/8391094762689882124" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/8391094762689882124" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/4KeOcnr5Y74/physician-group-says-no-to-kittens-in.html" title="Physician Group Says No to Kittens in Medical Training" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/physician-group-says-no-to-kittens-in.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-251498886438171766</id><published>2012-05-26T04:18:00.000-04:00</published><updated>2012-05-26T04:24:47.741-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="PLD" /><category scheme="http://www.blogger.com/atom/ns#" term="oral cancer" /><category scheme="http://www.blogger.com/atom/ns#" term="squamous cell" /><category scheme="http://www.blogger.com/atom/ns#" term="pegylated liposomal doxorubicin" /><category scheme="http://www.blogger.com/atom/ns#" term="maintenance chemotherapy" /><category scheme="http://www.blogger.com/atom/ns#" term="side effects" /><category scheme="http://www.blogger.com/atom/ns#" term="adverse effects" /><category scheme="http://www.blogger.com/atom/ns#" term="BRCA" /><title type="text">Squamous Cell Carcinoma of the Oral Cavity in Nonsmoking Women: A New and Unusual Complication of Chemotherapy for Recurrent Ovarian Cancer? PLD (pegylated liposomal doxorubicin)</title><content type="html">Squamous Cell Carcinoma of the Oral Cavity in Non smokingWomen: A New and Unusual Complication of Chemotherapy for Recurrent Ovarian Cancer?

Abstract
Purpose.
To describe occurrences of oral...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=LmGEvbfKb5s:HFJgx0SxjVs:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=LmGEvbfKb5s:HFJgx0SxjVs:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=LmGEvbfKb5s:HFJgx0SxjVs:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=LmGEvbfKb5s:HFJgx0SxjVs:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/LmGEvbfKb5s" height="1" width="1"/&gt;</content><link rel="related" href="http://theoncologist.alphamedpress.org/content/early/2012/05/23/theoncologist.2011-0216.full.pdf" title="Squamous Cell Carcinoma of the Oral Cavity in Nonsmoking Women: A New and Unusual Complication of Chemotherapy for Recurrent Ovarian Cancer? PLD (pegylated liposomal doxorubicin)" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/251498886438171766/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/squamous-cell-carcinoma-of-oral-cavity.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/251498886438171766" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/251498886438171766" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/LmGEvbfKb5s/squamous-cell-carcinoma-of-oral-cavity.html" title="Squamous Cell Carcinoma of the Oral Cavity in Nonsmoking Women: A New and Unusual Complication of Chemotherapy for Recurrent Ovarian Cancer? PLD (pegylated liposomal doxorubicin)" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/squamous-cell-carcinoma-of-oral-cavity.html</feedburner:origLink></entry><entry><id>tag:blogger.com,1999:blog-9029913.post-8325151250715893532</id><published>2012-05-26T04:07:00.000-04:00</published><updated>2012-05-26T04:07:23.423-04:00</updated><category scheme="http://www.blogger.com/atom/ns#" term="residual disease" /><category scheme="http://www.blogger.com/atom/ns#" term="postoperative" /><category scheme="http://www.blogger.com/atom/ns#" term="debulking" /><category scheme="http://www.blogger.com/atom/ns#" term="surgery" /><category scheme="http://www.blogger.com/atom/ns#" term="CT scans" /><title type="text">paywalled: Early Postoperative CT as a Prognostic Biomarker in Patients With Advanced Ovarian, Tubal, and Primary Peritoneal Cancer Deemed Optimally Debulked at Primary Cytoreductive Surgery</title><content type="html">Early Postoperative CT as a Prognostic Biomarker in Patients With Advanced Ovarian, Tubal, and Primary Peritoneal Cancer Deemed Optimally Debulked at Primary Cytoreductive Surgery

 CONCLUSION: Our...&lt;br/&gt;
&lt;br/&gt;
Ovarian Cancer? What You Need to Know&lt;div class="feedflare"&gt;
&lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=_E-IOEhd2Qs:GCYOYc6Pvwg:yIl2AUoC8zA"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=yIl2AUoC8zA" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=_E-IOEhd2Qs:GCYOYc6Pvwg:63t7Ie-LG7Y"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?d=63t7Ie-LG7Y" border="0"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?a=_E-IOEhd2Qs:GCYOYc6Pvwg:4cEx4HpKnUU"&gt;&lt;img src="http://feeds.feedburner.com/~ff/OvarianCancerAndUs?i=_E-IOEhd2Qs:GCYOYc6Pvwg:4cEx4HpKnUU" border="0"&gt;&lt;/img&gt;&lt;/a&gt;
&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/OvarianCancerAndUs/~4/_E-IOEhd2Qs" height="1" width="1"/&gt;</content><link rel="related" href="http://www.ajronline.org/content/198/6/1453.abstract" title="paywalled: Early Postoperative CT as a Prognostic Biomarker in Patients With Advanced Ovarian, Tubal, and Primary Peritoneal Cancer Deemed Optimally Debulked at Primary Cytoreductive Surgery" /><link rel="replies" type="application/atom+xml" href="http://ovariancancerandus.blogspot.com/feeds/8325151250715893532/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://ovariancancerandus.blogspot.com/2012/05/paywalled-early-postoperative-ct-as.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/8325151250715893532" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/9029913/posts/default/8325151250715893532" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/OvarianCancerAndUs/~3/_E-IOEhd2Qs/paywalled-early-postoperative-ct-as.html" title="paywalled: Early Postoperative CT as a Prognostic Biomarker in Patients With Advanced Ovarian, Tubal, and Primary Peritoneal Cancer Deemed Optimally Debulked at Primary Cytoreductive Surgery" /><author><name>Sandi Pniauskas</name><uri>https://profiles.google.com/104150638679323605960</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-pXxp-HXKY6M/AAAAAAAAAAI/AAAAAAAAAek/8dBEqVT6p0I/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://ovariancancerandus.blogspot.com/2012/05/paywalled-early-postoperative-ct-as.html</feedburner:origLink></entry></feed>

